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This work is aimed at understanding and unifying information on epidemiological 
modelling methods and how those methods relate to public policy addressing human 
health, specifically in the context of infectious disease prevention, pandemic planning, and 
health behaviour change.  This thesis employs multiple qualitative and quantitative 
methods, and presents as a manuscript of several individual, data-driven projects that are 
combined in a narrative arc. The first chapter introduces the scope and complexity of this 
interdisciplinary undertaking, describing several topical intersections of importance. The 
second chapter begins the presentation of original data, and describes in detail two 
exercises in computational epidemiological modelling pertinent to pandemic influenza 
planning and policy, and progresses in the next chapter to present additional original data 
on how the confidence of the public in modelling methodology may have an effect on their 
planned health behaviour change as recommended in public health policy.  The thesis 
narrative continues in the final data-driven chapter to describe how health policymakers 
use modelling methods and scientific evidence to inform and construct health policies for 
the prevention of infectious diseases, and concludes with a narrative chapter that evaluates 
the breadth of this data and recommends strategies for the optimal use of modelling 
methodologies when informing public health policy in applied public health scenarios.  
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Chapter 1 – Modelling in Context  
“The methods to aid decision makers are simply tools. They are tools for the willing 
clinician, they are tools for the worried patient. They are tools for the concerned 
policymaker and payer. They will not make a hazardous situation safe, nor will they make 
a lazy or incompetent clinician into a superior caregiver. If the methods do not eliminate 
controversy, they can clarify the reasons for difference of opinion.  In dealing with the 
realities and uncertainties of life and illness, they will enable the thoughtful clinician, the 
thoughtful patient, and the open minded policymaker to make more reasoned conclusions” 
– Dr. Harvey V. Feinberg, President, The Institutes of Medicine 
1.1 Purpose 
Public health policymaking seeks to address some of the most formidable social challenges 
facing contemporary human society.  Meaningful, high-impact action is required to 
confront the threat of infectious disease to human health. Thus, understanding the ways in 
which actionable health policy is created and implemented, and the types of methods used 
to accomplish this, are of critical importance. Rütten (2012) critically notes, “Unlike the 
broad debate on the production of scientific evidence for informing policy and improving 
the policy content in public health, the production of evidence on the public health policy 
process itself is not well developed yet“ (p.321). This body of research considers this 
process, and seeks to address three timely questions pertaining to the development of 
public health policies:  
1) How is knowledge about the clinical characteristics of infectious disease, and the social-
psychological characteristics of populations, best utilised in the process of modelling that 
underpins public health policies?  
2) How does the widespread use of contemporary modelling tools to inform public health 
recommendations influence the public’s projected health behaviour? 
3) What are the challenges and processes policy stakeholders face when using modelling 
methods?  
This body of work concludes with recommendations toward optimal use of scientific 
modelling in the public health policymaking process.  
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What follows in this introductory chapter is a brief description of the current evidence-
based public health policy landscape, an overview of the role of modelling methods for this 
kind of policymaking, the contextual justification of the 3 major research questions 
addressed in subsequent chapters, with summaries of the 3 original research studies 
contained within the main body of the thesis that seek to address these questions.  
Public health is, by its very nature, interdisciplinary and multi-method.  This research seeks 
to reflect this interdisciplinarity by employing multiple modelling, quantitative, and 
qualitative methods to explore questions at the intersections of epidemiology, public health 
policy, risk communication, human behaviour change, and the modelling-based 
methodological approaches that unite them.  While this chapter provides a brief overview 
of the evidence-based policy and modelling methods environment, in the spirit of the 
interdisciplinary nature of this work, each individual study in subsequent chapters 
addresses a different aspect of these intersections using diverse methods, and a more 
comprehensive, complete, and study-specific literature review and contextual background 
precedes each chapter.  
1.2 Evidence-based Policy for Public Health 
 
Public health policy is the primary means by which scientific evidence regarding health 
most directly and significantly influences individual lives.  Government vaccination 
programs, climate change mitigation initiatives, and emergency preparedness plans for 
epidemic or pandemic disease are but a few examples of how evidence from public health 
science manifests itself into policies and public programs.  Evidence-based policy for 
public health is rooted in the movement towards evidence-based medicine, where clinical 
decision making processes that emphasize explicit, data-justified management, treatment, 
and diagnosis have been the prevailing paradigm of practice and care for the past 20 years 
(Guyatt et al., 1992). This principle of using scientific evidence and methods to guide 
clinical treatment and health care operations is also now the prevailing model for the 
development of healthcare policy and public health practice.  
 
The evidence and metrics that may be used to influence or inform public health policy can 
include both the quantitative (epidemiological or experimental) and the qualitative 
(narratives from interviews or other documents); and the use of that scientific evidence 
occurs in a wide variety of settings that range from legal, government, and civic 
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organizations to clinical medical and social services provisions (Brownson, Chriqui, & 
Stamatakis, 2009).   
As with clinical medical decision-making, the understanding in health policy is that the use 
of extensive and robust data to assist in the development of health policy will, by virtue of 
evidence-base, create the “greatest and most equitable” population health gains 
(Katikireddi, Higgins, Bond, Bonell, & Macintyre, 2011).  However, public health 
policymaking and implementation are increasingly complex enterprises in the age of 
increased information and limited resources, and it is unlikely that there is a direct causal 
relationship between the use of evidence to inform policy and good health policies that 
always achieve optimal outcomes. 
The evidence base needed to formulate policies that address the needs of large, diverse 
populations can itself be highly complex and large in scale and scope. But mere access to 
information, or even the ability to generate for-purpose data in the course of policy 
development, does not necessarily assure that the policies stemming from the use of 
evidence are ideally designed or well-implemented: “These are often complex, 
multifaceted programmes with important ethical and practical dimensions, but the same 
principles apply as in clinical care. Success of interventions depends on local feasibility, 
acceptability, and fit with context—and hence on informed, shared decision making with 
and by local communities, using summaries and visualisations of population level metrics” 
(Greenhalgh, Howick, & Maskrey, 2014 p3725).  
There has been some discussion of how the various dimensions of evidence-based 
policymaking might be described, and how understanding those dimensions may play a 
role in generating solutions that would assist in optimising the policymaking process. 
Dobrow, Goel, & Upshur, (2004) identify what they deem as the “two fundamental 
components” of evidence-based policy: evidence and context. However, the authors note 
that it is the interaction between evidence and context, rather than the nature of the 
evidence or the context alone, which is the most crucial area of inquiry in the development 
of evidence-based health policy. They note that “Even when there is general agreement on 
what constitutes evidence, there is considerable observational work to suggest that the 
same evidence, utilised in different contexts, often leads to different decision outcomes” 
(p216).  
 
Several other basic models of the evidence-based policy approach have been identified in 
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the literature, yet none of them are particularly focused on the processes of evidence-based 
policymaking. These models, as identified and characterised through systematic review by 
Young, Ashby, Boaz, & Grayson (2002) include the: knowledge driven model, where 
research relevant to the policy topic actually leads and sets priorities for policy; the 
problem-solving model, where research follows policy and policy agendas are meant to 
shape the topics and agendas of research projects; and the interactive model, which is the 
model that is best fit for the concept of this body of research, in which research and policy 
agendas are informed by interaction with each other through “policy communities” (p216), 
wherein the interactions of policy stakeholders (including researchers), influences both 
policy and research agendas.  
Young and colleagues (2002) also describe the political/tactical approach, which suggests 
that the contribution of research to policymaking is overshadowed by the need for most 
policy decisions to be politically expedient and politically strategic, and the enlightenment 
model, where research is a separate entity from policy entirely and is only occasionally 
utilised to inform policy, but is almost never the deciding or underpinning factor in a 
policy. These models each contribute some understanding to the various roles policy and 
evidence might play in the evidence-based policy process. Yet none of them completely 
characterise the processes by which policy and research interact to form an evidence-based 
research agenda.  And while the interactive model suggests that policy and research do, in 
fact, inform and influence each other, it stops short at describing the specific domains of 
the evidence-based policy agenda. 
1.3 Modelling in Policy 
For that purpose, Brownson, Chriqui, & Stamatakis (2009) present the most cohesive, and 
widely accepted, characterisation of the process and creation of evidence-based policy. 
They describe 3 different domains of evidence-based policy: (1) process, the approaches to 
evidence-policymaking to enhance the likelihood of policy adoption; (2) content, specific 
policy elements that are likely to be effective; and (3) outcomes, the potential intended and 
unintended impact of policy.  Brownson and colleagues further suggest that there are 
specific steps that can be taken to further the cause of evidence-based policy, including 
communicating and presenting data more effectively, using existing analytic tools more 
effectively, conducting surveillance to identify trends in policies, and tracking policy 
outcomes with different types of evidence. The various policymaking bodies engaged in 
public health policymaking may be tasked with performing the evaluation and use of 
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different types of evidence from diverse sources across the aforementioned domains as 
identified by Brownson.   
 
However, the account of how evidence is used in the process of public health 
policymaking is incomplete. Policymakers across settings are known to face political 
pressure and priorities that may be at odds with the scientific process or conflict with 
scientific findings, and these challenges can adversely affect their ability to use evidence 
optimally in any of the domains as described by Brownson.  Early efforts to examine the 
role of scientific evidence as a regular component of public health policy identified a range 
of impediments to the evidence-based public health policy agenda that persist today 
(Black, 2001). For instance,  policymakers may feel time pressure: a need for immediate 
scientific answers to complex health risk questions for which the evidence is uncertain or 
where actual scientific risk is at odds with the public perception of possible health risk 
(Greenberg, 1992).  Policymakers may also experience pressure to implement policies 
based on political expedience to appease constituents and other invested policy 
stakeholders, rather than basing those policies on scientific evidence. Implementing, or 
refraining from implementing, the policy that the evidence suggests may be impeded by 
the lack of resources available to communities and governments, or by ethical and humane 
considerations (Black, 2001).   
 
Policymakers may have legitimate, ethical reasons for rejecting policy options supported 
by scientific evidence, but it is noteworthy that they may use evidence improperly or 
incompletely to justify what is an ethical or humane policy decision when the pressure 
exists to justify every decision with data (Black, 2001).  Further, scientific evidence may 
be rejected or overlooked by non-scientist policymakers in areas where understanding of 
conclusions often depends on what Black (2001) calls “tacit knowledge”. Tacit knowledge 
encompasses the idea that scientific literature is aimed at other scientists in fields relevant 
to the subject of the paper, and the language often assumes a certain amount of knowledge 
about, or familiarity with, the nomenclatures and subtleties of that area of scientific 
inquiry.  So rejection of critical evidence, which has the potential to inform policy in a 
meaningful way, can happen due to perceived irrelevance of the findings by non-expert 
policymakers.  This suggests that even when scientific evidence is readily available to 
policymakers that would like to utilise it, that utilisation is not necessarily optimal.   
 
Despite these known challenges, there has been a steep increase in the demand that public 
health relevant policies be increasingly evidence-based and data driven, with Head (2010) 
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noting that the evidence-based policy environment is becoming increasingly “supply and 
demand” driven, with the ‘needs’ of policymakers makers for “certain types of information 
about problems, programs and the effectiveness of options; and “supply” of an increased 
array of tools and techniques for analysis and evaluation of policy options that emerged 
over recent years. This call for a more interactive model of policy and evidence must be 
accompanied by a studied consideration of how evidence is being used in practice, and 
how to effectively use evidence in policymaking in the contexts in which it takes place. 
 
Central to any consideration of the current state of evidence-based health policy is an 
examination of the dominant methods and sources of evidence used by policymakers in 
their endeavours.  Modelling methods for complex systems, such as the ones that concern 
public health policymakers, involves the “use of formal models or simulations as explicit 
aids to increase our understanding of complex systems and improve the effectiveness of 
our actions within them” (Trochim, Cabrera, Milstein, Gallagher, & Leischow, 2006, 
p539).  Modelling typically plays a central role in assisting decisions during the 
development of public health policy in two ways: 1) by serving as a platform for 
manipulating existing evidence by simulating or suggesting potential outcomes given 
specific parameters, typified by techniques such as deterministic compartmental modelling 
and stochastic individual-based or spatial models, and 2) by being used to generate needed 
data on policy-relevant questions such as cost-effectiveness or quality of life, for instance 
by the use of cost-utility models and quality-adjusted life years (QALYs) (Marsh, Phillips, 
Fordham, Bertranou, & Hale, 2012) .  
These two uses, (rather than the various types), of modelling in particular are of central 
interest here. These modelling formalizations for the above two purposes differ from more 
traditional statistical modelling methods that are most familiar to those in the health and 
the social sciences. For instance, statistical analysis can be applied to longitudinal data in 
public health studies, but that longitudinal data is limited to representing that given 
phenomenon in one moment in time on a given timeline, presenting a more “static”, rather 
than dynamic, picture of phenomena. As the processes and populations that concern public 
health policymakers are by nature dynamic, (for instance, an epidemic of disease), a 
modelling tool that allows us to explore interactions between variables in real time is 
desirable in a policy setting (Gilbert, Nigel, Troitzsch, & Klaus, 2005).  
Due to this capacity for capturing complex and dynamic systems phenomena, modelling in 
evidence-based public health policymaking is usually performed to ensure better 
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characterisation of social or disease-spread phenomena (understanding or exploring) or for 
prediction, when trying to understand the impact of a policy decision on a given population 
in the future or for planning a response to something like a pandemic event (Gilbert, 2004). 
On a practical level, modelling methods are increasingly employed in public health 
policymaking not only due to their ability to capture complex systems dynamics, but 
because they can be used in situations and environments where other forms of evidence-
generation or exploration of outcomes is impossible due to resource or ethical limitations 
(Garnett, Cousens, Hallett, Steketee, & Walker, 2011).   
However, modelling for policy purposes can potentially become a complicated, costly, and 
time-consuming endeavour in itself.  Models are often developed incrementally using 
iterative processes, and can go through numerous repetitions of various design phases, 
translating the assumptions of the model into code, and attempting to validate the model 
with empirical data (Garnett et al., 2011). Various types of models can have a wide range 
of computational and data capacity requirements, and policymakers and stakeholders who 
are non-expert in modelling methods may be unaware of, or unequipped to address, the 
processes entailed in the use of these models. Conversely, expert researchers and modellers 
may be unprepared to construct models under the pressures and constraints of a 
policymaking environment (Desouza & Yuan, 2013). As subsequent iterations of the 
model are developed, various scenario possibilities and parameter values may need to be 
adjusted, explored to account for scientific, social, or economic uncertainty, various 
stakeholder perspectives, or emerging data (Bilcke, Beutels, Brisson, & Jit, 2011), and this 
can take a considerable amount of time that policymakers and researchers may not have.   
 
Although modelling plays a central role in the formulation of evidence-based public health 
policy, like all forms of scientific evidence in policymaking, evidence from models is 
subject to interpretation by both the modeller and the policymaker, and this can create 
further ambiguities or uncertainty in the final decision making process. Because of their 
dynamic, flexible nature and these layers of stakeholder interpretation, models may be used 
to justify a political agenda or decision, rather than being used analytically as is 
appropriate (Naess, Polack, & Chinsinga, 2011). One way to potentially offset some of 
these challenges is to encourage better communication and understanding between the 
model developer or researcher and the model user or policymaker, toward the end of 
developing a common nomenclature and shared situational orientation among both groups, 
so that the potential pitfalls of competing aims and multiple interpretations can be 
somewhat mitigated (te Brömmelstroet & Bertolini, 2008).   
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Despite these challenges, modelling for policymaking has particular strengths. This is 
especially the case for large-scale infectious disease projects, such as exploring the 
epidemiological dynamics of pandemic disease and the impact of behavioural 
interventions, or exploring the possible outcomes of immunisation policies. Dynamic, 
computational simulation models designed to explore disease transmission have 
significantly furthered the human understanding of biological transmission mechanisms, 
human response to risk communication, and the spatial features of infection during 
pandemic and epidemic events.  
 
Moreover, computational modelling can assist in the study of potential policy solutions and 
guide their design, and potential impact (Desouza & Yuan, 2013).  Desouza & Yuan 
(2013) also note how computational modelling allows policy stakeholders to anticipate the 
potential for unintended consequences of policy choices, and can assist in building 
consensus and communication amongst policymakers and researchers around a given 
policy problem. Because of the exceptional potential of modelling as a primary tool in 
policymaking, it is critical that we continue to foster its meaningful and optimal use, and to 
improve confidence in model-based conclusions.  In order to accomplish this, it is 
necessary to gain a more sophisticated understanding of how modelling functions within 
the public health policymaking infrastructure, and to assess how model assumptions, 
parameters, and interpretations influence and impact on policy decisions (Samsuzzoha, 
Singh, & Lucy, 2013).   
1.4 Research Questions and Study Descriptions 
As previously discussed in this section, there are several factors that come into 
consideration in order to determine if public health policies that are underpinned by 
modelling methodology will be effective. There is the question of the quality of the 
scientific modelling, and whether it has been done correctly and the output is being 
interpreted correctly, whether those outputs are being integrated into the decision-making 
process optimally. Additionally there is the matter of public confidence and how the use of 
modelling is perceived from outside of the policymaking process, and to what extent public 
confidence in modelling methods play in their projected behaviour change. In 
consideration of the above landscape, several critical research questions arise.  In this 
section, these questions are detailed, and the methods and approaches used in this work to 
address them are discussed.  
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Research Questions Details and Chapter 




Questions of how onward transmission and clinical severity are 
related are explored in Model 1 of Chapter 2, followed by an 
exploration of whether hand hygiene has an impact on 
epidemiological dynamics of note to pandemic planning efforts  
How Does the Use of 
Contemporary Modelling 
Tools to Produce Public 
Health Policy Influence the 
Public’s Projected Health 
Behaviour? 
Data is presented in Chapter 3 that explores what members of the 
public think scientists might mean when they talk about “models”, 
what methodologies constitute “good science” and how their 
perceptions of different forms of scientific evidence might influence 
how they would change their behaviour as recommended in policies 
surrounding pandemic disease and climate change. 
What is the Nature of the 
Relationship of Policy 
Stakeholders to these 
Modelling Methods and how 
are they Employed? 
A framework analysis is presented in Chapter 4 that explores how 
policymakers are using various forms of modelling and evidence to 
inform modelling in a real-time policymaking scenario. The 
challenges and processes surrounding the use of modelling in the 
policymaking environment are detailed and explored, with 
recommendations for new approaches. 
Table 1-1: Guide to Research Questions and Chapter Content 
1.5 Modelling Infectious Disease for Pandemic Planning: How does disease 
severity and non-pharmaceutical intervention affect epidemiological 
dynamics? 
Often, successful policy in public health requires some response or change in behaviour 
from the public.  Advanced public health policy practice thus requires an understanding of 
human psychology and health behaviour change, in order to predict and assess the impact 
that policies and risk communication that recommend behaviour change have on 
population health. Given the aforementioned ascendancy of modelling methods in the 
public health policy realm, the initial question that emerges at this juncture of policy and 
human behaviour pertains to the applied use of modelling methods to address a 
fundamental and pressing problem in public health policy: when we recommend a health 
behaviour in policy, such as handwashing during a pandemic, does that behaviour have an 
effect on epidemiological dynamics?  Whether or not the public adopts a behaviour that 
could limit transmission, and whether that behaviour is actually effective in preventing 
disease, could have a profound impact on pandemic policies in several areas, including 
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how we communicate about risk and how we plan for patient care during a pandemic 
event.  
Epidemic models are particularly well-suited to address epidemiological, economic, and 
behavioural questions that public health policymakers are typically confronted with during 
outbreaks of disease (Fenichel et al., 2011). Pandemics of influenza in particular can have 
extensive and grave consequences, and because of their potential to quickly overwhelm 
even a prepared public health system, and the extensive modelling literature surrounding 
these viral pathogens, it provides an ideal scenario for a case study for the modelling 
exercises in Chapter 2.  
 
In 1918, an influenza pandemic caused staggering mortality, killing an estimated 20 to 40 
million people (N. Cox, 2003). To put this in perspective, the 1918 “Spanish” flu pandemic 
killed more people in 24 weeks than the HIV/AIDS pandemic killed in 24 years.  Influenza 
pandemics have regularly occurred during the 20th and 21st centuries and the latest 
pandemics occurred in 1918–9, 1957–8, 1968–9 (N. J. Cox & Subbarao, 1999) and again 
in 2009-10. Since the 1918 influenza pandemic, global society has undergone significant 
social and ecologic changes that profoundly influence how a pandemic disease such as 
influenza is transmitted and controlled. These factors include exponentially increasing 
human population, and resulting close living proximity, rapid global transit by air and 
high-speed train, and larger populations of domesticated livestock that increase the 
likelihood of the types of human-animal interactions that could assist in the transmission of 
zoonotic organisms (Davey, 2007).  
Beyond the possibility of devastating outbreaks of influenza caused by known pathogenic 
subtypes, there are emerging strains of influenza, the clinical and epidemiological 
characteristics of which are yet incompletely characterised, which pose a consistent threat 
to the health of the global human population.  For instance, avian influenza strain, A 
(H5N1), caused a pandemic in domestic poultry and wild birds in 2003 affecting most of 
the world’s poultry population, as well as resulting in over 300 laboratory-confirmed 
human cases with a 60% case fatality ratio (Davey, 2007). While avian A (H5N1) 
influenza is not currently understood to be easily transmitted to humans or to cause 
widespread disease, whether or not an emerging zoonotic influenza pathogen such as this is 
likely to cause significant morbidity and mortality in the future is difficult to predict. Thus, 
understanding how to employ the best available technology in pandemic planning and 
mitigation efforts is of paramount importance.    
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More traditional scientific methods such as empirical or field studies that might be used to 
assess appropriate mitigation strategies to control influenza pandemics are “generally 
either infeasible (e.g. controlling movement of people within a city) or unethical (e.g. 
withholding vaccination of subpopulations to assess the effect on transmission)” (Carrasco 
et al., 2013, p.1 ). These more familiar methods may also have additional limitations, such 
as cost or other operational resource deficits. Therefore, computational epidemiological 
modelling is a highly suitable methodology that allows policymakers to explore the impact 
of various hypothetical pandemic preparedness or mitigation strategies.   
 
Due to their suitability for this purpose, there has been a prodigious increase in the number 
of influenza pandemic models in the last decade, particularly since the H1N1/A pandemic 
of 2009, and many of these models are increasingly sophisticated, employing new and 
emerging parameterization and validation techniques, economic analyses (such as QALY), 
and information on the behaviour of individuals (Carrasco et al., 2013).  Human health 
behaviour in response to infection risk is quite complex, and understanding this behaviour 
in the context of a pandemic of influenza is a fundamental task for researchers and 
policymakers alike. The primary question that the original modelling research presented in 
Chapter 2 addresses is one of how to most effectively explore the interactions of these risk-
response behaviours in conjunction with the complex infection transmission dynamics 
typically found in these epidemiological pandemic events. 
 
Contemporary approaches to influenza transmission mitigation often focus on changing 
individual behaviour, primarily through the recommendation of specific actions that are 
communicated to the public through a variety of means. Health promotion initiatives such 
as advertising campaigns, immunisation programmes that provide prophylactics like 
influenza vaccination, and formal policy recommendations from governmental and 
advisory health bodies have all primarily relied on public buy-in and compliance for their 
success.  
 
How the public understands their risk of infection and how they change their behaviour 
accordingly is of fundamental importance in mitigating the effects of a pandemic, and 
having data on this public behavioural response during times of pandemic influenza threat 
provides a valuable contribution to the deliberations of policymakers and other public 
health stakeholders when they design interventions and make recommendations (Jones & 




Behaviour change in the general population as a response to the threat of disease has been 
explored in the literature, particularly in the context of sexually transmitted diseases, but 
more contemporary work has sought to explore whether the lessons from the sexual health 
literature can be translated to other infectious disease threats that are emerging, such as 
pandemic influenza, and whether those threat-behaviour relationships are consistent across 
disease scenarios (Jones & Salathé, 2009b).   
How and when the data on public perception of risk during influenza pandemics is 
collected can have an impact on the quality of research conducted, as the data is rarely 
available to interested researchers in real time, and self-report from the public on their 
behaviours and their perceptions is time-sensitive (Jones & Salathé, 2009b). Because the 
communication of effective early intervention strategies is the most desirable course of 
action for public health policymakers, having information on the public perception of 
disease threat and their willingness to behaviour change is especially valuable (Jones & 
Salathé, 2009b).  
Many, if not most, influenza pandemic models rely solely on parameters from previous 
modelling studies, despite the availability of data external to other modelling-oriented 
studies, and those models are rarely validated using observed data about transmission 
dynamics as they might be mediated by human behaviour change as it is recommended in 
public policies (Carrasco et al., 2013). It is a characteristic of the modelling literature that it 
tends towards self-reference, and researchers in this area don’t often seek out information 
from non-modelling studies to inform their modelling exercises. Given the enormous 
impact that public health measures can have in mitigating the impacts of pandemics, 
Chapter 2 seeks to correct this feedback loop of self-reference in the modelling literature 
by informing models using data and information from a wide variety of clinical and 
psycho-social literatures.  
I present a modelling exercise that explores H1N1A influenza disease transmission by 
utilising data from the clinical and experimental, rather than the modelling, literature. The 
same approach is taken in the second modelling exercise in Chapter 2, by integrating the 
transmission information from the initial model in the chapter with psycho-social and 
experimental data related to personal risk mitigation behaviours (in this case, hand 
washing), that are actually prescribed by public health risk communication and public 
health policy entities during pandemic events.  
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In order for epidemic models to become optimally predictive, and of greatest use to 
policymakers attempting to alter the course of an influenza pandemic, ensuring the model 
is accurately capturing “real-life” epidemic dynamics as represented in the clinical, 
behaviour-change, and scientific literature is of central importance, and every effort should 
be made to adjust the parameters of the model from available scientific data (Daley, Gani, 
& Gani, 2001).  In Chapter 2, gaps in the literature surrounding the use of data on both 
transmission and transmission-disruptive behaviour change are therefore addressed. 
1.6 How Does the Use of Contemporary Modelling Tools to Produce Public 
Health Policy Influence the Public’s Projected Health Behaviour?  
Modelling methods are being increasingly employed to inform policies and programmes 
aimed at coping with, and planning for, pandemic infectious diseases (Riley, 2007). 
Modelling methods can be used to inform action in an increasingly wide range of 
scenarios, from the surveillance of disease risk in large-group gatherings (Khan et al., 
2012) to understanding the effects of global travel on disease dynamics (Balcan et al., 
2010).  
 
However, this increase in use isn’t necessarily domain specific. In addition to the their use 
in pandemic disease policymaking, modelling methods have also become the most 
frequently used method in impact assessments surrounding another pressing public health 
concern: climate change (Feenstra, Burton, Smith, & Tol, 1998).  Yet, despite their 
widespread use to address myriad issues of public health interest, these methods are often 
unfamiliar to individuals outside of public health research and policy environments where 
they are frequently employed.  Indeed, Pidgeon & Fischhoff (2011, p246) point out that the 
scientific modelling underpinning policy that recommends public behaviour change can be 
unfamiliar, confusing, and unclear to lay people.   
It is therefore critical to understand the relationship between modelling methodology and 
the potential for successful public engagement with health and climate change policy built 
on findings that rely on modelling. Specifically, the success of policies is mediated, in part, 
by responses to them by non-expert citizens. In order for policies to be successful, public 
support is required for two main reasons: politically because it allows politicians to 
propose them without jeopardizing future votes; and additionally in the case of policies 
that require individual level behaviour change as individuals and communities must be 
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both willing and able to make the recommended changes in their behaviour outlined in the 
policy.  
It is known that a range of individual, cultural, environmental and psychosocial factors 
influence behaviour change. Centrally important among these are the effects of health 
behaviour change and risk communication efforts, including the content, quality, and 
source of those messages and the manner in which they are delivered (Skinner, Campbell, 
Rimer, Curry, & Prochaska, 1999). It follows then that population and individual responses 
to policies that require the public to change their behaviour are likely to be mediated, at 
least in part, by the public’s perceptions of the quality of the evidence on which those 
communications are based. More specifically, willingness among the public to engage in 
recommended behaviour change is expected to be linked to their confidence in the methods 
(content) used to generate the science that underpins the recommendations.    
There are several different ways in which the public unfamiliarity or confusion around 
modelling methods may exert an undesirable effect on the public’s willingness to 
undertake recommended behaviour changes in the face of a potential health threat.  
The public may directly avoid uncertainty in health information, and may also manipulate 
uncertainty to their needs. For instance, health information (regardless of source) may be 
avoided primarily to limit feeling anxiety or fear; thus, if there is public sentiment that data 
from a particular methodology may be inaccurate or unreliable because that methodology 
is unfamiliar, this can contribute to the public justifying such avoidance, leading to the 
rejection of behaviour changes as per policy recommendations (Sairanen, Savolainen, & 
Anu Sairanen, 2010).  In fact, when people do not understand the basis for proposed 
policies, or when the best available science conflicts with “common sense” suggested by 
their existing cognition about what constitutes reliable evidence, the public are unlikely to 
adopt appropriate policies or generate political support for legislation to implement them 
(Sterman & Sweeney, 2007).   
In order to address this issue of public confidence in modelling methods and whether the 
public is willing to change their behaviour based on policies underpinned by modelling 
methods, Chapter 3  presents findings from a study employing quantitative (survey data) 
and qualitative (semi-structured brief interview) methods to ascertain: (1) the levels of 
confidence among the public in scientific predictions on the basis of the scientific 
methodologies used; (2) public opinion regarding the level of confidence required of 
scientific predictions before they are used to inform mitigation policies; (3) the forms of 
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evidence that would convince individuals that particular actions would be effective in 
mitigating harm from pandemic influenza and climate change; (4) public knowledge of 
current modelling methodologies. A fundamental understanding of the relationship 
between public knowledge and confidence in science is necessary not only in the case of 
whether the public will successfully adopt mitigation policies, but in the context of what is 
known to researchers and policymakers about public understanding of methods and how 
that understanding might affect a wide range of public health behaviours.   
Modelling methodology has given the scientific and policy community an unprecedented 
tool with which to predict events and behaviours, and to explore their resulting impact. 
However, the development of sophisticated interventions and policies from modelling tools 
to address intractable social issues such as climate change and pandemic disease is not 
sufficient to ensure positive outcomes. A detailed understanding of the relationship 
between the public perception of recommendations, public confidence in scientific 
methods, risk communication, and behaviour change is necessary if we wish to persuade 
the public to support sustainable action. The data in Chapter 3 seeks to address these 
issues.  
1.7 What is the Nature of the Relationship of Policy Stakeholders to these 
Modelling Methods and how are they Employed? 
 
In an evidence-based policy environment, it would be ideal for policymakers and policy 
stakeholders to have consistent access to a systemised process by which they evaluated 
evidence and considered the interaction of multiple variables in the complex social systems 
of their concern.  Desouza & Yuan (2013) argue that computational modelling in particular 
shows promise toward fulfilling that ideal by providing an environment capable of 
“capturing, synthesizing, visualizing, and interpreting massive amounts of information 
across a wide spectrum of forms, functions, and origins” (p16).  In fact, a vast array of 
computational models with various aims, levels of utility, and structures are indeed 
currently in use in the public health policymaking environment (V. J. Lee, Lye, & Wilder-
Smith, 2009). Yet, despite the growing ubiquity of modelling in the policymaking 
community, there are many challenges for the policymaker in utilising these modelling 
tools to optimal effect.  
 
One critical challenge surrounding the increased use of modelling in policy is the 
modelling-specific knowledge base of the policymakers that are using models to underpin 
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policy decisions.  Because modelling, and indeed systems thinking, are emerging ideas and 
methods in the realm of public health, policymakers and involved policy stakeholders who 
have received training in more traditional public health methodologies and approaches are 
unlikely to have extensive training in modelling methods, and modelling for policy is not 
currently widely featured in public health curricula or training (Luke & Stamatakis, 2012).   
Additional challenges for policymakers using modelling methodologies as decision making 
tools can arise from the collaborative process of working with researchers who are, in fact, 
expert modellers. For instance, the primary aim of modellers working on public health 
problems may be to gain mathematical information that may help answer questions 
pertaining to the mechanisms of disease transmission, while public health policymakers 
might require different metrics on pandemic severity: information that augments planning 
and capacity efforts (Arino et al., 2011). Policymakers and modellers may face competing 
political considerations, time constraints, and operational and budgetary deficits, all issues 
that can present roadblocks to the successful use of modelling methods to inform public 
policies (Arino et al., 2011).   
 
However, despite these challenges being fairly well-characterised in the literature, there is 
little evidence in the modelling literature to suggest that inroads have been made into 
understanding the process of modelling use in public health policy settings, with Desouza 
& Yuan (2013) calling for research on how modelling-generated evidence and outcomes 
might influence policy decisions and how policy makers perceive, and interact with, 
modelling methods in the policymaking setting.  It is in consideration of this critical gap in 
the literature that Chapter 4 of this thesis employs cutting-edge qualitative methodology to 
more fully examine how modelling methods are used to make critical public health 
decisions about immunisation programmes, and how policymakers and models function 
together in an applied situation.  
In Chapter 4, the deliberations of a major governmental advisory committee are presented 
and analysed using Framework Analysis, an emerging qualitative method that is becoming 
increasingly central to health services research. The discussions of the committee as they 
use multiple forms of evidence (including QALY and other modelling methods) in the 
service of determining whether or not to approve a new vaccine for inclusion into the 
adolescent and infant immunisation schedule are examined to more completely 
characterise the various interactions and tensions that arise as they make this high-impact 
decision.   
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However, this exercise was not solely undertaken in order to characterise the tensions of 
actual real-time model use to make public health policy decisions. It is imperative that all 
of this information is synthesized with a view toward developing recommendations that 
can help policymakers anticipate, and thus develop strategies to mitigate, some of the 
difficulties they might face when using modelling in the course of their duties. Some 
suggestions for these strategies are outlined in the 5th and final chapter of this thesis. 
Ultimately, advanced decision-making tools like models that can synthesise and analyse 
complex, multivariate datasets have almost unlimited potential to assist policy stakeholders 
in making the best evidence-informed decisions for human health. And although this 
process is often fraught with difficulty and partial understanding, the best avenue for a 
truly optimised modelling-policy interface is the continued interdisciplinary exploration of 




Chapter 2 - Modelling Infectious Disease for Pandemic Planning: 
How does disease severity and non-pharmaceutical 
intervention affect epidemiological dynamics? 
2.1 Influenza as a Pathogen, Risk from Pandemic Influenza, and Pandemic 
Planning 
Pandemic Influenza (PI) has caused substantial morbidity and mortality in the 20th century, 
and has also caused significant economic and social disruption. Prior to the H1N1 
pandemic of 2009, three major pandemics in the last century have been identified: the 1918 
Spanish flu, 1957 Asian flu, and the 1968 Hong Kong flu. Of these, the 1918 pandemic 
causing the greatest mortality; an estimated 30–50 million deaths worldwide (Horimoto & 
Kawaoka, 2005). Influenza viruses are classified into three types (influenza A, B and C), 
and of these, influenza A causes the most clinical interest and is the most clinically 
significant pathogen (Julkunen et al., 2000).  Influenza virus type A draws such interest 
due to its unique epidemiological, ecological, and evolutionary features: it is found in a 
wide variety of bird and mammal species capable of transmitting the virus to man, and the 
primary timescales of its specific disease dynamics are unique, with pandemic and viral 
evolution being happening at roughly the same time (Earn, Dushoff, & Levin, 2002).   
Influenza A is highly contagious and has been related to a large array of symptoms and 
complications in human hosts.  Influenza A infection maybe clinically characterized by 
fever, sore throat, headache, chills, myalgia and accompanying cough with associated 
general symptoms such as appetite loss, malaise and vomiting (N. J. Cox & Subbarao, 
1999).  While influenza A infection is often uncomplicated and self-limiting, some 
individuals may experience additional symptoms and develop severe, even life-threatening, 
complications. Children are particularly susceptible to complications from influenza A 
infection, and often suffer from otitis media, conjunctivitis, pharyngitis, sputum production 
and more severe upper respiratory tract symptoms such as croup during the acute phase of 
the infection (Julkunen et al., 2000). 
Primary viral pneumonia is the most severe complication from influenza A infection, and 
can develop quickly, from within 1–2 days from initial influenza infection. It may result in 
respiratory failure and death (N. J. Cox & Subbarao, 1999). Cox & Subbarao (2009) also 
note that patients who have chronic diseases or are immune compromised have a greater 
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risk of secondary bacterial and viral infection, and they also have a greater risk of other 
complications. Bacterial pneumonia, which usually starts several days after onset 
of influenza symptoms, is associated with Streptococcus pneumoniae, Staphylococcus 
aureus, Haemophilus influenzae or group A β-hemolytic streptococci (Barker, 1982).   
Influenza viruses are enveloped, negative-stranded RNA viruses, belonging to the family 
Orthomyxoviridae. Influenza H1N1A is of most recent pandemic interest, and the various 
viral “types” in influenza stem from the proteins encoded on the viral RNA. Influenza A 
virus RNA is composed of eight segmented genes, which encode for ten different proteins 
(Lamb & Krug, 1996). Viruses with HA protein types H1, H2 and H3 and NA types N1 
and N2 are pathogenic in humans. The main antigenic determinants of influenza A and B 
viruses are the haemagglutinin (H or HA) and neuraminidase (N or NA) transmembrane 
glycoproteins. Based on the antigenicity of these glycoproteins, influenza A viruses are 
further subdivided into sixteen H (H1.H16) and nine N (N1.N9) subtypes. While the virus 
is capable of replicating in a variety of hosts across species, in human hosts, influenza 
viruses replicate in the epithelial cell layers of the upper respiratory tract preferentially, but 
also can replicate in other cells, specifically macrophages and other leukocytes (Zeng et al., 
2013).   
Planning for pandemic influenza has raised questions regarding the origin of these novel 
influenza viruses, and has prompted much research and speculation, a current popular 
theory being the re-assortment of completely novel virus from both avian and human 
sources, but no precise origin has yet been identified (Potter, 2001).  There is increasing 
empirical evidence that suggests that these influenza viruses are assisted in their spread by 
the increasing ease, speed, and accessibility of global travel (Brownstein, Wolfe, & Mandl, 
2006). It is reasonable to conclude that as transmission is assisted by an increasingly 
connected global community, the efforts to mitigate risk and limit transmission will also 
have to be increasingly global.  
Influenza pandemics occur due to the introduction of novel subtypes of influenza A into an 
immunologically naïve population, and it is this immunological naivety that facilitates the 
rapid, and often devastating, spread of influenza across the globe (Potter, 2001).  
Pandemics of novel influenza A viruses are caused by either, 1) antigenic drift from 
previous strains of virus, in which case exposure to previous but similar mutants of the 
influenza virus may have conferred some partial, immunity to a host population as the 
virus has changed only slightly, or 2) antigenic shift from previous viral strains¸ in which 
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the virus is completely novel, and no host population has had any previous exposure with 
and thus has no immunity (Potter, 2001).  The 20th century alone has seen multiple 
pandemic influenza outbreaks, and this is likely to be an issue we will have to cope with 
continually throughout the next century. Planning efforts should focus on lessons learned 
in containing or mitigating previous pandemics, and creating policies that rely increasingly 
on evidence and best practices, such as ensuring the organizational structure is in place that 
would support successful epidemiological surveillance and can administer the appropriate 
infection control interventions (Godfrey & Schouten, 2014).   
 
Because the necessary biological information needed to cope with antigenic shift or drift in 
a novel virus may not be immediately unavailable, thus restricting the ample time needed 
to develop biologically-based prophylaxis like vaccine, it becomes necessary to attend to 
pandemic planning with a focus on non-pharmaceutical and behavioural interventions 
(NPI) to mitigate risk from pandemic influenza and to formulate public policy. In lieu of  
biological interventions for pandemic influenza, the alternative route to managing a 
pandemic emergency may employ NPI as a cost-effective way to mitigate the harms of a 
pandemic influenza outbreak by reducing host-to-host transmission (Wu, Riley, Fraser, & 
Leung, 2006). Pandemic planning using behavioural interventions, and a detailed 
understanding of human behaviour in the face of infectious disease risk, will become 
particularly useful in times of global economic austerity and in resource-scarce areas, or 
areas where the distribution of mass prophylaxis in the form of anti-viral medication or 
vaccine is not feasible.  
Pandemic planning for influenza is also highly transferrable.  Information and evidence 
gathered during pandemic planning research and practice could potentially be used to cope 
with a variety of other global threats and emergencies, including those from bioterrorist 
activities (Cox, 2003).  Yet, in spite of the overall usefulness of pandemic planning, and 
the high risk of morbidity and mortality posed by novel pandemic influenza pathogens, less 
than 30 countries worldwide have pandemic plans, and even fewer have policies or 
actionable protocols on how to deal with pandemic influenza when it occurs (Cox, 2003).  
In light of this, pandemic planning is not only a challenge to the global scientific 
community and policy stakeholders in public health, but an ethical imperative to gather and 
disseminate the best practices and knowledge globally and rapidly. Swift, coordinated 
global effort alone will allow public health scientists and officials to cope effectively with 
the serious threats to economic and social stability caused by future novel pandemic 
influenza.   
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Attempting to cope with influenza pandemics post-hoc instead of effective planning, pre-
emption, and communication is likely to be ineffective, as once a pandemic event begins, 
its rapid spread is likely to exceed the speed with which we can respond effectively (Cox, 
2003). Global capacity for pandemic preparedness has not yet reached its full potential, 
and remains a critical policy issue worthy of time, academic resources, governmental 
involvement, and economic support. It also requires that we use the best tools and best 
practices available, and this in turn requires interdisciplinary communication and 
collaboration, employing the functional, applied use of emerging tools for prediction and 
policy.   
2.2 Pandemic Planning, Models, and Prediction 
Davey, (2007) notes that planning, as opposed to post-hoc management, is essential for 
reducing or slowing transmission of a pandemic influenza event and for decreasing the 
number of cases, hospitalisations and deaths over time in order to effectively cope with the 
capacity limitations of healthcare delivery systems and limit overall morbidity and 
mortality. Pandemic plans and policies allow policy stakeholders and healthcare workers to 
maintain essential services and to mitigate the economic and social impact of an influenza 
pandemic. Pandemic influenza has the greatest impact on the poorest countries and 
communities, as a result of limited surveillance, healthcare resources, limited numbers of 
healthcare workers, and generally poor baseline health and nutritional status of 
underserved and impoverished populations (Uscher-Pines, Duggan, Garron, Karron, &  
Faden, 2007). 
Pandemic planning also requires a significant amount of political and social capital. 
Political support and commitment at the highest levels is often necessary to develop 
effective pandemic influenza preparedness plans. Inter- and intra- national and regional 
collaborations are not only critical for the creation and execution of pandemic preparedness 
plans, but are instrumental in lobbying for international support and resource allocation for 
these endeavours by pooling resources and increased power of advocacy by acting 
collectively (Stohr, 2003).   
Planning for pandemic influenza also necessitates effective and targeted information and 
communication from public entities such as health boards, health departments, research 
institutions, and other emergency response organizations. Communicating risk is critical 
both before, and during, a pandemic event. Pandemic plans should take a global 
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perspective, and should always include a strategy for appropriate risk communication that 
is flexible enough to target a variety of populations across the global geographic area, and 
will be effective through the duration of a pandemic influenza event (Reynolds & Quinn 
Crouse, 2008).  
Planning for pandemic influenza presents numerous challenges not only to the scientist, 
but for the large array of policy stakeholders and practitioners who would rely on scientific 
findings to create effective and feasible mitigation, prevention, and control plans. In order 
to plan, it is critical to be able to predict the epidemiological patterns of pandemic 
influenza, and anticipate the effectiveness of interventions ranging from vaccines, anti-
viral medications, and NPI’s such as behavioural change, and travel restrictions.  Using 
computational and mathematical modelling to this end is an effective way to inform 
polices and assist in making the necessary predictions to do so (Smith, 2006). 
Computational modelling specifically allows us to use powerful assistive technologies, 
such as sophisticated temporal and spatial visualizations, to inform planning policies in a 
way previously impossible. Utilizing these powerful tools in policy development should be 
a primary aim in the future.  
However, modelling is not without its own set of challenges in assisting with the prediction 
needed to formulate pandemic influenza planning policy. Models, by nature, are 
approximations, so they are necessarily operating under assumptions and also may be 
informed by incomplete or partial information (Smith, 2006). They also need to be tested 
against, (or include information from), experimental and observational studies.  Despite 
these challenges, models have been used successfully to direct and create effective 
mitigation policies in coping with other serious public health threats, such as the 2001 Foot 
and Mouth Disease outbreak in the United Kingdom that utilized mathematical modelling 
(Ferguson, Donnelly, & Anderson, 2001).  
In the context of pandemic planning, modelling is often informed by real data gathered in 
context. Smith (2006) argues that, “experimental epidemiological studies, such as the 
vaccination of school children or those that follow family units, provide core information 
for model design and parameterization, and (especially if there are multiple independent 
studies) for model testing.” Using existing information to underpin model formulation can 
assist in reducing the challenges created by mere assumption, thus allowing us to 
parameterise models in a wider array of scenarios, ranging from the impact of interventions 
to improved epidemiological surveillance. 
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Modelling for policy in pandemic planning is becoming the subject of increasing interest 
and review since the most recent pandemic influenza outbreak of H1N1a in 2009 (Coburn, 
Wagner, & Blower, 2009).  Both medical and behavioural interventions have been 
modelled thus far, using relatively simple variations of the Susceptible-Infectious-
Recovered (SIR) model of influenza transmission, and the SIR model is also used in the 
context of simulation frameworks and projects (Coburn et al., 2009). The modelling of 
pandemic influenza scenarios has generally been considered a successful endeavour that 
has contributed to human knowledge of the spatial-temporal dynamics of pandemic 
influenza transmission (Coburn et al., 2009).  
 Modelling pandemic influenza has greatly increased the human understanding of 
epidemiological dynamics in a manner pertinent to pandemic planning. One study 
compared the severity of seasonal influenza epidemics in the US, France, and Australia 
over the past three decades by estimating country-specific values of R0 (Chowell, Miller, 
& Viboud, 2008), demonstrating that epidemic severity in the three countries is similar 
every year, but year to year is highly variable. There have also been modelling studies that 
have been done to determine what effects various mitigation interventions may have had 
on disease dynamics in historical outbreaks. Bootsma & Ferguson (2007) estimated that 
public health measures such as social distancing reduced influenza mortality by 10 to 30% 
in US cities, suggesting that the timing of public health interventions can have a strong 
influence on pandemic influenza peaks.    
Models can also provide a platform for experimentation and data generation on broad 
scale, and for a greater diversity of interventions than is possible with other methods. 
Modelling methods for pandemic events have fewer ethical implications than experimental 
designs, and are optimal tools for examining complex scenarios with multiple interventions 
or behavioural variables that are beyond the scope of more traditional public health 
designs. These properties inherent to models therefore suggest that they could be a 
valuable tool for the creation and implementation of eﬀective interventions and policies for 
the control and prevention of pandemic events. 
However, most studies have focused on behaviour as it pertains to influenza transmission 
in a context largely limited to travel behaviours or mass isolation protocols, for instance, 
the effectiveness of quarantine (Coburn et al., 2009).  Since models are able to 
accommodate parameters that approximate multiple interventions or behaviours toward the 
aim of prediction and informing planning policy, it is desirable that we would use models 
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to also explore the full-range of behavioural and NPI’s. As our knowledge about the cost-
effectiveness and efficacy of different kinds of NPI’s and behavioural change in pandemic 
influenza becomes more complex and sophisticated, so can we build models that reflect 
this level of complexity and sophistication. 
Vespignani, (2009) states, “If fed with the right data, computational modelling approaches 
can provide the requested level of predictability in very complex settings” (p.425).  One of 
the current challenges to using modelling specifically for pandemic influenza planning is 
the relatively limited knowledge of human behaviour in the face of pandemic influenza 
threat, and the lack of longitudinal and comprehensive quantitative data about behaviour 
change or public perception of risk from pandemic influenza on a global scale (Vespignani, 
2009). However, Vespignani continues, “In recent years, however, tremendous progress 
has been made in data gathering, the development of new informatics tools, and increases 
in computational power” (p.425).  Harnessing that increase in computational power to 
explore the full range of data available about behavioural change and the efficacy of NPI’s, 
such as hand hygiene, could provide information that would allow scientists and 
stakeholders to finally optimize the global capacity for pandemic preparedness.  
Research conducted during and after the H1N1a 2009 pandemic provided major gains in 
these critical areas of behavioural inquiry that Vespignani (2009) identifies. It is this 
combination of increasing knowledge in the area of human behaviour change in pandemic 
scenarios, better understanding of the public perception of risk, and the knowledge of what 
behaviours people will adopt, and when and why they adopt them, that present a 
compelling opportunity to use modelling methodology to explore the impact of these 
previously oblique, but fundamental, variables in the pandemic influenza planning effort. 
The timely modelling of these behaviours, and integration of these findings in synthesis 
with virological, clinical, and epidemiological, information, is necessary to plan for 
pandemic influenza effectively, is thus the primary purpose of this inquiry. 
2.3 Modelling Behaviour Using H1N1a 2009: Needs and Challenges 
There is already varied use of computational models in the literature that explore the 
impact of human behaviour and NPI’s for the purpose of pandemic planning.  However, 
Smith’s review (2006) of the use of modelling for pandemic influenza planning reveals 
that a majority of the scientific inquiry that attempts to model behaviour pertaining to 
pandemic influenza focuses on slightly modifying relatively simple SIR models, and large-
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scale NPI’s such as quarantine and behaviours pertaining to global human travel patterns.  
For instance, some models have explored the effect of “one-off “community interventions 
(Milne, Kelso, Kelly, Huband, & McVernon, 2008), which focus primarily on social 
distancing measures such as school closure, increased case isolation, workplace non-
attendance, and community contact reduction. 
Other more computationally powerful, larger-scale global models have also been 
developed and used with success toward informing pandemic planning as it pertains to 
global social travel and more complex population mixing behaviour that would impact 
transmission and epidemiological dynamics of a novel influenza pathogen.  The Global 
Epidemic and Mobility (GLEaM) model employs a structured metapopulation approach to 
the stochastic modelling of disease dynamics, using high resolution census data worldwide 
and human mobility patterns at the global scale (Balcan et al., 2010). GLEaM has already 
been used to successfully simulate pandemic conditions using real data available from 
previous outbreaks of novel pathogens, notably H1N1 (Balcan et al., 2010). A modelling 
platform like GLEaM has enormous potential to inform policy by exploring more complex 
transmission-inhibiting behaviour and the effects of risk perception in a meaningful way, 
and has shown promise, through its accessible client-server interface, to assist a variety of 
policy and scientific stakeholders that are non-expert modellers in developing more 
sophisticated global policies that address the threat of pandemic influenza. 
The H1N1a 2009 influenza pandemic prompted research which gave additional 
information on human behaviour, risk perception, and NPI’s which was previously lacking, 
and have been identified as necessary areas of exploration for pandemic planning using 
modelling methods (Vespignani, 2009).  The rich and current data surrounding H1N1a 
2009 makes it an ideal pathogen to use for enriching pandemic planning globally, and for 
integrating the fundamental behavioural, intervention, virological, medical, and 
epidemiological information toward the aim of planning. It will thus be used throughout 
this chapter as our primary pathogen of inquiry.  However, the research surrounding 
H1N1a 2009 is far from complete or straightforward, and it requires attention to detail and 
an approach that focuses on synthesizing a wide array of information from various 
disciplines.  
While the importance of modelling behaviour has been introduced above, in this chapter, 
human behaviour and perception of risk in an H1N1a 2009 pandemic planning scenario is 
explored for the following reasons: 1) Behavioural interventions and NPI’s are typically 
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more cost-effective and accessible than biomedical interventions in the event of a 
pandemic, and how these behavioural interventions are perceived is likely to predict 
whether they will actually be adopted, 2) Information about risk perception, behavioural 
interventions, and NPI’s has increased since the 2009 pandemic and has remained 
relatively unexplored  with modelling methodology, and 3) There is a lack of information 
that successfully integrates and synthesises the clinical, behavioural, epidemiological, 
virological, and outcome-based evidence toward the aim of pandemic planning. 
This chapter also identifies challenges to this endeavour as well as fulfilling the needs 
identified above, and identifying these needs and challenges is the result of intensive 
interdisciplinary collaboration between international institutions.  In order to study the 
impact of behaviour change on pandemic influenza transmission in a meaningful way, it is 
necessary to understand several variables.  
First, it is important to understand how influenza virus is spread.  The question of onward 
transmission of influenza through either aerosolized routes or droplet/contact routes will be 
discussed in detail in this chapter. Secondly, it is important to understand how the different 
routes of transmission affect the severity of clinical illness, and that will follow the 
discussion about transmission in this chapter.  Third, it is important to understand the 
literature surrounding behaviour change during the course of an influenza pandemic, and 
the literature is reviewed regarding what is known about that behavioural change in an 
infectious disease threat scenario. Data in the literature regarding the use and effectiveness 
of NPI’s and behavioural changes, focusing on hand hygiene, will then be discussed.  
Finally, we will detail our efforts at successfully modelling this behaviour and the findings 
and implications that came from those efforts. 
We have met with some success in understanding how influenza may be transmitted, and 
what behavioural changes occur during a pandemic. However, it has been difficult to 
assess what the various routes of transmission have to do with the severity of disease in 
clinical cases. This would obviously have an effect on the epidemiological profile of any 
pathogen, and is critical information if we wish to use modelling methods to predict or plan 
for any number of epidemic or pandemic scenarios.  
In order to appropriately approximate severity in our model, it is important to understand 
how severity is defined and understood in the literature, if at all.  There seems to be no 
unifying protocol on how to classify severity of disease in the epidemiological, 
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intervention, or virological literature.  However, the clinical literature surrounding the 
diagnosis and patient care of H1N1 and other influenza infections has yielded a somewhat 
clearer picture. 
At the end of this chapter, the implications for pandemic influenza planning policy of our 
modelling efforts, and the challenges and gaps in the relevant literatures, will be 
summarized and discussed. We will also identify future directions for research and inquiry 
that pertains to planning policy.  
2.4 The Transmission of Influenza and the Role of Influenza Severity 
In order to effectively model complex risk-response behaviours, or to explore in a model 
the impact on the outcome of different forms of NPI’s such as hand-hygiene or mask 
wearing have on onward transmission, it is important to explore the literature surrounding 
influenza viruses and their transmission. It is also important to characterize the clinical 
symptoms of influenza infection that are likely to be epidemiologically relevant to onward 
transmission in order to identify NPI’s and behavioural change approximations in a model 
that are most likely to disrupt the transmission process.   
In this section, the transmission of influenza as a pathogen, human immunological 
response to influenza, and the development of clinical symptoms from infection are 
discussed. To this end, the virological, clinical, and medical literature will be used to 
present evidence from human experimental and natural setting studies, immunological 
response studies, animal experimental studies, and human NPI studies. Subsection 2.5 
provides characterization of what is generally known about how influenza is transmitted, to 
how it causes an immune response in the human host systemically and at the site of 
infection, and how that leads to the development of characteristic symptoms. In the 
following subsection 2.6, the characterization of the severity of those clinical symptoms, 
and symptom severity’s impact on onward transmission, will be explained. Then the 
selection of cough as a critical clinical symptom in the onward transmission of influenza, 
and its use as an approximation for severity in a modelling scenario, is discussed. 
2.5 Influenza Transmission and Symptom Development 
Brankston, Gitterman, Hirji, Lemieux, & Gardam, (2007) distinguish between four routes 
of transmission for influenza-like illnesses: direct contact, indirect contact, large droplet, 
and aerosolized airborne transmission. According to Brankston and colleagues (2007), 
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these routes of transmission are defined as follows. Firstly, indirect contact occurs by 
passive transfer via an intermediate object such as the hands of a care worker that are 
contaminated and not washed between patients, or contaminated instruments or other 
inanimate objects in an individual’s immediate environment. Secondly, direct contact 
occurs when transfer results from direct physical contact between an infected or colonized 
individual and a susceptible host (including skin contact through shaking hands, etc.). 
Thirdly, transmission via large droplets is described as being due to droplets generated 
from the respiratory tract of an infected individual during coughing or sneezing, talking, or 
during procedures such as suctioning or bronchoscopy. Large droplets are defined as those 
that travel less than 1m through the air and are deposited on the nasal or oral mucosa of the 
new host or in their immediate environment, and do not remain suspended in the air. 
Finally, aerosolised airborne transmission refers to the spread of microorganisms 
contained in droplet nuclei (airborne particles less than 5 μm) or in dust particles 
containing skin squamous cells and other debris that remain suspended in the air for long 
periods of time. Brankston et al., (2007) argues that since 99.9% of droplets resulting from 
natural coughing have sizes greater than 8μm, small droplets form primarily through the 
evaporation of large droplets.  
Tellier, (2009) considers an alternate range of transmission routes for influenza. He 
suggests that there are three main routes of transmission for influenza: 1) aerosol, 2) large 
droplet transmission, and 3) self-inoculation. Aerosolised transmission depends on 
particles that are sufficiently small enough to remain suspended in the air for prolonged 
periods due to their diameter and low settling velocity. Large droplet transmission relies on 
infectious particles that enter the body via intranasal inoculation. He also explains that 
higher doses are required for infection in the case of large droplet transmission, compared 
with small droplets. Transmission in the third category is described as being due to “self-
inoculation of the nasal mucosa via contaminated hands” (pS783).   
Natural, tidal breathing also appears to generate a large proportion (over 87%) of droplets 
in an infected individual, some of these droplets as small as 1 μm in diameter, indicating 
yet another potential source of influenza transmission (Fabian et al., 2008).  These smaller 
droplets may remain suspended in the air, and are prone to wide dispersion by air currents, 
the result of this being that they can be inhaled by susceptible hosts some distance away 
from their point of origin (Fabian et al., 2008).  There is also evidence to suggest that there 
are other factors that might influence the viability of H1N1a p09 and other influenza 
viruses in the process of transmission. Some current research has been focusing on the air 
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quality factors that might best facilitate aerosolized influenza spread, for instance (Yang et 
al., 2009). 
Tellier (2009) also summarises evidence in this area to conclude that ‘there is considerable 
support in the scientiﬁc literature for a contribution of aerosol transmission to the spread of 
inﬂuenza A. These include “prolonged persistence of infectivity in aerosolized inﬂuenza A 
virus at low humidity, the transmission to volunteers of inﬂuenza by aerosols, reproducing 
the full spectrum of disease, at doses much smaller than the doses required by intranasal 
drop inoculation (which mimics large droplet transmission), and the interruption of 
transmission of inﬂuenza by blocking the aerosol route through UV irradiation of upper 
room air” (p.S783).   
However, both of these categorisations present difficulties. Firstly, whilst Brankston’s 
categories overlap, Tellier’s fail to capture a range of possible transmission scenarios, thus 
neither represents a true taxonomy. For instance, Brankston (2007) notes that indirect 
contact occurs when the host is infected by coming into contact with the virus in the 
environment. However, the definition of droplet transmission includes the possibility of 
deposition of particles in the environment, which must then be acquired by the susceptible 
individual, thus implying indirect contact. On the other hand, Tellier’s reference to self-
inoculation via infected hands appears to ignore the role of other fomites in transmission 
processes. 
The transmission of influenza in volunteers during experimental study suggests that 
bronchial inhalation of small droplets is more likely to cause infection in comparison to 
inoculation by large droplets into the upper respiratory tract or conjunctival membranes 
(Alford, Kasel, Gerone, & Knight, 1966; Bridges, Kuehnert, & Hall, 2003). The problem 
of lack of definitional clarity in these characterizations means that it is difficult to draw 
scientific conclusions from existing research on most likely routes of transmission, 
especially in natural settings. Furthermore, neither classification of infection mechanisms 
lends itself easily to parameterization in a model, as it becomes difficult to understand 
what NPI or behaviour would disrupt transmission when transmission is not clearly defined 
in the literature. However, understanding the immunological response to influenza can 
assist in understanding how symptoms develop after infection occurs, and therefore, how 
symptom presentations in individual clinical cases might impact on onward transmission to 
susceptible hosts.  
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When influenza A enters a susceptible host, it does so through the through the respiratory 
tract. In the human lung there are about 300 million aveoli, or sacs, that function by 
exchanging inhaled gases to oxygen and transporting it to the bloodstream. The typical rate 
of ventilation in humans at rest is approximately 6 liters of air per minute, but even at rest, 
this can introduce large numbers of foreign particles into the lungs, including aerosolized 
droplets containing influenza virus into the lungs (Baigent & McCauley, 2003). Where 
those viral particles deposit in the respiratory tract depends on their size, as smaller 
droplets with a diameter of approximately 1 to 4 µm will likely deposit in the small 
airways, but larger particles are either not able to enter the respiratory system or are 
deposited in the upper respiratory tract (Biagent & McCauley, 2003). 
Biagent & McCauley (2003) explain that the entire human respiratory tract is covered with 
mucus-secreting cells and glands covered in cilia, or small hairs. Any foreign bodies that 
end up in the nasal or upper respiratory tract are captured in this mucus and transported to 
the back of the throat where they are then swallowed, but in the lower respiratory tract are 
brought up by the movement of the cilia of epithelial cells. In sacs that lack cilia or mucus, 
macrophages are responsible for destroying particles.  The main target for infection by 
influenza viruses are the upper and lower respiratory tract epithelial cells and this is also 
where the virus replicates. Once the virus has successfully infected these epithelial cells, 
replication of the virus occurs rapidly, and although the initial infection occurs in the 
respiratory tract, it can cause more general systemic symptoms.  
Cytokine response at the site of infection, specifically in the respiratory tract, causes 
inflammation at the site, and the bronchial system overreacts, the production of mucous 
can increase, and the small airways can become partially obstructed (Utell et al., 2015). 
The cytokines release hormones into the immune system which trigger the hypothalamus 
to cause fever as a general immune response to infection. The viral replication of an 
influenza infection in the respiratory tract then begins to cause cell damage and cell death 
via apoptosis (Oslund & Baumgarth, 2011).   
In general, the inflammation from the immune response to influenza causes irritation and 
reactivity at the site of deposition of virus, usually in the respiratory tract. The release of 
cytokines and hormones from the rapid replication of the virus and the apoptosis of 
damaged cells are related to more general immune response systemically.  It is now 
necessary to characterize the clinical symptoms of influenza A infection as they arise from 
these immune responses. 
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According to Lessler et al., (2009) incubation period of influenza is relatively brief, 
ranging from 1-2 days. The onset of the disease is usually sudden and has systemic 
symptoms such as high fever and chills, severe malaise, extreme fatigue, weakness, 
headache and myalgia, as well more localized respiratory symptoms arising from hyper-
reactivity from inflammation at the site of infection, such as non-productive cough, sore 
throat, and rhinitis.  
 
Table 1-2. Above is from data provided in Monto, Gravenstein, Elliott, Colopy, & 
Schweinle, (2000) characterising the proportions of patients presenting with a range 
of symptoms after lab confirmed influenza diagnosis. 
The most common symptoms in laboratory confirmed influenza A infection in Monto, 
Gravenstein, Elliott, Colopy, & Schweinle, (2000) are fever at about 37.8C, with elevated 
temperature below that classified as “feverishness”, and cough, occurring in 93% of 
patients.  In this study, fever and cough were the most frequently observed clinical 
symptoms in laboratory-confirmed influenza A infection. 
Adults infected with the influenza virus may be infectious from as early as 24 hours before 
the onset of symptoms until about seven days after symptoms subside, but 
immunocompromised patients might shed influenza virus for weeks, or even months 
(Klimov et al., 1995).  In general, the clinical course of influenza infection may be 
mediated by the patient's age, the degree of pre-existing immunity, properties of the virus, 
smoking, co-morbidities, immunosuppression, and pregnancy (Nicholson, Wood, & 
Zambon, 2003).   
However, the clinical progression of pandemic influenza is not always a straightforward 
matter, and in conjunction with the difficulties presented by inconsistent characterization 
of basic transmission, can complicate efforts to build and parameterize models that will 
accurately predict the effect of interventions and behaviour changes in a way useful to 
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policymakers. In subsection 2.6., the challenges of fully characterizing the role of 
transmission, symptom severity, and the impact of severity on onward transmission will be 
discussed.  
2.6 Symptom Severity and Onward Transmission 
There remains some contention in the literature regarding the strength of the evidence 
regarding transmission mechanisms and how to appropriately characterize the clinical 
features of influenza infection related to these routes of transmission (Vukotich, 2010). 
There are, however, consistencies in the findings that warrant consideration in the context 
of a model that could be used to inform policy. Thus far, the route of transmission, source 
of infection, and their relationship to clinical outcomes have not previously been related in 
the modelling literature.   
In the following subsections, the following will be discussed: 1) The connection between 
the route of transmission and the presence of cough in severe disease 2) Animal models, 
human experimental, and human observational studies that link severe infection with 
increased viral shedding 3) Implications of severity for onward transmission of influenza 
infection, and 4) The characterization of cough as an appropriate approximation for 
severity in our modelling endeavours. The challenges and gaps in the transmission 
literature that were encountered will also be addressed before discussion of modelling 
severity begins. 
2.7 Animal Models 
The experimental animal model literature predominately uses ferrets, and the studies 
pertaining to influenza offer some useful data regarding the relationship between route of 
transmission and symptom severity.  The ferret has been extensively used for studying 
various aspects of human influenza viral infection, its clinical course, and results of various 
routes of infection. The ferret is so extensively used as a model translatable to human 
influenza infection for the following reasons, 1) Influenza infection in the ferret closely 
resembles that in humans with respect to clinical signs, pathogenesis, and immunity; 2) 
Types A and B of human influenza virus naturally infect the ferret, thus providing an 
opportunity to study a completely controlled population in which to observe the interplay 
of transmission of infection, illness, and sequence variation of amino acids in the 
glycoproteins of the influenza virus; and 3) The ferret has other physical characteristics 
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that make it an ideal model for deciphering the manifestations of the disease (Herlocher et 
al., 2001). 
The clinical signs of influenza infection in humans and ferrets are very similar, and disease 
in ferrets is mediated by similar factors, the age of the host, the strain of the virus, 
environmental conditions, and the degree of secondary bacterial infection (Herlocher et al., 
2001). Ferrets tend to show similar disease patterns to humans that are infected with the 
same type A strains, commonly characterised by rhinitis that progresses to 
tracheobronchitis marked by cough (Renegar, 1992).  Areosol droplets are the primary 
mode of transmission in ferrets (Renegar, 1992; Herlocher, 2001), and the resulting course 
of clinical illness of the influenza virus in ferrets is very similar to that observed in humans 
(Herlocher, 2001; Matsuoka, Lamirande, & Subbarao, 2009). 
Notably, in the ferret model, there is a fairly clear relationship between the route of 
transmission of the influenza virus and the resulting disease due to the immune responses 
of the animals. When ferrets are experimentally inoculated intranasally with larger 
droplets, local replication of the virus in the upper airways occurs and, as discussed earlier, 
only rarely progresses to severe disease, but particularly virulent strains of influenza A are 
also capable of infecting the lower respiratory tract and causing cough and 
tracheobronchitis, however both ferrets and humans most prominently feature mild disease 
in the upper airways, where no bronchial activity would be evident (Herlocher, 2001). As 
with humans, when lower respiratory deposition occurs, it is likely to result in reactivity of 
the airway and cough, whereas infection primarily in the nasal cavity affects primarily that 
area.  Increase in cough due to lower bronchial infection is likely to generate more aerosols 
that would more readily be inhaled deeply into the lower respiratory tract of a susceptible 
host.  
Bodewes et al., (2011) present findings that confirm the notion that the route of 
transmission has a relationship with the resulting pathogenesis of influenza infection in 
ferret models, noting that intratracheal (inhalation) inoculation of ferrets with the same 
virus reproducibly “caused severe bronchointerstitial pneumonia”. They continue by noting 
the route of inoculation is important for primary disease presentation. The method of virus 
inoculation requires careful consideration in the design of ferret experiments as a model for 
influenza A/H5N1 in humans. Bronchial involvement here would also be reasonably 
assumed to cause cough and airway reactivity in the human in the case of inhalation of 
influenza particles into the lower respiratory tract.  Hinds (1999) notes that in humans, 
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aerosol particles ≤5 μm are capable of reaching deep into the respiratory tract and being 
deposited in alveolar tissues. 
Further, there is evidence that areosolation and the inhalation of the aerosol particles that 
deep into the bronchi can be confirmed in ferret models with the deposition patterns of 
influenza virus following inoculation not been previously in ferrets, but that fluorescent-
labeled influenza virus, when administered using our aerosol system, is deposited in the 
upper and lower regions of the ferret respiratory tract (Gustin et al., 2011).  Gustin et al. 
(2011) directly addresses the issue of route of transmission and how it relates to clinical 
disease by explaining that although the relative importance of different routes of 
transmission used by influenza A viruses remains controversial, it is likely that the modes 
of transmission are not mutually exclusive, and, whether transmission occurs at close range 
or long range, aerosols are likely to be involved. 
2.8 Human Experimental and Observational Studies 
In human studies, the characterization of severity and the relationship of clinical disease to 
onward transmission or route of infection is not straightforward. Classification and 
discussion of severity in the literature is not marked by the same kind of standardization in 
protocol than the more controlled experimental studies involving ferrets. However, there 
are still notable areas of scientific consensus that can be successfully used to identify 
cough as a marker of severity and to provide useful parameterizations for a modelling 
study that could be used to inform policy.  
Alford (1966) demonstrates the possibility of transmission via small, aerosolized droplets 
and larger droplets implicated in contact transmission. However, the issue of the relative 
importance of these routes in natural settings is largely unresolved (Hall, Douglas, Geiman, 
& Meagher, 1979). Previously discussed findings have suggested that onward transmission 
may also be affected by other factors than clinical symptoms generating droplets or 
aerosols.  These previously discussed studies noted that an immunocompromised patient 
might shed virus for months, even after initial symptoms of infection have waned. Indeed, 
Hall (1979) found that more severely infected patients demonstrated higher shedding of 
viral load.  There is additional information that supports the notion that severe disease is 
associated with longer duration of symptoms and higher viral shedding counts, which 
would logically create a greater opportunity for the onward transmission of influenza. 
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For example, a review by Carrat et al., (2008) showed that viral shedding, as measured by 
quantity of viral particles, tracked symptom score over time. Furthermore, more severe 
symptoms were shown to be associated with increased quantity and duration of viral 
shedding. In H3N2, there was a positive correlation in two studies between viral shedding 
(measured using nasal washes) and symptom severity (Carrat et al., 2008). Finally, 
respiratory symptoms resolved more slowly than systemic symptoms (Carrat et al., 2008). 
Further evidence for the relationship between more severe forms of disease and higher 
viral shedding, as well as longer duration of clinical symptoms can be found in three other 
studies. Firstly, Hall et al. (1979)’s paediatric study demonstrated that more severe illness 
was associated with greater viral shedding. Zambon, (2001) showed that cases with a 
larger number of positive test results also demonstrated longer recovery times and longer 
duration of cough symptoms among untreated (placebo) individuals. Finally, To et al., 
(2010) examined 74 cases admitted to hospital, focusing on severe cases of lab-confirmed 
H1N1 2009 during May-September 2009. These were categorised into three groups of 
inpatients with ARDS (Acute Respiratory Distress Syndrome) and immune response was 
measured via tests of cytokine activation while viral shedding was measured as viral load 
in sputum and endotracheal aspirates (aerosols). The two categories of severe disease had a 
high viral load for a longer period than those with less severe disease. Theoretically, more 
severe illness, which is more likely to be due to airborne transmission, should lead to the 
observation of increased R0 values, due to the longer duration and increased 
transmissibility of infection, which has clear implications for infection control. 
Understanding severity in the clinical setting presents some challenges, however. Hoeven 
et al., (2007) and Cunha (2008) caution that infection control for influenza should be based 
on laboratory findings during the diagnostic process and not from the presence or absence 
of clinical symptoms. They cite the difficulty in clinical diagnosis for those who are mildly 
to moderately ill, and the difficulties of making accurate differential diagnoses. Discerning 
the clinical presentation of mild to moderate influenza from other clinically similar 
illnesses, such as “influenza-like” illnesses (ILIs) caused by parainfluenza virus, 
respiratory syncytial virus (RSV), adenovirus, etc., is difficult as there is no clear clinical 
differentiation (Cunha, 2008). However, while this is an important note of caution, mild or 
moderate influenza is less likely to involve the lower bronchial tract, and therefore less 
likely to involve cough, which is the clinical symptom of our primary interest to use as an 
approximation of severity for a modelling exercise.   
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Cunha (2008) states that diagnosing severe influenza A may present a different scenario 
than that of the relatively undifferentiated mild/moderate influenza due to the presence of 
“characteristic clinical features which have diagnostic specificity (p. 92).” Cunha (2008) 
also notes that severe influenza is usually diagnosed through “A weighted point 
system…The point system is based on a weighted selected clinical/laboratory finding 
given different point scores.  This suggests that it is a combination of lab findings and 
symptoms that are used in a clinical setting to diagnose severe influenza”, Cunha 
continues, “Isolated clinical/laboratory features have little diagnostic specificity, but by 
combining characteristic findings the diagnostic specificity of clinical/laboratory signs is 
enhanced. Our point system is designed to clinically identify severe influenza A, but is not 
useful to diagnose mild/moderate influenza A or B.” 
Pertaining to the presence of cough in H1N1a specifically, Rello et al.,(2009) present 
findings from a  review of the clinical literature that implicates cough as present during 
severe influenza, but not necessarily as a symptom indicative of severity.  Rello also gives 
indication that severe influenza has a distinctive feature in prolonged viral shedding, even 
with anti-viral treatment in the clinical setting, “A common report is of a prolonged time to 
negative virus excretion associated with the need for higher oseltamivir dosing and longer 
duration of treatment than standard therapy (75 mg orally twice a day) (Rello et al., 2009).”  
Increased or prolonged viral shedding in those with more severe disease would certainly 
have implications in the community setting for onward transmission, even after the severe 
patient has been hospitalized.   
In Rello et al., (2009) severe H1N1 infection is also associated with the development of 
pneumonia, specifically secondary bacterial pneumonia, “Primary viral pneumonia was 
defined in patients presenting during the acute phase of influenza virus illness with acute 
respiratory distress and unequivocal alveolar opacification involving two or more lobes 
with negative respiratory and blood bacterial cultures. Secondary bacterial pneumonia was 
considered in patients with confirmation of influenza virus infection that showed 
recurrence of fever, increase in cough and production of purulent sputum plus positive 
bacterial respiratory or blood cultures.” 
The increase in cough in severe influenza would logically increase the likelihood of 
onward transmission by increasing both droplet and aerosol generation, and the respiratory 
distress may also increase droplet transmission during tidal breathing. Previous evidence 
during sections characterizing influenza have demonstrated that secondary pneumonia is 
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common in severe forms of influenza, and here it is explicitly detailed that those who were 
eventually diagnosed with the pneumonia after a primary diagnosis of H1N1 was made 
exhibited increased or marked cough.  
While laboratory testing to confirm severe influenza is desirable, it is not always feasible. 
This is particularly the case in low-resource or underserved settings, and thus a necessary 
consideration for a policy-building exercise. In the absence of laboratory tests, clinical 
diagnosis of influenza takes the form of an assessment of a range of symptoms. Ebell, 
Lundgren, & Youngpairoj (2013) reviewed the existing clinical decision rules for influenza 
diagnosis, synthesising these for the purpose of formalisation within their paper. According 
to their procedure, each of nine symptoms is rated on a 4-point scale of severity (0=none; 
1=mild; 2=moderate; 3=severe). The symptom set considered includes headache, sore 
throat, feverishness, myalgia, cough, nasal symptoms, weakness, and loss of appetite. In 
addition to individual symptom severity ratings, an overall illness score is also calculated 
as the sum of individual ratings.  
Clinical presentation can be used in comparison with laboratory findings to paint a precise 
picture of severe influenza infection. Zambon (2001) used a similar scale to compare the 
clinical diagnosis of community cases of influenza with various laboratory diagnostic 
techniques and found that the total symptom scores at baseline showed significantly greater 
severity of symptoms and an increased number of positive laboratory test results. This 
work demonstrates that there are biomarkers of more and less severe cases and that 
severity can be measured objectively. There is other evidence from the analysis of the most 
severe cases - those leading to death – that points to particular symptom clusters associated 
with severe forms. Shieh et al., (2010) report on a histopathological study of patients who 
had died from confirmed 2009 H1N1. Among these patients, cough was the second-most 
prevalent symptom (67%; following fever at 82%) for those individuals for whom 
symptom data were available. The third most prevalent symptom was shortness of breath 
(58%).   
Specifically in relation to cough symptoms, Cao et al., (2009) show that existence and 
duration of cough predict for longer duration of viral shedding (in a logistic regression 
testing viral shedding for less than or greater than 5 days) and indeed that cough is the 
most informative clinical symptom for the duration of viral shedding. Little, Gordon, Hall, 
& Roth (1979) also demonstrate cough persisting for less than 7 days in all five 
experimentally inoculated participants, while all those in the natural infection class 
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experienced cough for greater than 7 days. In summary, more severe forms of disease are 
associated with higher viral shedding and longer disease duration, especially cough 
resolution. These characteristics indicate increased opportunities for onward transmission 
among severe cases, both through longer shedding periods and quantity of virus shed into 
the environment. 
In summary, route of infection, via airborne or contact modes, has important implications 
for the symptom set of individuals and this in turn impacts onward transmission. There is a 
higher probability of persistent cough and respiratory problems as symptoms of severe 
forms of disease, and severe disease is associated with infectious viral load and probability 
of shedding virus for prolonged periods. Taken into consideration collectively, the 
epidemiological implications are fairly clear. 
Overall, following from the data above, these simplifications can be made: A) There are 
two forms of disease, mild and severe, characterised respectively by lack or presence of 
cough due to inflammation of the lower respiratory tract (B) Severe cases are caused by 
airborne transmission and the deposition of aerosolised droplets in the lower bronchial 
tract, whereas mild cases result from direct and indirect contact and cause mostly rhinorrea 
and upper respiratory discomfort and (C) severe disease is associated with overall higher 
probability of onward transmission, and especially, a higher probability of secondary cases 
generated by the airborne route. 
With these assumptions established, subsection 2.9 focuses on the construction of a model 
accounting for different routes of transmission and analyses of this model.   
2.9 Modelling Severe and Mild Disease 
This section focuses on the construction of a model that is appropriately parameterised 
using the information above, and the results of that modelling endeavour. Understanding 
how clinical severity and onward transmission interact and affect epidemiological 
dynamics is a key question for pandemic planning, and the chosen outcome indictors of 
this exercise in the section below speak directly to the type of information that 
policymakers and pandemic planners find necessary to create appropriate preparedness 
initiatives.  More generally, using this type of modelling in a non-expert scenario in order 
to generate policy-relevant epidemiological information provides some insight into the 
necessary processes and challenges policymakers face in using modelling methods to 
underpin preparedness policies.  Subsection 2.10 will discuss the parameterization and 
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structure of the model, Subsection 2.11 will discuss the results generated from the 
modelling exercise.  
2.10 Model Structure and Parameters  
Key outcome measures of interest were selected according to their importance for public 
health and pandemic planning, with each indicator providing critical information for 
policymakers and planners on how many affected people they can expect to see, how many 
people with severe cases they can expect to see, and thus, how much treatment or 
prophylactic capacity to plan for. They are as follows: (A) Total number of cases over 
course of epidemic; (B) Total number of severe cases over course of epidemic; (C) 
epidemic peak time; and (D) Number of cases (severe, mild, and total) at peak.  
 
The main structural differences between this model and a typical S-E-I-R model are that 
there are two infectious compartments to reflect to the two forms of infection: Infectious 
(Mild), IM, and Infectious (Severe), IS, and two exposed compartments Exposed (Mild), EM 
and Exposed (Severe), ES to distinguish between individuals who have come into effective 
contact with infectious cases of the two forms. The rates of transition between exposed and 
infectious forms are dependent on numbers in the exposed compartment with exposure to 
mild disease leading to less likelihood of causing severe infection; recovery rates also 
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Structure of the Model 
In the model above, the transmission terms, 𝛽𝑆 and 𝛽𝑀, are for severe and mild conditions 
respectively, and determine the effective contact rate for both forms of disease. Once 
exposed, the rate at which the exposed individuals in the model become infective is 
denoted by 𝜎. 𝐸𝑀 and 𝐸𝑆 denote individuals who have been exposed to disease and whether 
this exposure was via contact with a mild or severe case. 𝑃𝑀 And 𝑃𝑆 are the probabilities 
that an individual develop mild symptoms or severe symptoms. So, for example, 𝑃𝑀 is the 
probability that an individual who has contracted disease from a mild case goes on to 
develop mild symptoms, and the same rule applies to the severe condition. Finally, 𝛾, the 
rate of recovery from either mild or severe disease, is the final term in the mild-severe 
model. 
 
Solving the Model 
The epidemiological model was translated into code and run in R, which has several 
options for ordinary differential equation solvers that give highly accurate solutions and 
that automatically alert users to errors. The numerical differential equation solver package 
used was a standard one for solving this kind of model, called the deSolve package.  
 
Parameters of the Model 
The literature was examined to find parameter estimates for the terms in the model, and 
Table 2 below summarises these parameter estimates and their sources. After the table, 
more detailed explanations from the literature are provided for the following values in the 














       𝜷𝑺 and 𝜷𝑴 
 𝛽𝑀 at 0.0004 per day and 𝛽𝑆  at 0.0008 day, from Carrat, et al, 
(2008) 
           σ  
0.5, from Carrat et al., (2008); Cao et al., (2009); Lessler et 
al.,(2009) and Cowling et al.,(2009) 
            𝜸 
Mild: 1/ 𝛾M= 5 days and Severe: 1/ 𝛾S = 7 days, from Carrat et al., 
(2008) and Cao et al., (2009) 
𝐏𝐒 𝐚𝐧𝐝 𝐏𝐦 
Probability (𝑃𝑆) from exposed severe to infectious severe 
(𝐸𝑆, 𝐼𝑆)=0.8 
Probability (𝑃𝑚) from exposed mild to infectious mild 
(𝐸𝑚, 𝐼𝑚)=0.79 
from Carrat et al., (2008); Cao et al,. (2009); Lessler et al., 
(2009); and Little et al., (2009). 
          Days The time period in the Mild-Severe model 
 
Table 2-2. Parameter Values 
The latency period: 1/ 𝜎: 
There was no evidence in the literature that the latency period (1/ 𝜎), varies between mild 
and severe forms of disease. In their review of nasal inoculation studies, and Carrat et al. 
(2008) reported two mean latency periods from among the studies considered as mean time 
from infection to onset of symptoms of 1.7 days and 2 days. These values fall within the 
range found in natural infection studies: Cao et al. (2009) found a median of 2 (range :1-7); 
Lessler et al., (2009) found a mean of 1.4 days; in Cowling et al., (2009) a mean incubation 
time of 1.5-2 days. Therefore, I use the same value of sigma for both mild and severe 
forms of infection, choosing 1/ 𝜎 = 2.  
The recovery time: 1/ 𝛾: 
The estimates for recovery times (period from onset to resolution of symptoms) are based 
on Cao et al. (2009) and Carrat et al. (2008). Specifically, using resolution of cough 
symptoms as a marker, selecting the upper bound of the inter-quartile range (IQR) for the 
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duration of cough symptoms of those experiencing cough for >5 days versus <5 days, as an 
estimate of resolution time for severe and mild respectively, giving 1/ 𝛾M= 5 and 1/ 𝛾S = 7 
(Cao et al., 2009). The upper bound of the IQR was chosen rather than the median as the 
values reported for the duration of cough are likely to represent underestimates. 
Specifically, I note that 351 of 426 participants were treated with antivirals, 254 of whom 
within 48 hours of the onset of symptoms, while antivirals administered within 48 hours 
were associated with reduced infectious periods. The data that directly measured shedding 
times was also considered. On the basis of their review of experimental intranasal 
inoculation studies Carrat et al. (2008) provide a potential estimate of 1/ 𝛾M = 4.8 (range is 
1-8 days). This may be an overestimate of recovery time among mild cases, since 21% of 
participants did have a cough (Carrat et al., 2008), known to be associated with longer 
durations of viral shedding (e.g. Cao et al., 2009). 
Transition Probabilities: 
In estimating the transitions (𝑃𝑀, 𝑃𝑆) between exposed and infectious compartments, I use 
data from Carrat et al. (2008) for transitions from those exposed to mild cases by equating 
nasopharyngeal inoculation with exposure to a mild case without a cough. In this study, 
exposed participants had a cough (severe) with probability 0.21 (i.e. of developing severe 
disease (Is) from exposure to mild disease, PM); correspondingly, 0.79 had no cough, which 
means that mild disease exposure results in mild disease infection. 
For transitions from ES to Is Cao et al. (2009) was employed as a basis for parameter 
values, as this work related to natural infections and no large-scale experiment involving 
aerosol inoculation has been conducted. This study was useful as it minimised the usual 
difficulties of underreporting of cases that occurs in most studies of natural settings. Cao et 
al. (2009) report a prevalence of cough of 69%; however, this is likely to be an under-
estimate given that a large proportion of cases (254 of 426) were treated with antivirals 
within 48 hours of the onset of symptoms. Nonetheless, the fact that only 20% of cases that 
arise from intranasal inoculation (mild) lead to cough symptoms (severe) suggests that this 
underestimate is likely to be minimal. The suggestion that 0.69 represents an underestimate 
in our model is consistent with higher cough prevalence in other natural acquisition 
studies: Lessler et al. (2009) reports cough in 90% of cases, Little et al. (1979) in 100% of 
cases, although these studies suffer from issues of underreporting. As a compromise 
between these values, 0.8 was used as an approximation for the transition probability (𝑃𝑆) 
from exposed severe to infectious severe (𝐸𝑆, 𝐼𝑆).  
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2.11 Findings from the Model and Implications 
As stated previously, outcome measures of interest for this model were selected according 
to their importance for public health and pandemic planning, and the findings are presented 
in order for each of these key indicators: 
 
(A) What is the total number of cases over course of epidemic? The total number of cases 
at the end of the epidemic was 989 out of 999 individuals in the model, leading to a 98% 
rate of seropositivity at the end of the epidemic, a fairly high rate which was not 
unexpected, but could still place a significant burden on health systems overall: from 
general practitioners seeing an influx of more mild disease, to more urgent care settings 
and hospitals dealing with severe cough, but with most people ill to some degree in our 
susceptible population.  
 
(B) What are the total number of severe cases over course of epidemic? One of the key 
factors in effective pandemic planning is the ability to anticipate the number, or proportion, 
of cases you may encounter that are most likely to tax the resources available. These cases 
that are most likely to result in complicated mortality or even increased morbidity are those 
that feature more severe clinical symptoms, as characterised in this model by cough.  29% 
of total cases in this modelling scenario are mild cases, with 71% of total cases presenting 
with severe disease. This means that 71% of infected individuals in this scenario are likely 
to present with cough. Although the clinical significance of severe symptoms including 
cough will vary between and within populations, such a large proportion of people with 
severe symptoms could have notable capacity and planning implications for a healthcare 
system. Within both mild and severe conditions there are individuals that may not seek 
healthcare services (leading to an underestimation of both severe and mild cases, but mild 
cases particularly) and even some people with cough will have uncomplicated influenza 
that self-limits. Yet, the potential of coping with a large population of people with a severe 
symptom for which they may need extended healthcare services is a point of interest for 
the pandemic planner and policymaker. Understanding that there may be an 
underestimation of those who are actually infected with (and spreading) disease but may 
not necessarily all be seeking care also has implications for the control of disease and the 
understanding of epidemic dynamics, particularly in the case of influenza, where cases 
cannot be lab confirmed for epidemiological purposes if people infected are not seeking 




The following findings, (C) epidemic peak time; and (D) number of cases (severe, mild, 
total) at peak, should be considered in conjunction, and in a fashion that compares mild 
and severe cases to fully contextualise the potential importance of these findings to 




Figure 1-2. Severe and mild peak influenza times 
Overall, mild disease (in blue) and severe disease (in red) peak at the same time, and there 
are a significant number of additional cases that the model predicted in the severe (with a 
ratio of 3 severe: 1.08 mild cases).  This suggests several notable things about the epidemic 
dynamics. First, it suggests that the presence of proportionally more severe clinical 
symptoms doesn’t appear to have a significant effect on the overall epidemic peak time, 
although while the presence of severe disease is proportionally meaningful enough to have 
an effect on pandemic planning, severe disease as characterised by cough does not seem to 
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follow a different epidemiological pattern than mild disease. Since cases of severe disease 
and mild disease peak at the same time, it is unlikely that the appearance mild disease will 
precede cases of severe disease, and thus the natural disease dynamics would unlikely to be 
useful as a kind of “early warning system” to planners and policymakers that multiple 
cases of severe disease were forthcoming.  
 
In Chapter 5 broader implications of using information from models of this type are 
discussed in the context of pandemic planning and policymaking that seeks to mitigate the 
spread of infectious diseases like influenza.  The processes of a non-expert modeller using 
this method to explore these questions and make predictions about possible scenario 
outcomes during and epidemic are also discussed. 
Now that the implications of the Mild/Severe model have been explored, the following 
section will focus on understanding behaviour as it relates to pandemic disease threat, the 
public perception of risk, the communication of risk, and the adoption of non-
pharmaceutical interventions for pandemic disease prevention. In the final modelling 
exercise, a new variable is introduced into the above model that allows us to explore 
whether these non-pharmaceutical interventions impact upon the outcome indicators I have 
explored here.  
2.12 Human Behaviour Change, Public Risk Perception, Risk 
Communication & the Threat of Influenza Infection   
This section will explore the findings from the psychological, communication, and public 
health literatures to establish a characterization of human behaviour change in the event of 
a pandemic disease scenario.  Any sound planning policy will include detailed information 
on how to communicate effectively with a variety of diverse communities and groups in 
the event of a pandemic emergency. In Subsection 2.13, the public health, cognitive, 
health, and public health psychology literatures were reviewed in order to ascertain how 
people change their health behaviour in response to risk communication specific to 
infectious disease, why they change their behaviour, and to what extent this behaviour 
changes. Factors such as the nature of the communication, its source, and population and 
individual characteristics are also considered.  Subsection 2.14 specifically examines 
behaviour change in response to H1N1 outlining both commonly changed behaviour and 
the demographic characteristics of those likely to exhibit behaviour change, although direct 
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links between self-reported behaviour change and risk communication specific to H1N1are 
unclear. 
2.13 What is Known About Behaviour Change In the Face of Risk 
The ultimate goal of gathering data on infectious disease, either through real-time 
epidemiological surveillance or though model-based simulation of disease process, is the 
accurate planning, implementation, and evaluation of public health interventions, programs 
and communications (Heymann & Rodier, 2001; McQueen, 1999 ;Klaucke et al., 1988). 
However, in order for this surveillance or simulation to be of optimal utility, an 
understanding of health behaviour in response to these interventions, programs, and 
communications within and between populations is necessary (Veazie et al., 2001).  
The demographic factors that influence health and risk behaviour in response to 
information regarding disease are multivariate and complex.  It is key to note that both 
individual and social environmental factors influence what behaviours individuals change 
and to what extent (McLeroy, et al., 1988). The social ecological perspective (SEP), 
prevalent in both the public health and psychological literature, includes the notion that 
societal structures have mediating and moderating, in addition to direct, impacts on health 
behaviour, and that many of these factors will be specific to the population in question and 
the environment in which, and with which, they interact. The SEP was popularized by 
Bronfenbrenner's (1979) Ecological Systems Theory which identifies four levels of 
interaction: macro-, exo-, meso-, and micro-, each level describing influences as 
intercultural, community, organizational, and interpersonal or individual. Bronfenbrenner’s 
perspective (1979) was founded on the internal characteristics of the person, the 
characteristics of the environment, and the continuous interaction of the individual with the 
environment.  Bronfenbrenner argues that it is not solely the environment that directly 
affects an individual, but that there are mediators and moderators in between which may be 
multivariate and complex, all having impacts on the next level, with each echelon 
operating fully within the next larger sphere (Bronfenbrenner, 1979). 
The influence of person characteristics beyond basic demographics on health behaviour is 
also of note, and the effects of variables such as age and gender are discussed further. 
Some of the more “complex variables”, such as political orientation or values, have been 
examined in both public health and psychological forums.  
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Variables such as political ignorance or orientation, denial, obduracy, and cultural norms 
often compound the risk of infectious disease transmission in ways intractable to 
communication or education efforts (Albrecht, Fitzpatrick, & Scrimshaw, 2003). Further, 
standard public-health prevention theory has been based on the assumption that education 
leads to rational behaviour change. However, an approach focusing on education alone and 
on an expectation of individual behavioural responses to available information may not be 
appropriate in all circumstances, as the availability of educational information or materials 
does not always impact behaviour in expected or significant ways (Albrecht et al., 2003). 
This is important to note when examining patterns of disease transmission in specific 
populations, as the positive impact of efforts at risk communication may be mitigated by a 
cultural or political phenomena, and examination and post-hoc study or analysis of 
findings may become necessary to explore and explain these effects.  
There is evidence that one of the most effective measures for stemming an outbreak of an 
infectious agent is to externally control behaviour between populations, such as closing 
major air travel hubs, restricting the range of infectious, or potentially infectious, 
individuals. However, these measures are often met with firm opposition due to the 
economic, social, and policy implications of mass restrictions, and are rarely implemented 
despite their effectiveness (McLean, May, Pattison, & Weiss, 2005). Any outbreak of a 
novel and little-understood infectious disease is likely to be characterized by high levels of 
public concern. Sandman, (2003) argues that people’s willingness and ability to cope with 
risk, to bear anxiety, to follow instructions, to help their neighbours, and to return to 
baseline rates of health and behaviour when the crisis is over will all depend to a 
significant extent on the content of the risk communication in question, and the perceived 
severity of those contents by the target audience. 
Despite the unwillingness of most individuals and populations to capitulate to mass travel 
restrictions or quarantines, and the public health community’s caution in advocating these 
types of restrictions due to issues of panic and public backlash, it is possible to create 
positive health behaviour change in a variety of populations through effective health and 
health-related risk communication. For instance, The Health Education Authority for 
England's anti-smoking TV campaign was effective in reducing smoking prevalence 
through encouraging smokers to stop and helping prevent relapse in those who had already 
stopped (McVey, 2000). 
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Most people in the developed world get health information from two sources that can be 
considered “primary”: mass media and trusted sources within social networks, i.e., close 
friends and family, or trusted community leaders (Lunin, 1987). While the primacy of the 
mass media as the information source may be secondary in some cases to community 
contacts in the developing world, it still has major effect.  Thus, it is important to 
understand how the media gets its information, and how it formulates messages about risk 
to the public. Journalists will use established or official sources for information that is used 
to create news articles or items (Lunin, 1987). These should be credible, available, and 
must be able to supply reliable information (Gandy, 1982). Sources may be established 
spokespersons for government agencies, businesses or other powerful groups and elites in 
the social system (Hilgartner & Bosk, 1988; Donohue, Donohue, Tichenor, & Olien, 
1995). However, the media also serves as a translational entity, and how they choose to 
frame the information effects what the public believes to be fact and how they might 
change their behaviour in response to the risk (Makoul, 1991). 
Meta-analysis of available data suggests public response to media communication of risk is 
dependent upon such social cognitive variables as source credibility, fear, organization of 
arguments, the role of group membership in resisting or accepting communication, and 
personality differences (Perloff, 2003). This points to behaviour change in response to risk 
as an effect of persuasion as opposed to the simple dissemination of factual information. It 
is again important to note that multiple studies confirm that public education is highly 
variable across populations, and the act of education alone does not guarantee health 
behaviour change.  Studies show populations with higher educational levels are more 
likely to learn factual information about health and health risk than other populations 
(Hyman & Sheatsley, 1947). Therefore, merely increasing the flow of raw information is 
more likely to benefit or incite behaviour change in groups with higher educational levels 
than those from lower educational strata.  
The media venue from which individuals and groups garner information about health (and 
all groups appear to have this interest), also has an effect. Those who glean information 
from print media are more knowledgeable than those who get their information primarily 
from other media sources, i.e. television (Finnegan &Viswanath, 1996). Greater 
availability of diverse sources of information, and access to primary care providers as a 
source of health information, may work to the advantage of residents of larger 
communities, such as urban areas (Viswanath & Finnegan, 1996).  The internet, which has 
become central to any serious consideration of the function of risk and health 
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communication in behaviour change, is quickly becoming the primary media outlet from 
which individuals and groups garner information on health and health-related risk. Rainie 
(2001) reports that 80 million Americans regularly access the internet to obtain medical 
and health information. This includes a substantially high number of African-Americans 
and senior citizens than would be expected given overall demographics. Yet, access to the 
internet and the availability of high quality, high speed networks across age, race, and SES 
is unequally distributed, although the gap is closing (Venkatesh & Brown, 2001).  
The perception of the amount of risk a population is assuming bridges aforementioned 
variables of environment and individual characteristics, to an extent.  People are more 
likely to change their health behaviours if the risk is perceived to be grave, and if this 
perception is supported by other members of their self-identified groups (there is public 
“outrage”). However, it is noteworthy that even if the perception of risk is grave, mass, 
externally applied amelioration efforts (such as enforced quarantine), are generally ill-
received, whereas mass non-intrusive efforts (such as scanners at airports to detect elevated 
body temperature indicative of fever) care met with greater levels of compliance (Tan, 
Chlebicka, & Tan, 2010). This level of compliance is increased when examining strictly 
voluntary behaviours such as remaining home from work or public spaces when ill, if the 
individual perceives the threat as highly likely, highly dangerous, either, or both, and the 
risk outweighs the complexity level of the task the individual is being asked to perform 
(Demers & Viswanath, 1999). Bandura, who is the progenitor of the Social Cognitive 
learning theory now widely applied in public health settings, argues that it is the 
complexity of the behaviour change that dictates how likely an individual is to perform it 
(Bandura, 1994, 1998).   
Yet, the ready availability of information, and the means and desire to access it, does not 
necessarily mean that the recipient of information will understand the information 
available.  Nor is there assurance that even careful journalists using credible sources will 
accurately convey this information. However, it is possible to clarify some of the 
misinformation and confusion risks of using the media as the sole source of risk and health 
communication with the public. Targeted, culturally sensitive and audience appropriate 
health behaviour change campaigns direct from public health entities with established 
public presence have created desirable health outcomes effective across race, gender, and 
socioeconomic groups, but understanding the complex interaction of communication 
efforts at these intersectionalities is a continuing process (Williams, Mohammed, Leavell, 
& Collins, 2010).  
60 
 
In order to appropriately target audiences for competent communication, it is important to 
note that individual or group characteristics such as gender, age, race, or SES may still 
influence whether or not, or to what extent, communication about risk has an effect on 
behaviour.  How people get health risk communication or what they are likely to do about 
it once the information has been received often relies on the message’s ability to persuade 
the recipient to undergo health behaviour change.  
The influence that individual characteristics can have on behaviour change is well 
documented. For instance, individual characteristics, such as sex and gender, have been 
explored in a variety of risk and health studies, but does not always serve as a modifier of 
behaviour or risk perception (Prochaska & Velicer, 1997). The biological distinction of sex 
exists as a variable in most epidemiological studies, but the cultural effect of gender 
construction and its influence on health and risk communication perception may be 
lacking. Understanding the effects of gender, not just sex, should be considered central to 
any epidemiological research endeavor to appropriately inform an epidemiological 
surveillance or simulation effort although gender may not have a sizeable effect in some 
circumstances, but it may in others. This is particularly true in pathogen-specific studies, 
for instance, those that examine the socio-psychological variable that influence HIV 
transmission. Yet, the findings on gender as a modifier are too complex to generalize.   
However, there has been evidence that gender has a relatively weak effect on the 
likelihood of health behaviour change in the face of other infectious disease risk 
communication (such as those in influenza), “because of the absence of gender effects on 
health behaviour change, I conclude that health behaviour interventions do not need to be 
specifically tailored more for men or women; instead, health behaviour interventions can 
be similarly promoted across gender” (Prochaska & Velicer, 1997).  
2.14 Behaviour Change and H1N1 
The effects of demographic variables on health behaviour in the most recent pandemic 
influenza outbreak in 2009 are readily apparent.  Older individuals are more likely to 
engage in behaviour that prevents poor health outcomes due to an increased perception of 
risk for morbidity and mortality consistent with their age cohort. However, the short-term 
changes in behaviour documented in response to infectious disease are not necessarily the 
same in long-term behaviour change related to lifestyle behaviours pertaining to chronic 
illness, such as in Pretchroska, In fact, health behaviours, disease development, and 
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treatment outcomes can often be attributed, at least in part, to somewhat ineffable qualities; 
quality of life is impacted by work conditions, social connectedness, and community 
participation (von dem Knesebeck, Dragano, & Siegrist, 2005).  
Rubin, Amlot, Page, & Wessely, (2009) found that women, people aged 18 to 24, and 
parents of young children were significantly more likely to follow recommended infection 
control behaviours during the most recent swine flu outbreak. Participants who were not 
employed, were poor, had an annual household income of less than £30,000, or had no 
educational qualifications were significantly more likely to adopt avoidance behaviours to 
change their infection risk. The largest effects were for participants from non-white ethnic 
backgrounds, who were significantly more likely than white participants to adopt both 
infection control (handwashing) and avoidance (staying home) behaviours (Rubin et al.,, 
2009). This presents evidence for the confluence of personal characteristics (sex, age, 
income, education, and ethnicity) as important for what behaviours households report 
changing. 
It is impossible to definitively state that anxiety generated by risk messaging specific to 
H1N1 leads to efficacious behaviour change to avoid infection (Rubin, 2009; Kasperson, 
et. al, 1988). However, when behaviour change to avoid infection from H1N1 was 
reported, increased hand-washing was most commonly cited as the most-frequently 
employed method of infection avoidance in both the US and the UK (Jones, 2009; Rubin, 
2009) and is the most frequently recommended method of infection avoidance by the CDC 
(CDC, 2011). Hand-washing is also a more readily accepted method of infection avoidance 
for an H1N1 scenario than are other efficacious methods, such as vaccination. (Chor, et. al, 
2009)  
The findings of Jones (2009) are consistent with that of Rubin (2009); that in a large 
sample being female had a significant effect on increased hand-washing behaviour, 
however a potential criticism of both studies is that while they both have a large sample 
size, both sample populations skew toward the highly-educated and the evidence for hand-
washing (as opposed to social avoidance) comes from these samples.  However, that does 
not mitigate the extent to which hand-washing is advocated by the CDC across 
populations, therefore, there is ample evidence to argue for hand-washing as the most 




Ibuka, et. al., (2010) also confirms the findings of Rubin (2009) and Jones (2009) in a large 
US sample that women are more likely change their behaviour to avoid infection than men, 
and that there is a temporal effect to behaviour change in response to H1N1; individuals 
are more likely to increase protective behaviour at the beginning of an outbreak when their 
perception of risk of infection is high, as opposed to as an H1N1 outbreak wanes.  Ibuka 
(2010) also confirms that this phenomena across studies is consistent with the classic view 
of behaviour change in public health according to the Health Belief Model. 
While no study made an effort to directly link the behaviour change they found with 
specific messages about risk, Jones (2009), Rubin (2009), Chor (2009), and Ibuka (2009) 
all make the assumption that the widespread media coverage and the public health 
communication about risk from the CDC and WHO played the most significant role in 
their study population’s perception of risk and selection of infection control behaviour such 
as hand-washing. Duncan (2010) reported that international health bodies were the primary 
source of information for most individuals during the early stages of the H1N1 outbreak 
when anxiety about infection is likely to be at its peak, which supports the argument that if 
populations are responding with behaviour change to risk communication about H1N1 
specifically, they are likely getting those risk communication messages from the CDC, 
WHO, and NIH.  
Ibuka et. al., (2010) goes a step further than colleagues and examines the geographical and 
temporal effects on behaviour change in response to an H1N1 outbreak in a US sample. 
This study found that respondents willingness to change their behaviour in response to 
H1N1 tracked media interest in the subject over time.  The more interest the media had in 
the H1N1 pandemic, the more likely hand-washing would occur.  However, as media 
attention waned, as did protective measures.  In their review of the literature, Bish & 
Michie (2010) conclude that effective interventions in the future would account for this 
temporal effect and that future risk communication should focus on specific demographic 
groups and on raising levels of the public’s perception of the threat of pandemic disease 
and their confidence in the effectiveness of measures designed to protect against it.  
The use of hand-washing as an adaptive behaviour to avoid infection has also been shown 
to affect travel behaviour during H1N1 outbreaks, in that individuals are unlikely to change 
plans for international travel during an H1N1 outbreak as hand-washing lowers risk to an 
acceptable level (Raude, et. al., 2009). This is particularly key to the GLEaM model, as 
hand-washing behaviour is likely to allow populations to maintain their normal travel 
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behaviour as hand-washing is viewed as a sufficient measure with which to lower risk of 
infection to acceptable levels for most individuals.   
The next subsection will consider the use of non-pharmaceutical interventions for the 
prevention of onward transmission of influenza, and the selection of hand hygiene as the 
proxy for behavioural change using NPI in our model, and the challenges presented by this 
proxy.  Section 4 will then begin a discussion of the parameterization of the mild/severe 
model with this additional behavioural information integrated.   
2.15 Non-Pharmaceutical Intervention: Which One and Why? 
Not only is it critical to understand behaviour change in a pandemic disease scenario 
generally, but it is important to find an NPI that will fit a variety of criteria, from efficacy 
to adoptability and cost-efficiency.   There are findings in the literature that support the 
notion that effective prophylaxis can be obtained via a confluence of behaviour change and 
NPIs on multiple levels.  In one study, a consistent, daily, and multi-tiered NPI regimen 
was effective for the prevention of lab-confirmed and influenza-like illness: “elementary 
school students using a 5-layered NPI approach, including hand hygiene and cough 
etiquette, had 53% fewer laboratory-confirmed influenza A infections and 26% fewer total 
absences compared with a control group” (Aiello, 2008 reviewed in Vukotich, 2010). In 
other words, we can have some confidence that NPIs can limit transmission locally. 
However, it remains relatively unclear which aspects of multi-tiered interventions generate 
this effect. 
Nonetheless, some conclusions can be drawn in relation to specific interventions, notably 
hand washing, the use of facemasks, and isolation. Specifically, hand washing should, by 
definition, have no effect on aerosolized virus. Bridges (2003) suggests that the wearing of 
facemasks can reduce the risk of contracting aerosolized influenza virus, although some 
authors argue that small aerosolised particles pass easily through standard surgical 
facemasks (Tellier, 2009). It is also know that aerosol transmission tends to lead to more 
severe respiratory disease and longer duration of disease. 
Furthermore, the above studies focus on transmission among relatively small populations, 
and the effect NPIs on global dynamics has yet to be determined. This is particularly 
important in the case of pandemic influenza, where the nonlinearities inherent in 
epidemiological dynamics mean that even small influences on individual transmission may 
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have notable effects at the global scale, or alternatively that strong influences on individual 
transmission may only delay global pandemic rather than curbing its extent. 
Hand washing and hand hygiene are cited by most major health, safety, and scientific 
organizations as the single most effective and important prophylactic behaviour against the 
spread of infectious disease, including influenza-like illnesses (ILL) (Mehta et al., 2014).  
Several studies have also found that hand washing and hand hygiene are the most readily 
adopted prophylactic behaviours for H1N1 across a diverse range of populations (Biran et 
al., 2009; Rubin et al., 2009; Ibuka, Chapman, Meyers, Li, & Galvani, 2010). 
Stebbins, Downs, & Vukotich, (2009) states that individuals are more likely to adopt 
behaviours that are perceived as “more typical” than other behaviours.  For instance, the 
use of alcohol-based hand sanitizer, washing with soap, covering sneezes and coughs, and 
refraining from touching one’s face showed relatively high compliance as they are 
“typical”, while the use of facemasks showed conversely low compliance as it is perceived 
as “atypical” behaviour.  This suggests that the abundance of public risk communication 
that recommends hand hygiene for the prevention of H1N1 focuses on behaviour known to 
be readily adopted, as opposed to behaviour most likely to be efficacious.  
Summarising the findings from the different sections, public health communication might, 
therefore, be expected to have a negligible impact on health outcomes in the case of H1N1 
given its emphasis on the importance of hand hygiene, which to date has demonstrated 
negligible efficacy. However, (Snyder, 2010a) notes the more troubling possibility of 
instilling a false sense of efficacious prophylaxis in the public when hand washing is 
suggested as an effective behaviour, and similar arguments could be made for other 
ineffective behaviours (see also Hota & McGeer, 2007). For instance, trust in the efficacy 
of NPIs as adaptive behaviours to avoid infection has been shown to influence travel 
behaviour during H1N1 outbreaks, in that individuals are unlikely to change plans for 
international travel during an H1N1 outbreak if they perceive that NPIs lower risk to an 
acceptable level (C.-K. Lee, Song, Bendle, Kim, & Han, 2012). In light of this, if hand-
hygiene is not as efficacious as other prophylactic measures such as social avoidance and 
travel restriction, then the continued claims regarding the efficacy of hand washing in 
public health communication are not only inaccurate, but unethical. Demonstrating the 
possible impact of this miscommunication on public health outcomes using modelling 
methods could potentially inform future pandemic planning and communication policy. 
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The fact that more severe forms of the influenza are caused by aerosol transmission 
suggests that this route of transmission, rather than contact-based transmission, should be 
the focus when formulating NPIs and policies for infection control. This situation 
highlights not only the importance of establishing the viability of different transmission 
mechanisms, but also of understanding the proportion of infections due to the different 
routes, in order to predict the effect of different NPIs on epidemiological dynamics at the 
collective scale. 
Now that hand-hygiene (HH) has been identified as the most likely and efficacious NPI, it 
is important to examine the effects of this behaviour in our mild/severe modelling scenario 
on the key epidemiological indicators I identified in the previous modelling exercise. 
2.16 Modelling Behaviour 
 
Here, I introduce a new term ϕ, into the mild/severe model previously in the chapter that 
captures both the possible efficacy of hand-hygiene in preventing contract transmission 
that is associated with mild cases of influenza, in conjunction with the likelihood that 
people are actually adopting this HH behaviour. Essentially, ϕ = the probability of people 






=  −𝛽𝑆 𝐼𝑆𝑆 − (1 − ϕ)𝛽𝑀𝐼𝑀𝑆 
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= 𝛾𝑀𝐼𝑀 + 𝛾𝑆𝐼𝑆    
 
 
Model Structure and Parameterisation of ϕ: 
With the exception of the addition of the term ϕ, the model above is structurally identical 
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to the mild/severe model from the initial exercise in this Chapter.  In fact, it is useful to 
consider the mild/severe model previous to this one as a baseline, where the 
epidemiological dynamics of influenza transmission have continued uninterrupted by any 
type of intervention. In order to test the possible influence of human HH behaviour on 
these epidemiological dynamics, those mild/severe parameters remain unchanged in this 
scenario, and the term ϕ is the only changed variable in the scenario. As the previous 
outcome indicators from the mild/severe model are still of the most interest to pandemic 
planners and policymakers, and the findings for this modelling scenario will be organised 
in the same fashion as in the mild/severe scenario preceding.  
 
As noted above, ϕ represents a combination of two probabilities: 1) the probability that 
people will perform hand hygiene behaviour and 2) the probability that hand hygiene 
behaviour prevents mild-to-mild transmission. Thus, the term ϕ in this scenario serves to 
reduce the rate at which contact is effective in creating disease between an individual 
infected with mild disease and a susceptible person who has come into contact with them. 
It is known from the literature review on behaviour change and non-pharmaceutical 
interventions that precedes this exercise that hand hygiene is a readily adopted behaviour, 
but that its actual effect on transmission is somewhat less clear.  
Therefore, the effects of ϕ are likely to exist on a continuum, and we can assume that 1) the 
value of ϕ is greater than zero, (meaning there is likely some non-zero effect from 
handwashing and some probability that people are doing it) and that 2) the value of ϕ is 
also less than one, where all people are washing their hands as recommended and that this 
hand washing has a maximally preventative effect on mild transmission. Thus, I set ϕ=.33 
in this scenario, to reflect the fact that the performance of, and effectiveness of, hand 
hygiene are both likely to be moderate.  
 
Findings from the Hand Hygiene Model 
As in the previous mild/severe model in this chapter, these outcome measures of interest 
are important or public health and pandemic planning, and in this scenario aim to provide 
some insight into whether it can be said that moderate effectiveness from hand hygiene 
performed by even a limited proportion of people has any effect on the amount of mild 
disease we may see, or whether there is an effect from hand hygiene on overall 
epidemiological dynamics. These indicators are as follows: (A) Total number of cases over 
course of epidemic; (B) Total number of mild cases over course of epidemic; (C) epidemic 
peak time; and (D) Number of cases (severe, mild, total) at peak. As in the previous 
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mild/severe condition, the findings will be presented and discussed in the context of these 
outcome indicators.  
 
(A) What is the total number of cases over course of epidemic? The total number of cases 
at the end of the epidemic with the hand hygiene condition included was 988 out of 999 
individuals in the model, which, as is also the case in the mild/severe model, results in a 
98% rate of seropositivity at the end of the epidemic. The lack of change in overall cases 
over the course of the epidemic and the maintenance of a fairly high rate means that, even 
with moderate levels of hand hygiene behaviour that is also moderately effective, the 
overall case load could still place a significant burden on health systems overall. Moreover, 
unless there is some way to ensure increased compliance with hand hygiene behaviour or 
to ensure increase efficacy of handwashing, moderate levels of handwashing are unlikely 
to have an effect on the overall burden of disease in a mild/severe scenario.   
 
(B) What are the total number of mild cases over course of epidemic?  
 25% of total cases in this modelling scenario with hand-hygiene are mild cases. This is a 
modest decrease from the previous of percentage of mildly infected individuals in the 
mild/severe scenario, which was 29%. This is unlikely to be a meaningful decrease from 
the perspective of large-scale pandemic planning or capacity building activities, but it does 
point to a downward trend in mild cases, demonstrating the possibility that the current 
climate of communication surrounding the importance of hand hygiene may be serving 
some purpose if it encourages people to wash regularly and they comply. Increasing the 
efficacy of hand-hygiene, either through improved technique or through advances in 
product technology that allow the public to effectively kill the influenza virus when they 
wash, could potentially lead to a further decrease in the amount of mild cases seen over the 
course of an epidemic.  
 
The following findings, (C) epidemic peak time; and (D) number of cases (severe, mild, 
total) at peak, are also considered in conjunction here as they are in the mild/severe 
scenario, and in a fashion that compares mild and severe cases to fully contextualise the 
potential importance of these findings to pandemic planners and policymakers. Please refer 








Figure 2-2. Severe and peak times HH. 
 
Sensitivity Analysis and Parameter Adjustments: 
In the models above, ϕ represents a combination of two probabilities: 1) the probability 
that people will perform hand hygiene behaviour and 2) the probability that hand hygiene 
behaviour prevents mild-to-mild transmission. As previously discussed, the assumptions in 
the above models are taken from the existing behavioural literature regarding the extent to 
which that behaviour is likely to be undertaken, and the clinical literature to  extent to 
which that behaviour (hand hygiene) is likely to be efficacious in the reduction of disease 
transmission.  Below, Table 2-3 presents the results of a sensitivity analysis in which the 
upper and lower ranges of both the efficacy and the frequency of handwashing are 
explored. The assumptions in these model runs are that the effect of ϕ is likely to both 
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completely dampen the peak of the epidemic at highest probability of both performance 
and efficacy and that the peaks will reflect the same lack of separation as in the previous 
experimental conditions.  
 
In these models, the 1) the value of ϕ is either approaching one, (meaning there is a 
maximal effect from handwashing and maximum probability that people are doing it) and 
that 2) the value of ϕ is approaching zero, where few people are washing their hands as 
recommended and that this hand washing has a minimally preventative effect on mild 
transmission. It is also of note that in the two other scenarios in which either efficacy or the 
frequency of the behaviour is adjusted, there is unlikely to be any observable change from 
the above model. Thus, this is not explored in the maximal/minimal modelling scenario as, 
if no one is performing a behaviour, it’s efficaciousness is unlikely to matter, and likewise, 
if the efficaciousness of a behaviour is equal to zero, (no effect), the extent to which 
someone is performing it unlikely to have any impact. 
 
Findings from the Maximal/Minimal ϕ Hand Hygiene Model: 
These indicators are as follows: (A) Total number of cases over course of epidemic; (B) 
Total number of mild cases over course of epidemic. As in the previous mild/severe 
condition, the findings are presented and discussed in the context of these outcome 
indicators.  
(A) What is the total number of cases over course of epidemic? The total number of cases 
at the end of the epidemic with ϕ maximized at .98, (. 99 resulted in no infection 
whatsoever) suggesting the highest level of efficacy and performance. The infected agents 
totalled 2 out of 999 individuals in the model, which results in a rate of less than 1% 
seropositivity at the end of the epidemic. The lack of change in overall cases over the 
course of the epidemic and the maintenance of a very low rate means that with high levels 
of hand hygiene behaviour that is also highly effective, the overall epidemic would be 
practically eliminated, presenting no burden on health systems overall. This would suggest 
that if there were some way to ensure increased compliance with hand hygiene behaviour 
and to ensure increased efficacy of handwashing, high, sustained levels of handwashing are 
likely to have a net positive effect on the overall burden of disease in a mild/severe 
scenario.  Similarly, in the minimal scenario, (ϕ=.02) a corresponding uptick of infected 
individuals were observed, with all 999 subjects in the model infected. This interesting 
because in a given scenario of pandemic outbreak, where an epidemic is beginning and no 
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precautionary measures are being undertaken, a high rate of infection could be expected. 
However, what percentage of those cases might be subclinical due to partial immunity 
from previous infection or from vaccination is unknown as those variables are not 
available in the model.  
(B) What are the total number of mild cases over course of epidemic?  
100% (n=2) of total cases in the maximal efficacy/performance modelling scenario with 
hand-hygiene are mild cases. This is isn’t expected to have any effect on pandemic 
planning scenarios, however if points to the possibility that when an epidemic is well-
contained, there may be a decrease in severely infected individuals, which would in fact 
have an effect on pandemic planning or prevention initiative.  Likewise, in the minimal 
efficacy/performance scenario, solidly 100% in the model can be assumed to be severe 
cases, suggesting that with no intervention at all, (or intervention that is ineffective), there 
is likely to be an exceptionally high burden of disease on health systems. 
 
In general, the sensitivity analysis demonstrates the robustness of the model design, as the 
model reflects logically projected outcomes given maximal/minimal intervention 
scenarios. However, the parameterization of the model with appropriate values is still 
dependent upon the behavioural and clinical literature, and the possible limitations of that 
parameterization are discussed below.  
2.17 Limitations of the Study 
As in the figure from the mild/severe disease scenario, mild disease (in blue) and severe 
disease (in red) peak at the same time.  This means that, while hand hygiene at a moderate 
rate with a moderate efficacy may lower overall cases of mild disease seen throughout the 
course of the epidemic, it does not seem to have the effect of changing the time at which 
cases peak, or changing their simultaneous peak with severe cases.  Again, the overall 
value of moderate hand hygiene behaviour is of questionable significance from the 
perspective of pandemic planners and policymakers, as moderate handwashing behaviour 
and efficacy seem to have a limited effect of overall disease dynamics during the epidemic, 
and the small effect it does have in limiting mild transmission is unlikely to have a 
profound effect on planning or capacity building efforts.  
 
There were some limitations to the methods used in this study. First, parameterising 
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modelling exercises using data from experimental or observational studies always comes 
with some caveats. A model’s ability to predict outcomes is dependent upon the quality of 
the information available to inform it.  As so much of the literature on human behaviour 
change and influenza transmission is inconclusive, so too are the modelling findings to be 
considered in the context of fields of knowledge that are still developing. Secondly, both 
the transmission issues and the behavioural issues considered in the two modelling 
scenarios are likely to exist on a continuum. This means that the transmission of influenza 
and the behaviour of individuals are likely to change from epidemic to epidemic in “real 
world” scenarios, and this model has been developed using general assumptions about 
epidemics of existing strains of influenza and what is currently known about human 
behaviour change during them.  
 
Thus, when we consider how both transmission and behaviour might change in the face of 
an emerging epidemic or pandemic, the generalisability of this model becomes somewhat 
limited. Finally, time constraints on this exercise prohibited the exploration of the full 
range of behavioural and transmission scenarios. Adjusting the given parameters as new 
epidemiological or behavioural information becomes available could dramatically alter the 
output of the model, and thus, the actions of policymakers and planners considering it. 
Nonetheless, it has been demonstrated it is possible to integrate human behaviour change 
into an epidemiological model that considers multiple routes of transmission and different 
states of clinical severity, providing a richer picture of prophylactic behaviour in a complex 
epidemic scenario than was previously available.  
 
Further, the parameters in this model were chosen from the best available information in 
the literature at the time. As discussed in the chapter previously, there is a surprising lack 
of clarity from the clinical literature as to the details of influenza transmission and 
symptom severity. These models are merely an estimate as informed by the data that exists, 
and, like all models, will be prone to error.  However, it was a critical task to design a 
modelling experiment that both accounted for epidemiological and clinical characteristics 
of influenza as it explored the potential impact of a frequently recommended non-
pharmaceutical intervention. As more robust information from the clinical and 
experimental literature becomes available, these types of models become more robust and 
predictive by integrating that new data.  
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2.18 Discussion and Conclusions 
 
In the initial mild/severe modelling scenario, it was possible to use the existing 
experimental and observational literature on disease transmission and clinical severity to 
examine the ways in which different kinds of symptoms might have an effect on 
epidemiological dynamics. his has significant implications for policymakers and planners, 
as being able to anticipate how many severe cases, meaning cases most likely to need 
protracted clinical care, is fundamental to the task of building surge capacity, planning 
staffing, and deciding upon the appropriate risk messaging and interventions to promote to 
the public. For instance, in the mild/severe scenario, we see that there may be a roughly 3:1 
ratio of severe to mild disease. If a planner or policymaker can anticipate an epidemic that 
is likely to carry a proportionally high number of severe infections, they can adjust 
everything from staffing to budgetary measures to meet that demand and decrease the 
increased morbidity and mortality that comes with a higher proportion of severe cases.  It 
is also important for policymakers to know that they are likely to see both mild and severe 
cases peak at the same time, suggesting that there will be no influx of mild cases that 
would precipitate the severe ones, and that the epidemic would bring both mild and severe 
cases to the healthcare system’s attention at the same time.  This is important information 
for capacity planning, but also for triage systems, where healthcare workers and 
transportation workers monitoring fever can be informed that influenza that presents with 
various clinical features (cough/no cough) have differing impacts on onward transmission, 
and thus, on overall public health. 
When considering the hand hygiene model, the data here suggests that unless the efficacy 
of handwashing and the rate at which it is performed is increased from moderate levels, 
this kind of “background” level handwashing is unlikely to have an effect on 
epidemiological indicators of interest to policymakers or planners.  Conversely, this is of 
some concern to public health communicators who may have a vested interest in 
communicating about the benefits and limitations of hand hygiene on the public health in a 
meaningful, factually accurate manner. Understanding that their efforts should be focused 
on good technique (to increase effectiveness) and frequency (increasing the adoption of 
behaviour) could help them design more targeted, evidence-informed health 
communication initiatives pertaining to non-pharmaceutical interventions like hand 
hygiene.   
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Suggestions for future work include continued in-depth and systematic review of the 
literature to ensure that the model parameters as they are presented here are reflecting the 
most accurate and up-to-date data. It would also be useful to have more experimental and 
observational studies that explore the actual efficacy of hand-hygiene of preventing or 
limiting droplet and contact transmission of influenza, more studies that gather accurate 
data on the widespread adoption and frequency of hand-hygiene amongst the public, and 
more information about the pathogenesis of influenza with better characterisation of 






























Chapter 3 - How Does the Use of Contemporary Modelling Tools to 
Produce Public Health Policy Influence the Public’s Projected Health 
Behaviour? 
3.1 Introduction 
This chapter will introduce and discuss the public’s relationship to the scientific methods 
that underpin public policies that require behaviour change, focusing on scientific  
 
modelling.  The background portion of this chapter will provide justification for a study 
that was conducted in a general public sample which concludes this chapter. In the 
background, I will begin by discussing the increase of the use of scientific modelling as a 
way to inform evidence-based policy, with a discussion of what factors may play a role in 
whether or not people change their behaviour in accordance with policy recommendations. 
Secondly, frameworks for the development of modelling knowledge from the 
philosophical literature are briefly reviewed, including a brief discussion of the influence 
of formal and informal learning about models on the public understanding and acceptance 
of these methods. Finally, at the end of this chapter, a study conducted to ascertain the 
public’s confidence in modelling methods, and the public willingness to adopt policy 
recommendations for behaviour change informed by modelling, is detailed and discussed.  
3.2 Background 
Scientific modelling is rapidly becoming a primary tool for scientific inquiry and policy 
responses to some of the most pressing contemporary social and environmental issues such 
as health and climate change (Feenstra et al., 1998).  Public policy recommendations for 
behaviour change pertaining to issues in science and health are increasingly the result of 
work with scientific models (United Nations Sustainable Development Programme, 2002). 
However, although the use of modelling methods to inform policy has increased, the 
relationship between scientific evidence and policymaking is not always an easy one. 
Evidence-based policy is usually informed by a range of considerations, including those of 
interest groups, stakeholders and current political leaders and may also take into account 
issues such as cost-effectiveness (Mays, Pope, & Popay, 2005). Although these objectives 
may in some instances act in competition, policy typically has a strong scientific 
component (Sackett, Rosenberg, Gray, Haynes, & Richardson, 1996).  
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However, traditional forms of evidence, such as experimentation, don’t always provide a 
clear path from findings to policy recommendations, “research evidence, especially from 
the social world, is unlikely to be sufficiently clear cut and unambiguous to be translated 
directly into policy (Elliott, 2000).”  While this may also be partially true in the case of 
scientific modelling and policy, the use of modelling methods to inform policy may have 
some distinct advantages over more traditional methods of inquiry, such as 
experimentation.    
One of these advantages for policymakers and researchers alike is the flexibility of 
modelling methodology. This flexibility means that it is possible for a policymaker or 
researcher using a model to change the parameters of the model in order to explore not 
only possible outcomes of different conditions, but the impact of different interventions 
using both existing data and their expert experience, “the output of a model can help the 
modeller to learn and to develop intuition by playing out different rule sets and initial 
conditions and exploring their consequences (Boschetti, Grigg, & Enting, 2011).”  Models 
allow for the integration of the assumptions of the researchers or policymakers, in order to 
project the outcome of a multitude of possible factors that may moderate the response of 
their intervention.  
This facilitates quantifying phenomena in a novel way, as unlike more traditional 
experimental methods, modelling allows researchers and policymakers to explore possible 
intervention outcomes in a way that is generally prohibited by other methods. The ability 
of a policymaker to use a model as an experimental platform in this way, by integrating 
their personal expertise and insight into the model, is critical because “policymaking and 
decision-making take into consideration that research evidence may hold equal, or even 
less importance, than other factors that ultimately influence policy, such as policymakers' 
values and competing sources of information, including anecdotes and personal experience 
(Brownson et al., 2009).” The ability to explore the possible impacts of an intervention, or 
to simulate the impact of behaviour changes in a large population, in a manner that is 
quantifiable and meaningful to policy objectives, while also being considerate of 
constraints of time and resources, is almost exclusively the domain of modelling 
methodology. 
The additional circumstances in which modelling is an attractive alternative in the realms 
of public health science are typically more practical, as both researchers and policymakers 
are both often concerned with limitations when performing their duties, including time 
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constraints and economic austerity. Modelling methods in particular allow both 
communities to explore multiple possibilities in limited time frame with fewer material 
resources than required by other research methodologies.  
In this context, the increased popularity of modelling methods to inform public policies 
that require behaviour change under complex circumstances is understandable.  Modelling 
provides features which more traditional modes of inquiry and policy development cannot, 
and those features speak to the aims of improving the content of policies under constraints 
of both the policymaking and research inquiry processes. 
Despite the utility of modelling for policymakers and researchers, the success of a 
modelling-informed policy ultimately depends on public support. Regardless of the 
sophistication of a given policy or the potential benefits of the behaviour-change 
recommendations within it, a policy cannot be considered successful if it lacks the support 
of the public and the recommendations therein remain un-adopted. Unsupported policies 
are politically costly, and their effective implementation is reliant on the wide adoption of 
the recommendations they make for optimal effectiveness. Constituency support is not 
only critical to garnering the political will needed to implement behaviour change policies, 
but to ensure that the public will actually perform the behaviour changes required (Burgess 
et al., 2007). The evidence-based policy agenda would therefore benefit from 
understanding the link between public understanding of the evidence base and their policy 
support.   
In the next section, factors which may influence the public’s willingness to change their 
behaviour in accordance with recommendations made in evidence-based policies are 
detailed and discussed. 
3.3 Behaviour Change, Modelling-informed Policy, and Communication 
Effects 
It is first necessary to understand what underlies human behaviour change in relation to 
policy recommendations. It is known that a variety of factors influence behaviour change, 
including, but not limited to: age, gender, socio-economic status, and attainment of 
education at a range of levels, noting that all of these spheres of individual and social 
environmental influence may interact in combination to influence what behaviours 
individuals change and to what extent (McLeroy, Bibeau, Steckler, & Glanz, 1988). Yet, 
while individual decisions to support policy or change behaviour may be predicated on a 
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range of social and economic variables, increasingly research has focused on individual 
responses to communication materials (Skinner et al., 1999).  Human behavioural 
responses to communication about risk and health are themselves moderated by several 
factors.  
Two fundamental factors known to influence individual responses to communication 
efforts are trust and confidence (Siegrist, Earle, & Gutscher, 2003). As Siegrist et al. (2003, 
p. 706) explain, trust relies on social interdependence and that the “objects of trust are 
person-like entities”, while confidence is defined as “the belief, based on experience or 
evidence, that certain future events will occur as expected”. 
It is important to distinguish these two concepts of trust and confidence, as they are 
qualitatively different, although may be used interchangeably. Confidence and trust can be 
delineated by an individual’s assessment of risk, “a confidence judgment typically has a 
very specific referent, and is influenced by base rates and prior probabilities. A trust 
judgment has a broader scope and referent (Adams, 2005)”. Moreover, trust is only an 
issue in “the presence of risk, uncertainty, vulnerability and the need for interdependency 
with another person (Mayer et. al., 1995 in Adams 2005).” In the context of evidence-
based policy, trust therefore relates to policy-makers, politicians and those who 
communicate with the public, whereas confidence relates to the evidence base 
underpinning the policies. 
It is also important to consider what the public will do with information that is 
disseminated in a policy that asks behaviour change of them. In the public realm, 
individuals seek information only to the point where they feel they have enough 
information to justify action in some way, and do not examine a policy issue more deeply 
than is necessary to come to some satisfactory conclusion regarding the action they should, 
or should not, take (Jenkins, 1999) . The confidence that an individual has in the method 
that underpins a particular policy recommendation may thusly play a major role in whether 
or not the individual acts accordingly with the recommendation in the policy. 
Further, attitudes toward behaviour change, particularly in the face of uncertainty about a 
policy issue, may be deeply rooted in the perceived reliability of the communicator, and 
that perception of reliability is highly context-dependent. This suggests a function of trust 
rather than confidence.  It is reasonable to assume that even if the trust an individual has in 
a communicator is somehow compromised, a familiarity with the scientific method used to 
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inform the policy, and confidence in that method, may help moderate that uncertainty and 
compel the individual toward the adoption of the proposed behaviour change.         
It is notable that there is ample discussion in the literature about the effects of trust on the 
public’s relationship to public policy that asks behaviour change, and far fewer 
examinations of the effects of public confidence in the methods used to inform the policies 
in question.  This creates a gap in the understanding of how confidence moderates 
behaviour change in the policy-modelling interface, and what other factors confidence may 
be moderating in this process.  
The general familiarity the public has with modelling also plays a role in whether or not 
they have confidence that the chosen method can accurately inform behaviour-change 
policy.  Despite its utility and increasing use in research and policymaking, scientific 
modelling as a major methodological tool may not be well understood in all domains.  In 
fact, these methods are often unfamiliar to individuals outside of the fields in which they 
predominate, and to members of the general public, “(scientific modelling) is an unfamiliar 
form of inference not just for lay people but even for scientists whose disciplines use 
observational methods (Pidgeon & Fischhoff, 2011).”  This could be identified as a source 
of reticence to change behaviour in the public, as it is impossible for an individual to make 
a confidence judgment of a particular policy recommendation if they are unfamiliar with, 
or confused by, the scientific methods used to come to that conclusion. 
Nonetheless, as modelling has become a ubiquitous method for prediction and policy 
development, there has been an increase in public exposure to modelling methods through 
media reports about scientific topics and formal education. A search on AlphaGalileo for 
News Releases including the keywords “model” or “modelling” and categorised under 
Science, Health, and Applied Science returned 3407 results for the 5-year period 
commencing 1 January 2003, and 5422 for the respective period starting 1 January 2008.1  
Evidence supports the idea that media messages on television about science can influence 
individual beliefs about scientific topics (Hwang & Southwell, 2009), and the Agenda-
Setting hypothesis actually suggests that shifting public opinion on a scientific matter may 
be the result of the extent or salience of media coverage pertaining to that topic (Brulle, 
Carmichael, & Jenkins, 2012). Finally, the frequency with which an issue appears in media 
                                                 
1 Search conducted 16 January 2013 using http://www.alphagalileo.org/AdvancedSearch.aspx; defaults used 
for all other search options. 
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coverage has been found to usurp actual content in swaying public opinion about the 
relevance and importance of a particular matter (Andrews & Caren, 2010). 
Therefore, the extent to which the public is exposed to the concept of modelling in news 
reports about public policy issues of importance may be not just be moderating how 
familiar they are with modelling as a tool in scientific inquiry, but also how confident they 
are in scientific modelling as a standard part of the scientific process, thereby influencing 
their willingness to change their behaviour as recommended in policies that have been 
informed by modelling methods. A “fixed” understanding (or existing mental model) of 
how “good science” is conducted may stand as a primary barrier to behaviour change when 
the recommendation for that change is generated from an unfamiliar source (Sterman & 
Sweeney, 2007) if the public is unfamiliar with modelling as an integral part of that “good 
science” or policy practice. 
In the next section, this critical area of modelling knowledge is discussed, with a focus on 
the formal and informal learning scenarios during which the public may encounter models. 
Existing frameworks for building modelling knowledge are also discussed.  
3.4 Modelling in Formal and Informal Learning Settings and Frameworks of 
Modelling Knowledge 
In conjunction with increasing familiarity with modelling through its ubiquity in policy, 
formal and informal education in science may also contribute to public understanding of 
models and modelling. This is likely to be more prevalent among those having been 
involved in higher education in a scientific or allied area, as well as among younger 
members of the population who may have encountered modelling at school. Although 
there is currently limited focusing on modelling in school science education, authors have 
commented that increased exposure to modelling and other technologies in the classroom, 
and encouragement to apply classroom science to everyday situations, would increase the 
public understanding of modelling technologies (Cajas, 1999) and that “a central role for 
models and modelling would greatly increase the authenticity and utility of the science 
curriculum” (Gilbert, 2004, p.127).  
Nevertheless, there is some suggestion in the literature that, with even a moderate facility 
with modelling, or exposure to modelling through formal education, students of modelling 
may still be considered “novices”, and that there may be a lack of sophistication with, or 
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understanding of, modelling methodology in a general sense (Harrison & Treagust, 1998).  
The threshold at which modelling knowledge begins to instil confidence in an individual 
member of the general public has not yet been explored. Contributing to this issue is that 
modelling is unlikely to be taught as an integral part of contemporary scientific practice in 
classrooms.  
Danusso, Testa, and Vicentini, (2010) argue that the science education literature has 
demonstrated modelling activities to be used only rarely in science classroom situations, 
despite demonstrations that even short interventions can support more sophisticated 
knowledge (Gobert et al., 2011; Schwarz et al. 2009; Pluta, Chinn, & Duncan, 2011). 
Indeed, a range of studies have shown that both teacher and learner knowledge of the 
nature of models is generally limited (Danusso, Testa & Vicentini 2010). For instance, 
without specific instruction, students tended to understand models as miniatures of real-life 
objects that corresponded in every way except scale (Grosslight, Unger, Jay, & Smith, 
1991). Similar studies of public understanding of models are missing from the literatures. 
Informal learning scenarios, outside the classroom, may also play a role in the public’s 
general familiarity with models and their confidence in them.  Informal learning can be 
understood in contrast to the formal, structured, classroom-based learning discussed above, 
however, informal learning is not entirely passive, “informal learning is usually intentional 
but not highly structured (Marsick & Watkins, 2001).”  
In fact, the importance of informal learning for improved scientific literacy should not be 
understated, “The majority of students’ science learning experience actually takes place 
outside of the formal classroom setting and in informal learning environments, and such 
learning may take place at home, in museums, through media, club membership activities, 
or simply in everyday experiences (Gerber, Cavallo, & Marek, 2001)”.  This is key, as in 
the previous section, the increased exposure of the public to modelling methods through 
media reports on public policy issues was discussed, and it is reasonable to assume that this 
may be playing a role in increasing the general knowledge and understanding of the public 
in reference to modelling methodology.  
However, it should be noted that it is impossible to make specific claims about the role of 
informal learning in the public understanding of modelling methodology, as there has been 
little to no inquiry that specifically addresses this issue. Yet, while it is impossible to make 
direct claims about the role of informal learning on public understanding of the policy-
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modelling interface, it would likely be beneficial to explore ways in which the public are 
exposed to this technology and the role this exposure may play in their understanding and 
acceptance of policies that are informed by it. 
While there is a lack of inquiry into the role informal learning has to play in the public 
understanding and acceptance of modelling methods, there have been many attempts to 
detail and apply frameworks of modelling knowledge to this issue. Different 
understandings of scientific modelling are, in part, related to the numerous uses of 
modelling in science, some of which may be more salient than others for the lay public. 
Following frameworks on the nature of science, researchers in the science education 
literature have developed a number of schemes for considering knowledge of modelling.  
Schwarz et al. (2009) distinguish between a range of elements of meta-modelling 
knowledge, grouping these according to nature of models, purpose of models and criteria 
for evaluating models. Following the evaluation thread, Pluta, Chinn, and Duncan (2011) 
consider epistemic criteria for good models, comparing the criteria generated between 
students and experts. Considering notions more in line with the nature or purpose of 
models, Van Driel & Verloop (1999) distinguish between descriptive, explanatory and 
predictive models, while Treagust, Chittleborough, & Mamiala (2002) distinguish between 
10 kinds of models: scale models; pedagogical analytic models; iconic and symbolic 
models; mathematical models; theoretical models; maps, diagrams and tables; concept-
process models; simulations; mental models; and synthetic models.  
However, their framework makes no distinction between models are and what their 
purpose is.2 Odenbaugh (2005) focuses on the different purposes of models in science, with 
a focus on theoretical ecology. Although he acknowledges that the same model may have 
multiple concurrent roles, his taxonomy distinguishes between the use of models by 
scientists: to explore possibilities; to provide a tool for simplifying and thus investigating 
complex systems; to provide conceptual frameworks; to generate predictions; and to 
develop explanations. This framework has been adopted by Svoboda and Passmore (2011) 
to the context of science education. Among these frameworks, I choose to focus on the 
                                                 
2 Although Harrison and Treagust describe their framework as a typology, there seems to be some overlap 
between certain categories: for example, some of the examples given for mathematical models also 
appear to fit within the description of iconic and symbolic models. The framework also suffers from a 
lack of clarity in the definitions of model types as these are communicated only in the form of examples 
rather than general principles. As a result, we found it difficult to distinguish between types and discuss 
this framework no further. 
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framework by Odenbaugh (2005). This framework appears to provide the most complete 
and authentic description of the purposes of modelling as employed by scientists, and thus 
of its uses in the science that underpins policy, as understood by scientists themselves. 
In summary, the last few decades have witnessed a shift in the policy agenda towards 
evidence-based policy development, while in the scientific arena, methodological 
developments have led to an increase in the use of modelling. Although scientific 
modelling has become common in the development of policy and in media reports, public 
responses to these developments remain unclear, be it in relation to their understanding of 
the scientific methods or confidence in the evidence they provide for use in policy 
contexts. Indeed, in research on behaviour change policy, attention has focused primarily 
on the concept of trust and especially trust in expert communicators and governmental 
entities (Blake, 1999); the concept of confidence has attracted less attention, particularly in 
relation to a comparison between public confidence in different sources of scientific 
evidence.  
This chapter has detailed a research gap in the literature, specifically focusing on the role 
of confidence in different sources of scientific evidence as a mediating factor in the 
adoption of policies that require behaviour change. What follows in the next sections are 
the methods of a study conducted to fill that gap, and to further explore what confidence 
the public has in a range of scientific methodologies, specifically modelling, and whether 
that perception of confidence may moderate their projected behaviours as recommended by 
public policies.  
In this study, I sought to answer two main questions. Firstly, how does the public 
understand scientific models and their use in relation to other sources of scientific 
evidence? Secondly, how do perceptions of the source of evidence relate to projected 
responses to evidence-based policy? To address these questions, I conducted a survey in 
the form of a paper-based questionnaire that provided evidence in relation to both 
questions, supplemented by mini-interview data on public understanding of scientific 
modelling that contributes to answering the first question. In this section, I describe the 
data collection process, providing information on participants as well as a description of 
the two forms of data collection and their analysis. After the findings of the study are 
discussed, recommendations for further research and potential policy implications of the 




3.5.1 Participants and Participant Characteristics 
Participants were volunteers asked at random to respond to the paper-based questionnaire 
and mini-interview questions during their attendance at one of two public events in a large 
Scottish city in June 2011. The first of these events was a community science festival and 
the second a public street festival held the following week that had no explicit science 
element. Individuals were asked to participate in both the mini-interview and the 
questionnaire but could decline to participate in either or both. Due to possible difficulties 
participants might have understanding the questions, participants under the age of 16 were 
removed from the questionnaire sample, leaving a total of 95 respondents in the 
questionnaire analysis. 
 
Of these, only 10 participated in the questionnaire only, and an additional 7 the mini-
interview only (leaving mini-interview n=102, with 3 eliminated for lack of consent form 
signature) and 78 total for both the questionnaire and mini-interview together. While the 
sample size for this questionnaire data is relatively small at under n=100 participants 
included in the analysis, and cannot provide a significant amount of statistical power, it is 
of sufficient enough size and depth to provide the basis for an exploratory study such as 
this which is seeking to characterize the presence, rather than the extent, of a phenomena. 
 
Across the full adult sample, the mean age of participants was 34 years and the ratio of 
male to female respondents was 47:53. Participants possessed a range of science 
involvement experiences: 3 reported primary school education, 31 high school education, 
26 undergraduate, 15 postgraduate, 7 professional involvement in science; 13 individuals 
declined to respond. Participants were also asked about the frequency of their attendance at 
public science events: 12 attended more than twice in the last year, 24 attended one-two 
times over the last year, 24 attended previously, but not for a while. 15 never attended; 20 
individuals refused to respond.   
 
Male subjects responses (M = 6.10, SD = 1.40) did not differ significantly from female 
respondents from female respondents (M = 6.22, SD = 1.48). Neither did the comparison 
of those who were sampled at the science fair (M = 3.39, SD = .31) and the public event 
(M = 3.47, SD = .31) revealed any significant differences between the groups. Exploration 
of other demographic characteristics was somewhat prohibited by the high number of 
refusal responses to these questions and the skewed distribution in some other potential 
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indicators of group difference, such as educational level, but they also yielded no 
significant group differences. On those indicators however, (especially educational level) 
there may indeed be group differences, but a larger and more consistent sample is needed 
to draw more certain conclusions about the possibility of real differences between 
respondent groups. 
3.5.2 Questionnaire 
Questionnaires were administered and completed at the site of recruitment. The 
questionnaire was content-validated by pilot use in a previous pilot study that had provided 
the motivation for the work described here in the form of the demonstration of a lack of 
trust in modelling compared with experimental science (Lough, 2011). In addition to 
demographic questions on age, gender, educational level in science and recent attendance 
at public science events, the questionnaire contained questions in three main formats.  
The first class of questions aimed to understand perceptions of confidence, first by 
assessing levels of confidence in scientific predictions on the basis of the sources of 
evidence used, and second by assessing levels of confidence expected by individuals for 
science that is used as the basis for policy-making. These questions used predefined levels 
of confidence drawn from the guidance on describing levels of scientific confidence in 
reports by the Intergovernmental Panel on Climate Change (Le Treut et al., 2007). There 
were five categories of confidence with explicit numerical meanings: very low (less than 1 
out of 10), low (about 2 out of 10), medium (about 5 out of 10), high (about 8 out of 10), 
very high (at least 9 out of 10). The second class of questions used standard incremental 
Likert scales to gauge levels of agreement in five classes from strongly agree to strongly 
disagree. In this class of questions, individuals were asked to choose a level of agreement 
with statements relating to the role of models in science and in policy making. The final 
class of questions asked participants to select one or more sources of evidence in relation 
to the following: sources of evidence that they believed to underpin scientific 
understandings, sources of evidence that would lead them to believe that policy 
recommendations would be effective, and sources that would lead them to take particular 
actions.  
Categories of sources of evidence, piloted in a previous study (Lough, 2011), were 
motivated by reading of the science education literature. These consisted of: Experience of 
experts, Experiments, Mathematical models, Computer Models, Historic studies, Current 
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data and No support (a fuller description is provided in the questionnaire, available in the 
online supplementary materials). I wished to distinguish between symbolic mathematical 
or analytic modelling and simulation. The language used to describe these two modelling 
approaches was selected on the basis that the terms computer models and mathematical 
models were more commonly used on the BBC news website than other terms in the 
scientific literature used to describe these concepts and I assumed the public would be 
familiar with them. 
I chose the areas of climate change and pandemic influenza as policy-related areas of 
science where interventions required individual behaviour change. Our interests were in 
understanding projected mitigation behaviours and beliefs about the behaviour’s efficacy, 
and how behaviours might be related to understandings of the source of evidence 
supporting them. The influenza mitigation behaviours were drawn from the from the 
National Health Service Flu leaflet that was sent to all households in the UK in during the 
most recent H1N1 pandemic in the case of pandemic influenza (National Health Service, 
2009) while the climate change mitigation behaviours were chosen among those listed in 
official UK guidance on climate change mitigation actions on the DEFRA web page 
‘DEFRA: What can you do?’ (Department for Environment & Department for 
Environment, 2011). Two versions of the questionnaire were developed, one with the 
pandemic influenza questions preceding those on climate change, and the other with the 
order reversed. Participants were randomly provided with one of the versions in order to 
reduce ordering bias. 
Questionnaire data were analysed using commercially available statistical processing 
packages (SPSS 16 for Windows, and R) using descriptive statistics including cross 
tabulation, Spearman correlation tests, Wilcoxon Signed Rank test, and figures generated 
in Excel 2007. Any p values of <.05 were interpreted to be statistically significant, and 
where correlations were significant at the p <.01 level, this is noted. This combination of 
statistical techniques was chosen to reflect the need to both quantify our ordinary and 
normally distributed data, but I made the choice to augment this analysis with the use of 
non-parametric tests to leverage the flexibility of these tests,  and their ability to describe 
phenomena in data that is non-ordinary or of any distribution.  As this paper seeks to 
characterize a phenomenon rather than to test a particular hypothesis, the use of non-
parametric tests was particularly important in conjunction with more traditional parametic 




The semi-structured mini-interviews consisted of three questions and were recorded at the 
recruitment site (see Participants). Respondents were first asked ‘what do you think 
scientists mean when they talk about models?’ following their response, they were 
prompted with the follow-up question ‘what do you think (climate/health) scientists mean 
when they talk about models?’ Finally, individuals were asked ‘what do you think 
(climate/health) scientists do with models?’ The climate and health conditions were 
alternated to correspond to the order of the questions in the questionnaire that each 
individual had been assigned with a view to eliminating possible priming effects. The 
mini-interviews were administered prior to the questionnaire as the latter introduced ideas 
relating to possible uses of models, and I wished to avoid priming effects of this type. 
Responses were captured using a digital voice recorder and converted into MP3 format for 
transcription and analysis. The MP3 files were then transcribed into text for coding and 
analysis with NVivo 9.  
To analyse the mini-interviews, I employed Template Analysis (Cassell & Symon, 2004), a 
form of Content Analysis. I began with a priori themes from Odenbaugh et al. (2005) 
relating to the uses of models, as described above. The process of data analysis was carried 
out as follows. Firstly, one of the authors (RM) read all mini-interviews to familiarize 
herself with the content. This allowed me to identify excerpts that were poorly described 
by the a priori codes from Odenbaugh’s (2005) taxonomy and to note that these a priori 
codes were better suited for coding responses relating to the uses of models than for 
responses relating to what models are. As a result of this examination, two dimensions 
were constructed - what models are and what models are for - and additional codes created 
for the first dimension to create an initial coding scheme that captured the a priori and 
additional conceptions of models arising from the data.  
This set of codes was provided to the other two authors (JE and AK) who initially coded a 
randomly selected sample of interview text corresponding to around 20% of the full set. 
These two authors (JE and AK) met with a third author (RM) to discuss the initial coding 
and together developed the final template for coding discussing all problematic cases from 
the initial coding until consensus was reached. In both dimensions, a category was created 
to capture responses that were either non-scientific or vague; during this phase, no text was 
coded into categories generate new ideas or theory. The retained codes were used as nodes 
in the NVivo database. 
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It was agreed that text that specifically mentioned a keyword would be coded into the node 
that corresponded with that keyword. For instance, the participant quote, “models are ways 
of them trying to understand and analyse the environment, or world, for the purpose of 
making predictions about weather climate changes, and such”, was coded into the 
prediction node because it used the word prediction. However, some quotes from 
participants contained none of the keywords, and context was used by the coders to place 
the quote in the appropriate node. It was also agreed that multiple coding would be applied 
where participant responses fitted with more than one category; as a result, the number of 
coded segments exceeds the number of participants. 
Finally, two authors (JE and AK) coded the full dataset independently. Once coding was 
completed I eliminated 34 of the original 99 mini-interviews considered invalid due to the 
young age of participants (cut-off age of 16 years) or because participants did not respond 
to all of the mini-interview questions, leaving 65 valid mini-interviews. Reliability 
coefficients were calculated for the remaining 65 mini-interviews3 and percentage 
agreement ranged from 91.58-99.80 %, indicating excellent overall agreement, with an 
overall Kappa coefficient of 0.96. 
3.4 Findings 
Findings are presented according to the research questions: I begin by presenting findings 
relating to the public understanding of scientific methods, focusing specifically on 
modelling, and then move on to consider their use in policy making. Qualitative findings 
are presented in conjunction with the quantitative findings where appropriate. 
3.4.1 Public Understanding of Scientific Methods 
I begin this section by presenting data on the sources of evidence the public believes to 
underpin findings relating to climate change and pandemic influenza, with specific focus 
on the perceived role of modelling and consider public perceptions of achievable 
confidence levels associated with each of source. I then present findings on qualitative 
understandings of models and their use. 
                                                 
3 While not all authors approve of the use of reliability coefficients for template analysis, our realist 
epistemological framework, use of Template Analysis as an extension to Content Analysis, and desire to 
link conceptions of models to the quantitative data acquired from the survey meant that this was an 
appropriate approach for our study. 
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In response to the question asking participants about the sources of evidence believed to 
underpin findings about climate change and pandemic influenza (Figure 3-3), the most 
commonly selected sources of evidence for future climate predictions were those of 
computational models, historic studies and mathematical models (all around 60%), with 
current data also featuring fairly strongly, but rather fewer respondents indicating a role for 
experimental methods (around 36%). Both mathematical and computational modelling also 
featured strongly in responses relating to the sources of evidence for the link between 
human energy consumption and climate change.  
In relation to the analogous question in the context of influenza, respondents selected on 
average fewer sources of evidence, with the experience of experts and current data figuring 
most strongly. For these questions, more respondents believed that modelling is involved 
in predictions about the spread of influenza than in the relationship between behaviour 
spread. Computational modelling appears to have a stronger public association with 
climate change research than influenza: 67% of respondents indicated a belief that current 
evidence for climate change predictions comes from computer modelling compared to 50% 
in the infectious disease context. 
 
Figure 3-3. Public understanding of data sources for climate change versus influenza. 
In your opinion, how are the findings relating to the following supported? Perceived 
sources of evidence for predictions about climate change and pandemic influenza, as 
well as for the link between behaviour and the two application areas. (Bars are in the 
same order as shown in the legend.) 
 

















































supplementary question asking whether models were perceived to be a part of ‘good 
science’ (see Figure 4-3). In the context of climate change, 78% of respondents agreed or 
strongly agreed, increasing to 86% in the context of pandemic influenza; responses relating 





Figure 4-3. Public understanding of the importance of models in science. Percentage 
agreement with the statement that ‘models are an important part of good science’ for 
infectious disease and pandemic influenza conditions. 
 
In response to the question relating to the level of confidence that can be achieved in 
predictions based on each of the sources of evidence, a relatively clear pattern emerges 
(Figure 5-3). I focus on responses indicating high or very high confidence (8/10 and 9/10) 
since medium confidence corresponds to a 50-50 chance of predictions being accurate4. 
Participants expressed the highest levels of confidence in predictions based on 
experimental science (86% high or very high), with this figure falling to 69% for 
mathematical models, 66% for life experience of experts and again to 60% for computer 
models. Historic studies and current data attracted the lowest levels of confidence.  
                                                 
4 In fact, a 5/10 or 50% probability of predictions being accurate may be considered as successful science and 
largely sufficient to justify policy interventions, particularly in the context of competing theories or when 





































Figure 5-3. Levels of confidence in the various sources of scientific evidence. In your 
opinion, what level of confidence can we have in scientific predictions or 
recommendations based on the following, assuming that any research is carried out 
properly?  
 
To summarise, the diversity of responses regarding the source of scientific evidence in the 
questionnaire suggests that the public recognises a role for multiple sources of evidence in 
scientific enquiry, with an acknowledged role for modelling in the context of climate 
change and pandemic influenza. Although more respondents believed that evidence for 
climate predictions came from modelling than for infectious disease predictions, fewer 
respondents believed that models formed an important part of good climate science than 
infectious disease. Despite the acknowledgement of an important role for modelling in 
science, participants reported higher levels of confidence in predictions and 
recommendations based on experimental science than either form of modelling. 
I used the qualitative data collected to explore the disparity between apparent knowledge 
of the role of modelling and lack of confidence in models, by focusing on how the public 
understands modelling as a scientific approach. As explained in Methodology, we analysed 
the qualitative interview data along two dimensions: firstly public understandings of what 




























Very low confidence (less
than 1 out of 10)
Low confidence (about 2
out of 10)
Medium confidence (about
5 out of 10)
High confidence (about 8
out of 10)
Very high confidence (at
least 9 out of 10)
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In the mini-interviews, although most understandings were rather incomplete, it was 
nonetheless possible to categorise responses according to the extended version of 
Odenbaugh’s (2005) framework. Because I allowed multiple coding, I had data on 
numbers of coded segments and numbers of respondents providing particular responses; 
we refer to these as responses and respondents. Among our coding categories, proportions 
of total responses ranged from 0.8% to 14.2%. In Dimension 1 the non-scientific or vague 
category accounted for 2.7% of responses, while in Dimension 2, this accounted for 2.1% 
of responses, collectively accounting for just over 4.8% of total responses. An example of 
a respondent quote where the answer was classified as non-scientific or vague was the 
following: “probably talking about … health of people ... I don’t know, I really don’t 
know.” However, most of the responses that were included in this category included the 
participant completely deferring knowledge of any sort about modelling by saying “I don’t 
know” or “I’m not sure” or some variation thereof. Of our total sample, only 4.77% 
respondents were unable to provide a meaningful response in either dimension.  
Across all categories, prediction attracted the highest number of responses at 14.2% of the 
total responses (Figure 6-3), with just over 3% more responses categorised in this way than 
for the next most popular category, exploration. Most of the prediction quotes explicitly 
stated an understanding that models are used for predicting future events or trends. For 
example, the responses categorised as prediction typically included this keyword and a 
contained relatively decisive claim that models are used to predict the future: “models, um, 
well it’s like a system for predicting what’s going to happen at some point in the future; 
put in the information that we know and look forward, or find out, what would happen 
based on that information.” Even where the word “prediction” was not used, models were 
described as something that may be used to understand what would or will happen through 
use of the future tense as in the following example: “um, usually it’s kind of for health 
scientists, they are usually working out different demographics or … groups of people or 
different [drugs] and how it will affect people.” Here, the focus is not prediction in the 
abstract, but the creation by the respondent of a concrete example of a scenario in which 
scientists might use a model to predict the outcome of a specific intervention.  
Overall, the second dimension, the use of models by scientists, attracted more responses 
than the dimension that related to what models are. However, a noteworthy proportion of 
responses to this second dimension were actually provided in response to the question 
prompt for dimension one. Similarly, the category of prediction, which attracted the 
highest percentage of responses, is in the dimension of what scientists do with models. 
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This suggests that respondents found the uses of models more salient or easier to formulate 
than descriptions of models as entities, and hints at the idea that public understanding of 
models as tools used for specific scientific purposes is better developed than their 
understanding of them as entities. 
 
Figure 6-3. What models are and what models are for. Percentages of responses in 
each coding category along dimension one (left group) and dimension two (right 
group). 
 
Focusing on the first dimension, the category that attracted the most responses was that of 
unspecified representation at 10.9%, followed by duplications of reality at 9.0%. For 
example, an unspecified representation quote from one of our respondents was: “I suppose 
like just examples then really, yeah, like a model, yeah, I suppose like an example, almost, 
of like a kind of general example.” This quote indicated the essence of unspecified 
representation in that the model is understood as a representation of something, as an 
example to be used, but exactly of what is left vague. Interestingly, models were much less 
frequently viewed as simplifications (2.0%) than as duplications or copies of reality 
(9.0%). Some of the less commonly used categories appeared to be those that relied on 
vernacular (as opposed to scientific) understandings of the term model: models as mock-
ups or models as idealised or perfect cases5. For example, one participant stated, “I think 
                                                 
5 Although idea of models as perfect or idealised cases may spring from vernacular understandings of the 
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they mean, like, they do a model before they do the real thing first.” This quote indicates a 
fairly precise but concrete understanding of the use of a model as a tool to represent 
something before it is scaled or built. Finally, individuals tended to provide responses that 
were coded into a single node. It is possible that this is because their understanding of 
modelling methodology is very limited, but it should be noted that this may also be the 
result of the mini-interview format, which was very brief, semi-structured, and did not 
leave room for prolonged free-form responses. 
In summary, the data inform us that although respondents recognise a role for a range of 
methods including modelling in generating findings about PI and CC and despite 
recognising modelling as a part of good science in both areas, they have higher confidence 
in experimental methods. A majority of individuals were able to provide answers to the 
question of what scientists mean by modelling, and although across the sample there was a 
good deal of diversity, individuals tended to focus on a limited number of uses, with 
prediction being the most commonly cited use. 
3.4.2 Public Views of Sources of Evidence in Policy-Making 
I now consider the role of source of evidence in perceptions relating to the application of 
scientific findings in policy making, focusing on policies that require individual behaviour 
change in the context of CC and PI. I present data on the level of confidence the public 
demands of scientists before predictions are used to inform policy that requires specific 
behaviour changes, which sources of evidence are perceived as being most likely to 
provide the confidence required, and data specific to the role of modelling methodology in 
this kind of public policy.  
Participants were asked how confident they believed scientists should be in their 
predictions before the government uses them to create policies that require behaviour 
change in general, as well as in relation to CC and PI. In the general case, individuals 
demanded a relatively high level of confidence (84% demanded either high or very high 
confidence; see Figure 7-3). Interestingly, the level of confidence demanded of scientists 
was lower for both the CC and PI conditions. Although the reason for this finding is 
unclear, it may be that respondents required lower levels of confidence in the case where 
the possibility of explicit adverse effects is relatively clear. Nonetheless, chi square 
analysis revealed a significant association between confidence required in the general case 
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and CC (χ2 (9, N=95) = 18.06, p=.034), the general case and PF (χ2 (9, N=95) = 36.81, 
p<.001), and between CC and PI (χ2 (9, N=95) = 37.47, p<.001).   
 
Figure 7-3. Levels of confidence demanded of scientists before predictions are used in 
policy making.  
 
 I was interested in understanding whether participants believed that each of the sources of 
evidence considered was capable of providing sufficient confidence to be used to inform 
policy, and whether projected behaviour change was dependent on the source of evidence. 
To investigate this, I compared perceptions of maximum achievable confidence from each 
source with overall level of confidence demanded before findings were used to inform 
policy. For each individual, an index was constructed for each source of evidence that 
indicated whether the maximum perceived confidence by an individual was at least as high 
as the level that same individual demanded to inform policy6. Findings are shown in Figure 
8-3, and show that from the range of available sources of evidence, scientific experiments 
were perceived as capable of providing sufficient levels of confidence for the highest 
proportion of participants (68% of respondents). Levels were markedly lower for other 
                                                 
6 Although it is clear from Figures 5 that experimental evidence is generally perceived as providing the 
highest levels of confidence, the individual level of analysis provides additional information. Specfically, 
it is likely that acceptance of policy is contingent on the relationship between perceptions of confidence in 
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sources. Interestingly, the life experience of experts inspired sufficient confidence for 51% 
of respondents, a similar proportion to mathematical models.  
 
Figure 8-3. Confidence required versus achievable. Proportions of respondents for 
whom sufficient confidence is achievable for each source of evidence.  
 
A similar pattern emerged from consideration of public perception of methods and 
projected actions. When respondents were asked ‘I would do the following things if the 
evidence was based on [range of sources of evidence]’, scientific experiments were the 
source of evidence most likely to be associated with intention to carry out each of the six 
behaviours (see Figure 9-3 for climate change related behaviours)7. Interestingly, I see the 
same pattern as in the confidence responses where the life experience of experts was 
selected in second position. 
                                                 
7 A similar pattern can be seen in response to the questions that asked whether respondents believed that 







































Figure 9-3. Ways of combatting climate change. The recommendations above have 
been provided by the Government on ways to combat climate change. How do you 
think they are supported? Specific projected policy-based behaviour change in 
relation to sources of evidence to support them. 
 
Specifically in relation to modelling methods in policy, when asked if ‘the government 
should use predictive models in planning for [CC or PI]’, although there was tendency 
towards agreement with the statements (52% agree or strongly agree in the CC condition 
and 76% in the PI condition), these values were lower than for the corresponding 
statements relating to whether models form an important part of good science (Figure 10-
3). Notably, a significant proportion of respondents (22%) declined to answer the question 
on whether the government should use models in planning for CC and although the reasons 
for this are unclear, this led to markedly lower agreement for the climate change than 
pandemic influenza condition. Nonetheless, I found a significant positive relationship 
between levels of agreement with the statement that models are an important part of good 
science, and responses that affirmed that predictive models should be used in planning and 
policy for both infectious disease and climate change (r=.583, p<.001 and r=.659, p<.001 
respectively using Spearman correlations), indicating a tendency to hold similar beliefs 




Figure 10-3. Are models a good part of science? Percentage agreement with the 
statement that models are an important part of good science about climate change 
(left group) and with the statement that models should be used in planning for 
infectious disease and climate change scenarios (right group). 
 
In summary, although the public demonstrated a tendency to accept a role for models in 
government planning, they were more likely to believe that policies would be effective and 
would be more likely to implement behaviour changes if the evidence for them came from 
experimental studies. Experimental studies were also perceived as providing sufficiently 
high levels of confidence to inform policy requiring individual behaviour change for the 
highest number of respondents. 
3.4.3 Limitations of the study 
There were some limitations to the methods used to collect our data for this study. First, 
the qualitative semi-structured mini-interviews did not allow for free-form responses of 
great length, so it is likely that I missed additional perspectives. Secondly, the issues 
surrounding behaviour change and the science behind climate change and infectious 
disease are politically charged and often values-based. I did not ask about individual values 
or political orientation so failed to capture these moderating factors. Thirdly, there was 
very little literature on which to base our questionnaire, given the lack of studies of public 
understanding modelling, and future studies should benefit from the evidence presented 
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whether it would have been helpful to collect additional demographic information, 
including political orientation in the context of policy-related understandings; it may also 
have been useful to ask specifically about experience in use of models and modelling 
rather than just experience with science in general. Nonetheless, I have demonstrated that 
Odenbaugh’s (2005) framework can be used as a flexible categorisation scheme for this 
type of inquiry. I also found it useful to ask about scientists’ use of models as opposed to 
just simply inquiring as to their epistemic concept of what constituted a model in the 
abstract.  
 
Finally, the smaller sample size of the questionnaire respondents, in conjunction with the 
brief mini-interviews, may somewhat limit the overall generalizability of these findings, 
and the selection of the participants was limited by my geographical mobility and the 
limitation of resources to incentivize large numbers of participants, which limits the 
statistical power of the study. However, the mixed-methods approach of the research 
strongly suggests that additional resources should be allocated to exploring this 
phenomenon, and those are discussed both here in the next section and in the extended 
Chapter 3 conclusions in Chapter 5. 
3.5 Discussion and Conclusions 
In our public sample, respondents had the highest confidence in evidence from 
experiments and believe that policies would be effective if based on experimental 
evidence. Among our respondents, the requirements for high levels of confidence before 
findings are used inform policy requiring behaviour change are generally unrealistic. This 
finding suggests the public has an expectation that behavioural recommendations are 
always made under optimal levels of certainty. Unfortunately, such a functional 
relationship between science and policy is unlikely to be achieved.  
 
The use of a mixed-method approach was critical to ascertain not only what role models 
were thought to play in a public conception of “good science” but what the public’s 
conception of modelling itself was.  The best way to explore the public’s conceptual 
understanding of modelling was through the semi-structured mini-interview, however, the 
extent to which these concepts and cognitive constructs surrounding modelling can be 
accurately surmised through such brief encounters may be limited, but they represent a 
richer picture of cognition than questionnaire data is able to, hence the design of the study. 
It was important to both present data on the quality of the public’s perception of good 
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scientific practice in conjunction with those conceptions of what modelling methods might 
encompass.  
Our data suggest that confidence in methods, and not trust alone, plays an important role in 
the projected actions of the public in response to behavioural recommendations in policies. 
In fact, experimental evidence was found to be more convincing than the experience of 
experts, the closest source of evidence in our study to a notion invoking trust. Although our 
study does not address the same kind of questions, this is interesting in light of Brossard 
and Nisbet (2006) finding that ‘deference to authority’ was the strongest predictor of 
support of agricultural biotechnology among a ‘low-information’ public. Attending to the 
confidence the public has in various scientific methods is likely to elicit more direct action 
from target populations of policies. Confidence may also be related to trust in that, if the 
public understand how scientific methodology works, and are confident that prevalent 
methods are scientifically sound, they are more likely to also trust that the advice they are 
being given to mitigate risk is trustworthy and will be more likely to follow instructions. 
Suggestions for future work include more in-depth interviewing and qualitative analysis to 
gauge the full breadth of understanding of the concepts and functions of models. It would 
also be useful to understand to what extent projected behaviour change in this study maps 
to actual behaviour, both in the domains considered here and in others such as social or 
economic policy. I also suggest investigation with different target populations with varying 
demographic characteristics.  
The evidence presented here describes several different kinds of sophisticated phenomena 
and relationships, all with implications for the formulation of evidence-informed policies 
that require behaviour change and how those policies should be discussed in the public 
theatre. Because of the high expectation of certainty the public has of the scientific 
findings used to inform policy, and the unlikelihood of that level of certainty being 
achieved, explicit discussions with the public about levels of confidence pertaining to 
specific evidence, or about risk, would likely be beneficial toward assuaging unreasonable 
public expectations.  
The public attachment to experimental science is likely due to traditional, rigid conceptions 
of what constitutes “good science”, an attitude that seems to persist despite 
acknowledgment that modelling methodology also constitutes an important part of good 
science in both the climate change and pandemic influenza contexts. Indeed, Dagher and 
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Boujaoude (2005) report a rejection of historical, non-experimental evidence in relation to 
acceptance of evolution. This is reflected in the finding that public acknowledgment that a 
method forms an important part of “good science” does not equate to an acknowledgement 
that this same method informs “good policy”. Thus acceptance of a source of evidence as 
contributing to good science is not necessarily enough to precipitate behavioural changes 
needed for effective mitigation policies.  
It may then be beneficial to expose the public and learners in formal education to various 
forms of scientific inquiry and discuss their appropriateness in given topical situations in 
conjunction with recommendations. Explicit discussion of the suitability and reliability of 
various methodologies in the service of specific policy goals may go far to appease public 
concerns about the methodologies used to formulate behavioural change policy. 
3.6 Implications for Policy and Practice 
This chapter and the evidence it presents could be used to inform improvements in research 
practice at it pertains to public policy that is informed by modelling methods.  The primary 
objective of those policies would aim to address the issues of modelling in education and 
the communication of behaviour-change recommendations in a manner that is sensitive to 
the multiple socio-demographic and scientific literacy issues that this chapter has identified 
and addressed. Increased attention to the introduction of modelling methods in formal 
educational settings, as well as more awareness of the role that public confidence and 
knowledge in emerging scientific methods has to play in the willingness of the public to 
enact those policy recommendations.   
These objectives could be achieved in a variety of ways, including, but not limited to, a 
change in science curricula and pedagogical approaches that are improved as far as 
modelling content, and focused on both formal and informal ways in which learners may 
interact with models as a concept and as a methodological tool; increased attention to how 
policy recommendations that request behaviour change are communicated to the public 
when those recommendations are based off of model-generated evidence, including 
protocols for strategic communication; and improved communication between the media 
and the scientific-policy community, to ensure that when modelling methodology is 
present in widespread media reports, it is accurately represented as a standard 
methodological tool that is accepted by the research and policy communities as an integral 
part of good scientific practice.   
101 
 
Options for the development of the aforementioned protocols for communication and 
education pertaining to the use of modelling for behaviour-change policy will be addressed 








Chapter 4 - What is the Nature of the Relationship of Policy 
Stakeholders to these Modelling Methods and How are They 
Employed? 
4.1 Introduction: The Evidence-Based Policy Agenda and Policymaker 
Relationship to Scientific Evidence   
There is an increasing agenda toward the creation of evidence-based policy that requires 
the public to change their behaviour to achieve desirable public health outcomes. In order 
for this endeavour to be optimally successful, the policymaking and scientific communities 
must collaborate more closely than in the past, and this collaborative effort takes place in 
an increasingly multi-variate and complex policy environment (K. E. Smith & Joyce, 
2012). This collaboration occurs ideally, but not always, in interdisciplinary teams that can 
include researchers and a diverse array of policy stakeholders (Sutherland et al., 2012). 
This cross-discipline use of evidence and data from the scientific literature in policymaking 
opens up possibilities to investigate how policymakers perceive and use the evidence 
available to them in order to facilitate the evidence-based policy process.  
 
The development of public policy that requires behavioural change from the public is time- 
and resource- intensive. Sophisticated, effective policy requires behaviour change at many 
levels, including at the individual, organisational, and community levels (Glanz & Bishop, 
2010), and public policies must be designed to account for this. The most successful public 
health policies are not only informed by a fundamental understanding of human health, but 
by knowledge of the contexts in which the policies are being implemented, and this 
includes the social, economic, and political environment (Glanz & Bishop, 2010).  
Due to this increase in the evidence-based policy agenda, and the need for policymakers to 
consider evidence from diverse sources to addresses these multiple levels of influence and 
context, policymakers may be increasingly exposed to novel or unfamiliar scientific 
methodologies. For instance, scientific computational and mathematical modelling is 
rapidly becoming a primary tool for scientific inquiry into a variety of policy-relevant 
social and public health issues, in conjunction with more traditionally employed 
methodologies such as scientific experimentation (Coll & Lajium, 2011). As policymakers 
continue to interact with modelling-based literature and to collaborate with researchers 
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with modelling expertise, is necessary to glean detailed information regarding policymaker 
perceptions of, and use of, emerging modelling methods. 
Having this information is particularly important as the success of the policy-modelling-
evidence interface is dependent on involved stakeholders and researchers overcoming a 
variety of challenges. For instance, the objectives, priorities and demands of policymakers 
and the scientists they collaborate with may occasionally be in competition. Constraints on 
time, resources, and differences in epistemology, including research approaches or 
theoretical frameworks all contribute to roadblocks in the collaborative processes 
necessary to develop and implement effective policies. This in turn creates a situation in 
which policymaker access to large amounts of empirical information, and indeed even 
ready access to scientific experts themselves, may appear to have little effect on policy 
choices (K. E. Smith & Joyce, 2012).  Due to potential social impact of poorly designed or 
implemented policies, a clearer understanding of how policymakers perceive emerging 
scientific methodologies in the context of their use for policy development is necessary.   
Previous chapters have explored how modelling exercises can be used by non-experts to 
explore policy-relevant epidemiological issues, and how the public’s understanding of 
modelling methodology might influence their projected behavioural responses to policy 
recommendations underpinned by these methodologies. In this chapter, I briefly review the 
literature on scientific evidence and methodology in policymaking itself, and explore 
policymaker understanding of scientific methodology, with a focus on modelling, in order 
to identify gaps in our knowledge regarding the question of how policymakers may 
understand and use scientific information and modelling in the policymaking process.  
 
I then provide a justification for the collection of qualitative data toward the development 
of a theoretical framework that describes critical issues and challenges using modelling and 
other scientific methods for policymaking activities.  These critical issues and challenges 
are explored using transcripts of meetings of a major UK policymaker advisory committee 
that detail their decision-making processes.  I then present the body of a qualitative 
Framework Analysis to address the need for a more sophisticated characterisation toward 
filling these gaps in knowledge. Finally, I will discuss these research findings and 
introduce recommendations for the optimal use of evidence in public health policy 




4.2 Review of the Literature   
4.2.1 Brief history 
Evidence-based public health policy that requires behaviour change from the public is 
created in environments informed by a range of considerations, including those of: interest 
groups, major policy stakeholders, and current political leaders. The development of these 
policies often aim to achieve maximum beneficial health outcomes with fairly limited 
financial resources (Mays et al., 2005).  The agenda to increase the evidence-base in public 
health policy often requires that policymakers have direct contact with scientific literature, 
findings, organisations, and methods (Sackett et al., 1996). Efforts to create and 
disseminate behaviour-change public health policy with a scientific evidence-base also 
increasingly demand policymakers to have direct and sustained contact with scientific and 
health sciences researchers (Sutherland et al., 2012). This process in public health practice 
and research is also transferrable to a wide array of policymaking scenarios that are not 
limited to public health. For instance, ancillary population health endeavours in ecology, 
environmental conservation, and climate change behaviour change policy-making often 
benefit from the lessons learned in more traditionally-defined public health public health 
practice (Feenstra et al., 1998).  
 
The model of evidence-based practice in medicine and public health can be used explore 
possibilities for parallel practice in fields that are critical to population health, like 
environmental resource conservation (Pullin & Knight, 2003), thus furthering the argument 
that understanding the processes of public health behaviour change policymaking is central 
to optimizing the evidence-based population health policy agenda in general. However, 
because managing the relationship between scientific information and policymaking is not 
always entirely successful or easy, achieving the best translation of scientific knowledge 
for use in public health policy development demands that we understand these barriers and 
their origins.  
 
Some of what is problematic in the evidence-based policy agenda has been identified and 
discussed in the literature. For instance, the availability, access to, and quality of scientific 
evidence for use by policymakers has been identified as a critical problem (Black, 2001). 
For example, Pullin, Knight, Stone, & Charman, (2004) cite poor accessibility and 
usability of scientific information and a deficit of an appropriate information infrastructure 
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“support” system for policymakers as a key barrier to the creation of policymaking. The 
authors further suggest that, rather than explore and compare the subjective value of 
different sources of evidence, it was necessary to glean information from policymakers 
regarding their perspectives on the availability and ease of access of scientific information 
in general that they might use in policymaking endeavours.  In their findings, they state 
that the amount of evidence or scientific information actually being used in the service of 
developing public policy is disproportionately limited compared to the amount of scientific 
evidence that may actually be useful for informing or driving health policy initiatives. 
Pullin, Knight, Stone & Charman (2004) explain the lack of use of available scientific 
evidence as an issue of operational deficit; this deficit can present as a lack of time. When 
policymakers are faced with the day-to-day pressures of executing the policymaking 
process, decision makers do not feel they have sufficient time to access the primary 
information they might require to judge effectiveness of alternative actions, and thus 
cannot perform a full analysis of policy possibilities (Pullin & Knight, 2001).  Therefore, 
even when the necessary scientific information is available to policymakers and 
stakeholders, and even when they are working in collaboration with outside experts, there 
are still operational and process constraints for policymakers that may inhibit the best use 
of evidence in policymaking. This evidence supports the hypothesis that when 
policymakers are lacking the guidance to readily facilitate the appropriate use of scientific 
evidence and methods in the creation of policy, necessary critical evaluation and use of 
scientific methods and evidence may be neglected in the policy-making process, and 
further, that policy decisions may thus be based on anecdote or personal experience of 
policymakers rather than on data or evidence (Pullin & Knight, 2003). 
Conversely, it can be difficult for researchers and research-funding bodies to both 
understand and identify which research methodologies or findings would be most 
beneficial to policymakers, a phenomenon which may stem from a two-fold issue: how 
policy-oriented research is perceived and valued in the culture of the traditional academy, 
and how research that may be useful to policymakers is identified and supported (Clark & 
Holmes, 2010).  Similar to the operational and day-to-day concerns of policymakers, there 
are also practical considerations for academics whose research might influence policy or 
who might be working directly on policy projects. For instance, policymaking bodies or 
governmental organisations and projects tend to have higher staff turnover rates than 
academia, making a sustained relationship for an academic group with a group of 
policymakers difficult, and there may be a perception amongst academic practitioners that 
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most beneficial policy-oriented, goal-directed research exercises are something primarily 
initiated, or even commissioned, by the policymaking bodies themselves (Clark & Holmes, 
2010).  
Emerging and increasingly popular scientific methodologies such as computational 
modelling may present new and difficult challenges for policymakers and stakeholders. 
These challenges may include policymaker understanding of the technical aspects of 
modelling, how to interpret modelling-derived findings, or negotiating the limitations of 
the modelling methodology (Daley et al., 2001).  These difficulties highlight why 
collaborative processes when using modelling methodology to support public policy 
development in public health is so important: It is critical that policymakers support the 
inclusion of expert modellers into policymaking teams that wish to use modelling-derived 
data, who can help policymakers overcome these technical challenges in the policy advice 
process, ensuring that the quantitative insights they seek are readily available (Van 
Kerkhove et al., 2010). 
The need for policymakers and researchers to build and maintain these relationships 
becomes particularly evident in urgent public health crises such as pandemics, where 
policymakers may need to act quickly to employ plans for mitigation and management. 
Van Kekhove et al. (2010) suggest that scientific information about occurrences such as 
epidemics may become available too late to be of good use to policymakers who need to 
make more immediate decisions regarding preparedness or human services during the 
pandemic or epidemic event. They continue to argue that investigators who are involved in 
this kind of modelling-derived data should consider involving policymakers in their 
activities, in order to establish connections and communication channels that can facilitate 
the delivery of the necessary information in a more timely fashion.  
Despite these challenges that both scientific investigators and policy and decision makers 
face, the use of evidence, particularly modelling-derived evidence, in the process of 
making policy decisions is likely to continue to trend upward. To assist in addressing these 
challenges, what follows is a brief critical review of the literature that first explores how 
policymakers currently use scientific evidence in policy development. The second section 
of the review discusses the understanding and use of scientific and modelling methodology 
specifically by policymakers when developing public health programmes and concludes by 
detailing some possible research questions for further inquiry. Finally, the details of a 
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qualitative investigation into the modelling-derived, evidence-based policymaking process 
are presented. 
4.3 How Do Policymakers Use and Perceive Scientific Evidence in 
Behaviour-Change Policy Development?   
There is still a significant lack of clarity in the research and practice communities 
surrounding the question of how policymakers use scientific evidence and how to advance 
the use of evidence and various scientific methods in policymaking. There exists a body of 
literature on the role of evidence in policymaking, but it can said to be descriptive rather 
than prescriptive in nature. While some limited theoretical frameworks for explaining the 
process of using evidence in public policy have been proposed, there is a lack of empirical 
evidence that supports these frameworks (Granados et al., 2009).   
Innvaer, Vist, Trommald, & Oxman (2002) conducted a systematic review of the literature 
with the aim of summarisng the evidence from 24 studies where qualitative interviews with 
health policymakers were conducted. Policymakers working on healthcare issues were 
asked to identify facilitators of, and barriers to, the use of research evidence in their work.  
Searching multiple databases (including Medline, PsychLit, etc.) in June 2000, Innvar et al. 
(2002) included interview studies with health policy-makers that covered the policymaker 
perceptions of the use of research evidence in their health policy decisions at national, 
regional or organisational levels, and identified by an inductive process of theme 
development, an array of barriers that may prevent effective collaboration between the 
research and policy communities. The authors cite the most commonly reported barriers to 
using scientific evidence being: absence of personal contact with researchers (11 of 24), 
lack of timely relevance of research (9 of 24), and mutual mistrust or misunderstanding (8 
of 24).  They concluded that there was often the perception from policymakers of ‘two 
communities’, where the policy and scientific communities were unable to take the 
perspectives of the other, and there was a specific finding wherein policymakers felt that 
information from researchers alone was insufficient for solving critical issues, which 
required what they termed “political judgment” in addition to evidence.   
The identification of what is meant by “use of evidence” was also discussed in the review, 
and there was a differentiation in the degree to which evidence is used in policymaking.  
This can be identified in two parts: 1) evidence that is used in an enlightening way or 
selectively, for instance using a study to inform discussion or deliberation about possible 
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policy alternatives and 2) evidence that is used directly, such as research data being cited in 
policy proposals to support the strength of the policy suggestion  (Innvaer et al., 2002). The 
use of scientific evidence may also vary in relation to the different types of decision-
makers using it and whether or not they occupy upper, middle and lower level positions, 
with upper level policymakers usually using scientific evidence in an enlightening, 
informative, rather than concrete, manner. Various types of policy questions: vague and 
complex, or focused and simple, may demand different kinds of evidence-use depending 
on the policy goal, and whether the aim is adoption of a health behaviour versus 
implementation of a programme, or decision-making on issues versus action during crisis. 
(Innvaer et al., 2002).   
Innvaer et al. (2002)  concluded that there are ways in which researchers could facilitate 
the use of their research in policy relevant areas by developing more active, personal 
dialogue with policy stakeholders and decision makers, designing scientific research that 
speaks directly to policy objectives, and ensuring that their research is perceived by 
policymakers as timely, relevant and of high quality. While these suggestions are well-
considered, they do place the onus of communication, advocacy, and awareness primarily 
on the researcher, suggesting that researchers ensure findings are relevant to the current 
deliberations of policy decision makers and not simple contributions to overall knowledge. 
Despite this seeming imbalance, there are in fact valid concerns about the adaptation of 
original research into a policy-friendly format.   
 
 Researchers have an ethical imperative to minimize issues such as bias, and policymakers 
may have interests and political imperatives that compete with those of scientific 
objectivity, however, assumptions in the evidence-based policy literature appear to support 
the notion that there is a linear relationship between research-based evidence and policy, 
which is consistent with a positivist view of science (Black, 2001).  Black (2001) argues 
that accepting this linear relationship places the policy-evidence enterprise at risk by 
quantifying the value of research solely by its utility for use in policy as judged by the 
policymakers using it.     
This is clearly problematic, as researchers and policy-makers may have competing or 
counter aims and different accountability needs. As Black (2001) argues, policymakers 
may have goals other than simply contributing to knowledge or judging the clinical 
effectiveness of an intervention. They must consider social, financial, operational, and 
political aims and costs when considering evidence that may not be at the forefront of 
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scientific consideration. Black continues that there are other roadblocks to effectively 
integrating scientific evidence into policy, in that non-expert policymakers may dismiss 
research evidence as irrelevant if it is derived from a different discipline, sector, or 
specialty, or that there may be a lack of consensus about research evidence dependent upon 
the complexity of scientific evidence, any standing scientific controversy, or multiple 
interpretations of findings. Importantly, Black also notes that other types of evidence may 
compete with the empirical in the development of policy, and that policymakers employ a 
range of information sources when making decisions, including their personal experience, 
local information about the community, eminent colleagues' opinions, or medicolegal and 
governmental reports.  
In addition to considering the variety of sources of evidence policymakers may use, some 
of the issues with the effective integration of scientific evidence into policy may pertain to 
policymaker perceptions of the consensus surrounding the goal of the policy in question. 
Black (2001) states that the use of research in policymaking depends on the degree of 
consensus amongst the policymaking team, including researchers, on the policy goal.  
Evidence can be used rather concretely if it generally supports the team consensus of what 
needs to be achieved, but can be used selectively if there is a lack of consensus as to what 
the ultimate aim of the policy should be. Black further argues that scientific researchers 
might be naïve to the political considerations policymakers are facing. Researchers may 
have limited understanding of policymaking processes and have unrealistic expectations 
about what research can achieve in the policymaking environment. Thus, any investigation 
that would seek to inform or instruct the exchange of information or collaborative process 
between scientific experts and policymakers would be sensitive to the sometimes 
competing needs, imperatives, and limitations faced by both groups.  
Another key issue in the use of scientific evidence to support policy may come from the 
divergent ways in which policymakers and scientists view the certainty of findings that 
result from scientific inquiry, and this includes the way in which scientists may “hedge” 
their findings, meaning that scientists can be quite sensitive to the limitations of their data 
and will, when striving to provide proof for something, will add caveats and limitations to 
their own data—but policymakers may eschew these qualified explanations for a much 
more simplified, succinct response to a query on issues that scientists find much more 
complex (Choi et al., 2005). Further complicating the process by which evidence is used in 
policy, Choi and colleagues (2005) cite  the increasing pressure on scientists to comply 
with the views of governments that are increasingly responsible for setting agendas and 
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priorities for the allocation of research funds, and some scientists might grapple with the 
concern that research initiatives which pertain to public policy could potentially create 
incentive for biased scientific practice by panders to trendy policy topics rather than 
meaningful inquiry.   
While Black’s (2001) argument places the burden of the process of evidence-integration 
into policy on the political naivety of researchers, some research has described how 
policymakers themselves may not use evidence in policies in the appropriate manner, with 
some policymakers “cherry picking”, or adopting evidence into deliberations or policies 
only if it supports what they have already decided are their policy aims, and are more 
likely to reject sound evidence when it conflicts with their policy goals. Choi et al. (2005) 
cite an example, wherein a university research unit funded by the government that was 
evaluating a government policy programme for effectiveness, but the government was 
already implementing this programme long before participant recruitment for the 
randomized controlled trial has begun. 
However, there are ways to improve the collaboration of researchers and policymakers 
toward the aim of effective use of scientific evidence in public policy.  Capacity-building 
for this type of work might include creating institutions and groups that are built around 
the notion that researchers and policymakers should be working together regularly, 
providing education for, and ensuring regular employment of, translational scientists, and 
providing the necessary administrative support to facilitate regular communication and 
meeting (Samet & Lee, 2001).  In fact, research that focuses specifically on the modelling-
policy interface conducted as early as the 1990’s advocated for increased contact and 
mediation between modelling researchers and the policy-makers that use their research, 
citing that the value of the interpersonal relationship between the two groups “cannot be 
overstated” (Alcamo, Kreileman, & Leemans, 1996, p. 27). 
 
The issue of improving the problem-solving capacity of governmental and policymaking 
bodies can be framed as an issue of effective knowledge management, where stakeholder 
partnerships are specifically managed to promote and facilitate a two-way transfer of 
information, ensuring both that policymakers are effectively using information, and that 
those policymaking processes are transparent enough to researchers and the public to 
ensure accountability and improvement if necessary (Riege & Lindsay, 2006).  This is 
accomplished by articulating very clear goals and strategies for knowledge management 
across the life of a project from its inception, and having plans for implementation and 
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measurement of these strategies and goals that are agreed upon by all involved 
stakeholders (Riege & Lindsay, 2006).  
 
This knowledge management and exchange model becomes particularly important in 
consideration of the current climate of open access, “transparent” policymaking and data 
availability, with transparency in this case meaning there is a public expectation that public 
officials should be open and responsive about the reasons for their decisions, and restrict 
information only in instances where there is a clear argument for public safety or larger 
public interest in withholding information (Curtin & Meijer, 2006).  Curtin and Meijer 
(2006) also point out that far from transparency being a mere “passive right” of the public 
to know about policymaking processes, its definition extends to include the responsibility 
that policymakers hold to actively provide the public access to their deliberations, and to 
do so in a manner that is readily available without major impediments (for instance, via 
internet or electronic access). This approach to transparency has particularly important 
implications for policy and outcomes research, as it places the onus of the provision of 
critical qualitative and quantitative data on policymakers, and allows interested parties to 
apply analytic methods to examine these processes in the public interest. Such data is 
employed in the qualitative characterisation of policy proceedings included in this chapter, 
and this type of policy research is likely to benefit from the continued move toward open 
access and transparency initiative which allow researchers and analysts free access to this 
critical data.  
Pursuant to this discussion of knowledge management and information access, the 
identification and use of appropriate  scientific evidence for policymaking purposes often 
falls into the domain of health ministers, non-profit, and governmental directors with little 
to no research experience, yet there are expectations that their reports and policies will 
reference and use evidence in order to create accountability for their policy choices, 
“Public policymakers can encourage more informed policymaking by asking to see 
systematic reviews on priority issues, commissioning reviews when none exists, and 
placing more value on such work in their deliberations and in their interactions with 
stakeholders” (Lavis, Posada, Haines, & Osei, 2004, p. 1555).   
There has also been some limited research evaluation literature that aims to help guide 
policymakers who wish to use scientific evidence in their development and implementation 
activities in making decisions about which scientific research to use to inform their polices 
and how to identify quality research and systematic reviews that may be relevant to them 
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(Lewin, Oxman, Lavis, & Fretheim, 2009).  However, there is little analysis that can be 
found in the literature that supports the impact this actually has on the policymaking 
process, or how this evidence is used ‘in-vivo’ to formulate models for the specific task of 
policymaking.   
Lavis and colleagues (2004) also identify key issues of transferability of health-systems 
research into actionable public health policy. When policymakers wish to bring about 
behavioural change in complex health systems, and wish to use scientific evidence or 
research to do this, the policymaking body may find that the research, while of high 
quality, may not account for whether or not a proposed solution will work within the 
constraints of the healthcare delivery system in which it would be delivered. This issue 
speaks to an imperative for researchers engaged in health policy relevant activities to 
consider the implications of health systems delivery when looking at a specific behaviour-
change problem, such as HIV prevention. 
Even if a potential solution to a particular public health issue is identified by policymakers 
from a review of the literature or collaboration with researchers, and even when the 
suggested intervention is potentially feasible and cost-effective, policymakers need to 
consider another dimension of needs before they can implement a particular policy.  Often, 
since policymakers proposing a particular intervention will need to account for the 
political, financial, and human resources required to implement a solution to a complex 
public health problem, they may eschew the research-supported suggestions for 
alternatives that speak to these other social dimensions of need, despite the pressure on 
them to justify every decision with scientific evidence (Lavis et al., 2004).   
 
Clear and direct communication with collaborating researchers as to the limitations by 
which policy is constrained is likely to go some way in fostering an optimal collaborative 
relationship. If researchers are aware that their work may be abandoned in the 
policymaking context due to circumstances beyond the policymaker’s control, there may 
be less conflict between the two communities when there are disagreements about how to 
proceed. For researchers, understanding the complexities of the healthcare system for 
which their research may be relevant could be key (Lavis et al., 2004). 
As illustrated above, there is some substantial discussion in the literature regarding these 
issues of how scientific evidence generally is used and perceived in the policy-research 
exchange, what the challenges of using scientific evidence may be, and how policymakers 
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might view contemporary scientific methods such as modelling.  Yet, there is not as much 
discussion in the literature about modelling-derived evidence in policy, as opposed to the 
actual use of modelling in the development of policy. This is key to note as this use is only 
likely to increase as the demand for data-driven decision-making also continues to rise. 
The next section discusses how the use of modelling methods specifically plays a role in 
policymaking, and introduces a study that seeks to contribute a fuller characterization of 
evidence and modelling use in a real-world policy setting. 
4.4 The Understanding and Use of Scientific and Modelling Methodology by 
Policymakers When Developing Public Health Policy 
As discussed in the previous section, many forms of evidence, from the empirical to the 
advice of colleagues, are fundamental to the development of policy and are used by 
policymakers in various ways with a range of success.  For access to primary health 
research on a variety of topics, policymakers may make use of scientific databases and 
libraries relatively independently, without much primary contact with researchers, and in 
fact, they may view this to be the most effective and efficient way for them to inform their 
polices (Wilson, Moat, & Lavis, 2013). However, with an increase in the use of modelling 
methods by researchers in research projects that are policy-relevant, researchers are 
increasingly exposed to evidence generated by these methods with which they may be 
unfamiliar, and as evidenced in the previous section, the success of the policymaker-
researcher interaction may be one of the fundamental building blocks for the success of 
evidence-based public health policy.   
Modelling methodology in particular can be a highly valuable tool for the development of 
public health policies and can assist in a variety of endeavours that are central to the aims 
of policymakers working in the area social improvement.  In particular, modelling offers 
the policymaker an opportunity to explore the possible outcome of multiple policy options 
in complex environments, and can typically provide this at less operational overhead than 
more traditional methods (Desouza & Yuan, 2013).  Modelling methods can also play a 
central role in exploring policy issues such as the appropriate allocation of limited supplies 
during an emergency, how many people to vaccinate or how effective travel restrictions are 
at containing a pandemic (Epstein, 2009).  While there are multiple examples of modelling 
methods that have been used for policy endeavours, there is little literature that explores 
the perspectives of policymakers on modelling methodology specifically, despite the 
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research community’s continued and increasing use of modelling methods in research that 
policymakers may use to develop recommendations.   
There is some limited research to suggest that the role of modelling in public policy 
development is in question, and that the role of models to support recommendations on the 
cost-effective use of medical technologies and pharmaceuticals is controversial. What 
drives this controversy is the degree to which experimental or other empirical evidence 
should be required to be evaluated or used to inform the model prior to model use 
(Weinstein et al., 2001).  Logan & Graham (1998) note that there is little literature that 
provides guidance for best use of modelling methods for the kind of multi- and inter-
disciplinary approaches most often occurring in the current policy development 
environment, particularly now when modelling teams from research institutions and 
universities may be increasingly called to collaborate with policymaking institutions and 
groups. 
Logan and Graham (1998) also describe what they have termed “social factors” in the 
course of this critical collaboration between policymakers and researchers that can exert 
powerful influence on the use of modelling methods specifically in the policy development 
process.  These social factors may include the personalities involved, the political climate 
of the society or of the organizations involved in research exchange, and also the 
underlying belief systems of the stakeholders and researchers involved.  This is particularly 
important when scientific or outcome certainty is a primary need for policymakers, but 
speaking in certain terms represents unethical practice for scientific researchers. As 
discussed in previous sections, the working relationship between policymakers and 
modellers is fundamental to the success of the policy-evidence interface, and therefore, the 
social dynamics within and between the two groups warrants careful consideration.  
Policymakers are seek a level of certainty that can be used to convince and persuade a 
constituency or group of stakeholders, as opposed researchers who may be trained to 
contribute to knowledge in a general sense. In the research community, models may be 
seen as just another tool used to generate or explore scientific data, whether or not 
empirical evidence from experimentation is included in those models. Weinstein et al. 
(2001) argue that some of the controversy surrounding the use of models in policy stems in 
part from arguments as to whether the role of models is to establish objective truth or to 
guide clinical and policy decisions. According to Weinstein et al. (2001) resistance to the 
use of modelling methods in the development of policy can potentially come from a variety 
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of parties who may be involved in the policymaking process, and for various reasons, 
citing examples of physicians who claim that clinical judgment cannot be quantified, 
empiricists who warn that input data can be inaccurate, epidemiologists who worry that 
logical assumptions about cause and effect may be wrong, from technophobes who worry 
about the model malfunctioning in some way, and from other stakeholders who fear that 
proponents of a medical practice or product can manipulate models in hidden ways to 
mislead decision-makers and persuade them into supporting a policy they find 
unfavourable. 
Weinstein et al. (2001) acknowledge that some of these aforementioned concerns may be 
valid to certain extent, but note that empirical validation of the predictions of these models 
is often prohibitively expensive or even impossible, but that their conclusions are 
disseminated widely and form the basis for decisions that involve substantial resource 
commitments and health consequences. Weinstein et al. (2001) also note that while 
modelling methods are widely accepted as exploratory tools for planning in other domains, 
such as defence, and that decision makers in these domains acknowledge the limitations of 
models but rely on them nevertheless, these models are less accepted in healthcare and 
clinical medicine but the reason why is unclear. Weinstein et al., (2001) conclude that is 
inappropriate for policymakers expect—or demand—that models be used solely as tools 
predict the future accurately, because even when used in a predictive manner, they can 
only incorporate what is known at the time the model is used to inform deliberations.   
Weinstein and colleague’s (2001) conclusion reflects the notion that policymakers are less 
familiar than researchers with the various uses of models (for instance, exploratory uses) 
and critically, that they are less aware of the limitations of modelling methods in providing 
predictive certainty. This is particularly challenging when predictive certainty is typically 
favoured by policymakers who may be under pressure to forward an agenda in high-
pressure, low-resource environments. The expectation policymakers have that certain 
scientific methods may provide levels of certainty that are unlikely, but desirable for 
policy, may play directly into the challenges faced in policy-research collaborations.   This 
disconnect between how researchers and policymakers understand, and what they expect of 
modelling methodology should thus be a focus of further scientific inquiry.  
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4.5 Research Questions 
The lack of literature that directly explores the process of using modelling methods for 
public health policymaking is, in general, what needs to be addressed. The effective use of 
these models as possible generators of concrete supporting evidence, or as platforms for 
outcome exploration in policy settings, also requires an examination of the policymaking 
process to better inform our understanding of how various policymaker uses of modelling 
influences policymaking or underpins policy. In combination with the discussions in the 
literature surrounding the challenges and proposed solutions pertaining to the use of 
evidence in policy generally, understanding policymaker relationships to modelling 
methodology specifically can help provide the necessary missing information on what the 
use of modelling methods looks like in a real world, successful policy setting, what 
challenges are faced, and how they are overcome.  In order to begin to develop a 
framework for more successful research-policy collaborations in the contemporary 
paradigm, this study seeks to characterize the following main phenomena: 
 
1) What are the primary challenges that public health policymaking settings experience in 
using modelling methods to make decisions in real time? And how are these challenges 
expressed? 
2) How are policymakers using the models to inform their policies as deliberations 
progress in a natural setting?  
3) How are modelling exercises used to directly inform policy recommendations?  
While these are the primary research questions from the chapter, I am looking to also 
present a general characterisation of the use of scientific evidence in these types of policy 
deliberations. Accessing qualitative data that was generated during real-time policy 
deliberations should provide us with a unique and highly ecologically valid insight into 




4.6 Method   
4.6.1 Purpose 
There has been little detailed inquiry as to the process of using scientific modelling 
methodology amongst policymakers. This study aims to provide a detailed qualitative 
analysis that will give provide an embedded account of the deliberations, decision making 
and dialogue that policymakers engage in as they attempt to assimilate, incorporate and 
evaluate the use of scientific evidence and modelling methods in a natural setting. 
4.6.2 Study Design 
Data Source and Sample: 
In this study, I utilised publically-accessible meeting minutes from the Joint Committee on 
Vaccination and Immunisations (JCVI), a UK-based statutory advisory committee formed 
by the UK National Health Service (NHS) in 1981.  This committee provides advice and 
recommendations based on consideration of scientific and other evidence that is used by 
the UK Government to inform, develop and make policy on issues of immunization (JCVI, 
2013). JCVI is not a policymaking body in its own right and has no regulatory function, 
but functions as the committee which considers evidence for the purpose of informing 
these policy decisions ultimately enacted by government. JCVI has no statutory basis for 
providing immunization-related advice to the Scottish or Northern Irish heath ministries 
however, health departments from these countries are free to use the recommendations and 
information from the committee in their final decision-making processes (JCVI, 2013). 
 
JCVI develops their advice and policy recommendations based on a group appraisal of  
what they cite as the “best scientific and other evidence available and reflecting current 
good practice and/or expert opinion” (JCVI, 2013, p.19) and state that their sources of 
evidence under consideration include (but are not limited to) the following: advice from 
international and national bodies (e.g. WHO, ACIP, IoM, NICE); commissioned attitudinal 
research; commissioned bespoke mathematical and modelling studies of impact and cost; 
commissioned clinical research to examine safety; commissioned epidemiological analyses 
of the incidence or prevalence; commissioned operational analyses to assess aspects of 
implementation; correspondence with key experts; relevant published literature; 
unpublished data from entities such as pharmaceutical companies; and stakeholders in 
community organisations. While this list is by no means exhaustive, the sources of 





The JCVI exists primarily as an advisory entity, and the policy recommendations it 
generates may be adopted by health departments throughout the UK who are seeking 
guidance on immunisations to prevent infections and disease. It is important to note that 
JCVI is tasked with undertaking these policy deliberations explicitly using scientific 
evidence to inform their debates. They are to consider burden of disease, vaccine safety 
and efficacy, impact, and cost effectiveness of immunisation strategies. This is a wide 
range of considerations for any given policy or program, and considering the voluntary 
nature of JCVI, it may be expected that there would be some limitation, or at least 
selectivity, when evidence is being considered. 
Appointments to the JCVI Chair and regular members are made on merit by the Secretary 
of State, in consultation with senior officials. Members are not appointed as representatives 
of their profession, employer, geographic area, or interest group, but rather on their 
suitability as professionals as measured against established criteria (JCVI, 2013). This 
ensures a diversity of opinion and expertise, which in turn allows for more balanced debate 
and skillset when making policy decisions.  Committee members serve for an average of 
three years. Renewal of appointment is not automatic, and suitability for the role is 
determined by regular evaluation and oversight. This committee is well-regulated, diverse 
in membership, and presents as a highly-visible and active advisory body with clear policy 
objectives.  As a result their deliberations present the ideal scenario for addressing the 
research questions outlined above. 
 
Thus, meeting minutes from the Joint Committee on Vaccination and Immunisation (JCVI) 
pertaining to the use of scientific evidence and modelling methodology for determining 
appropriate vaccine policy constitutes the primary source of data for this analysis. There 
are 8 full-committee meeting session minutes included in this analysis, at 15-30 pages 
each. JCVI meets at 3 main sessions every year, which are held on the first Wednesday of 
February, June, and October (JCVI 2013). The minutes of each meeting is uploaded online 
within six weeks of the meeting and are publically accessible, with no special permissions 
required for access, and in a standard format Word document format.  Meetings under 
consideration for this study took place from August 2012 to October 2014.   
 
The meeting minutes themselves are transcribed from the deliberations and they do not 
verbatim identify the input of each individual member. Rather, they are a somewhat 
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summarized, generalized recording of the proceedings and deliberations, and therefore 
some aspects of analysis, (such as identifying roles and stakeholder contributions) would 
necessarily be limited.  The minutes also are unable to provide a detailed account of the 
efforts involved in consulting with information sources or interrogating experts that occur 
outside of the formal policy deliberations. Nor do the minutes capture external events that 
may come to bear on the deliberations in some way, such as media attention or world 
events.  
 
There are other documents available to the public that are generated from JCVI’s work, 
and they’re not included in this analysis. These include consultations open and closed, 
position papers, actual policy recommendations, white papers, etc. As the primary purpose 
of this study is to examine the processes, rather than the products per se, of these types of 
policy deliberations, the focus of this study is on the committee’s iterative process of 
weighing evidence and creating recommendations. It is important to note that the 
deliberations themselves do not necessarily reflect on the final decisions as they are written 
in official documents.    
 
Finally, the deliberations used in this analysis deal primarily with vaccinations for 
Meningococcal B, influenza, and HPV.  However, in the course of its duties, JCVI may 
consider a full complement of infectious agents, and it may do so simultaneously. Different 
pathogens carry with them a host of varying considerations, and the socio-political and 
clinical implications of one disease may vary widely from the next.   
 
The Framework Method of Qualitative Analysis:  
A Framework Method was used in this study to facilitate a systematic qualitative analysis 
and summary of transcribed JCVI committee meeting minutes.  This qualitative method 
has been used since the early 1980’s, and was originally used for large-scale research in 
social policy (Gale, Heath, Cameron, Rashid, & Redwood, 2013), but is becoming 
increasingly prominent as a means by which to approach medical and health policy 
research.  The Framework Method is related to qualitative approaches to analysis like 
thematic analysis or qualitative content analysis, which seek to: 1) characterise similarities 
and differences in a data set suitable for qualitative analysis, 2) summarise complex data 
while maintaining reference to original data, and 3) present conclusions around core 
themes with the aim of being descriptive and/or explanatory (Gale et al., 2013). 
 
Qualitative Analysis with the Framework Method results in a matrix output: rows (cases, 
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or in this instance, transcribed minutes of JCVI meetings as one set), columns (codes, or 
themes identified that are relevant to our questions about modelling and evidence use in 
policy) and ‘cells’ of summarised data. This approach provided a structure where I could 
reduce, systematically, a large amount of text from the JCVI meeting minutes into 
summaries in order to analyse it by case and/or by code, if so desired. The Framework 
Method provided a significant amount of flexibility for this analysis, as a “case” can be 
adapted to other units of analysis, such as predefined groups, sets, or organisations as the 
researcher needs (Gale et al., 2013). In this instance, this meant I could reduce our group of 
meeting minutes into a single set (row), in order to focus on the themes that arose across 
all available cases. I could perform our analysis of the individual minutes and see how 
themes arose across the whole data set.  The summary cells also enabled us to paraphrase 
specific instances from within individual cases (each individual transcript of a JCVI 
meeting), which gave us the ability to maintain vital links to the original data. The need to 
reduce, summarise, and to look across our cases as a whole and yet summate from 
individual cases, made the Framework Method a natural fit for our purpose. 
 
Framework analysis was particularly suitable for this kind of health services research as it 
could be used to develop multiple themes and sub-themes relating to the use of evidence 
and models across multiple sessions of policy deliberations. By allowing us to create 
themes inductively from the text of the meeting minutes themselves, but also deductively 
from our review of the existing literature, I was able to develop concepts that described or 
explained various aspects of the policymaking process both from the critical literature 
review and at a idiographic level, where individual instances of evidence use and model 
use were evidenced from the transcripts. Themes often included multiple instances across 
and within cases (as is typical in this type of analysis).  However, sub-themes were created 
when multiple instances from a single theme were ascertained to be poorly differentiated 
although roughly thematically similar, and when there was a discernible difference in 
comparison to other instances under the same theme. 
4.7 Data Analysis 
Familiarisation and Interrater Reliability 
Themes were developed both from the research questions and inductively from the 
narrative of modelling use within the meeting minutes, and deductively from the literature 
review concerning the use of evidence and modelling in policymaking that precedes this 
analysis.  When thematic categories were considered too broad, or where there were 
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phenomena that could be delineated from one another but still fit into the same thematic 
group, sub-nodes were created to reflect this difference.  
 
Within the resulting framework matrix, all cases were treated as one set (named “JCVI 
Minutes”) in order to provide a holistic picture of this activity across time and cases, while 
individual examples are drawn from specific cases to anchor these observations to the 
original data. What follows is a step-by-step description of methods that were used to 
complete the analysis, and concludes with illustrations of each summary cell from the 
matrix with direct supporting quotes from the original data and the resulting interpretation 
of the data in the context of our research questions. 
 
Both researchers (JE and KR) thoroughly familiarised themselves with the transcripts by 
close reading, studying their format, and began to determine which areas of the text 
supplied information that pertained to the research questions.  Each researcher took notes 
about possible themes that were emerging and which portions of the transcript provided the 
most pertinent information. Since neither researcher was present during the JCVI meetings, 
it was critical that our initial impressions of the data were consistent, and that we regularly 
exchanged notes as we agreed upon themes that were arising from this inductive process.   
 
There were clear instances where JCVI were utilising evidence and modelling to assist in 
their process and underpin their recommendations.  These instances/verbatim examples 
from the transcripts were highlighted within NVivo and assigned an initial ‘node’ or 
theme.  After building an initial framework of themes, we agreed that we had sufficient 
notation to begin to generate our framework in NVivo. This process of initial framework 
building and familiarisation also allowed us to be alert to areas that would be of interest in 
the process of coding, which was essential considering the volume of data I were 
examining 
 
After the initial development of the theme framework from review of the dataset, initial 
coding of a limited number of cases began by two coders in order to establish internal 
consistency of coding. NVivo version 10 with Framework Analysis capabilities was used 
to store and analyse data. A Kappa coefficent of 0.97 was generated, and it was agreed that 
high agreement was established. Regular team meetings were used to facilitate our critical 





Using the framework capability in NVivo 10, nodes were created for each theme and 
highlighting began on the pertinent sections of text, adding them to nodes, and notes were 
taken that described how each example may fit into the theme.  These were initially larger 
blocks of text, but as Framework Analysis is supposed to assist in summarising complex 
textual data, it was recommended by the supervising researcher (KR) that attempts were 
made to highlight the parts of paragraphs that would only be most useful in reflecting the 
critical area of thematic content 
 
During this process, reflexive notes were created that would assist in the next steps of 
summarising examples in plain language as well as highlighting examples from the 
original data that could be used to strongly support those summaries and anchor researcher 
observations to the original textual data. At that point, any necessary sub-nodes (two in all) 
were created that served to specify phenomena that, while similar in theme, constituted 
separate issues and needed to be delineated from each other in order to create a more 
detailed explanation of the JCVI proceedings during the data interpretation phase. 
 
Summarising and Analysis  
When coding of all of the minutes had been completed into the framework, data was 
summarised into each cell according to the corresponding theme, and matched with 
specific examples from individual cases that supported that summary. NVivo 10’s 
framework function allows the researcher to easily return to specific examples coded into 
the themes and place them within cells individually. Some summarisations were lengthier 
than others, particularly in cases where sub-nodes were added and individual phenomena 
had to be described within themes. Each summarisation included terminology verbatim 
from the minutes in order to ensure consistency of operationalisation and to further anchor 
the summaries of observation to the original textual data.   
After the observations across all minutes were summarised in each cell and appropriate 
illustrative quotes from individual cases were determined for each cell summarisation,  
conclusions from the summaries and data were extrapolated, which will be presented 
theme by theme in the “Findings” section following. Format for this findings section is 
taken from the originators of the Framework Analysis method (Gale et al., 2013).  An 
example of how the cells look after summary has been completed is below in Figure 11-4: 
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                                      Theme: Modelling In Policy        
 
  
Figure 11-4. Illustrating a complete summary cell from the matrix. 
 
Each of the summary points in the cell is directly linked via index in NVivo to a 
highlighted direct quote (or multiple quotes both within and across meeting minutes) that 
has been coded across the entire data set. In the cell summary, data is summarised across 
time for thematic phenomena that has occurred across the data set. In the findings section, 
these cells are used as the basis of characterisation, meaning they provide data support for 
the creation of the final themes. Direct quotes from the individual meetings are used to 
support those characterisations, so “memos” are created on each theme, and finally, are 
conclusions drawn regarding how the findings have addressed the research questions.  
Below, these “memos” are presented by theme, and an example of their format, (also 
following Gale et al., 2013) is below in Figure 12-4. After the findings are presented in this 
JCVI Minutes
•Modelling is considered a complex analysis and takes time to 
conduct
•Data that is provided from various sources, (for instance, from 
pharmaceutical companies or from other government agencies) 
must be carefully considered before it is used as a parameter in a 
model
•Deliberations on which data is most appropriate to use in a model 
or to parameterise a model can be extensive and difficult
•Modelling exercises require collaboration with outside entities 
and must be coordinated, which is also time and resource 
intensive
•Independent, outside evaluation of modelling is often required to 
limit uncertainty
•Current epidemiological data may conflit with the 
epidemiological data used in a modelling exercise due to changes 
in transmission dyanmics or control efforts
•Models used don't offer societal perspectives on potential policy 
actions, and this is noted to be "standard procedure"
•Sensitivity analysis of models can only be used in certain cases
•Issues of cost-effectiveness and economic impact may have to me 
integrated into a model after the model has been completed as 
that information frequently changes
•Populations the modelling cover may need to change or be 
adjusted post-hoc in light what population is most affected by a 
current outbreak of disease
•Each stakeholder has a different perspective of approprioate 
priorities, which can lead to the usefulness of a given model for a 





format for each theme, a Discussion section follows which addresses all of these findings 
in tandem (across themes) as they are relevant to each of the research questions.  A 
discussion of how this data fits into the larger body of work on the use of modelling and 
scientific evidence in policymaking, and how to potentially improve this process using the 
characterisation presented here, is given in the final sections of this chapter. 
   
                Theme: ‘Theme One’ 
The definition of the theme as agreed upon by the researchers and defined from both 
inductive and deductive processes is presented. 
Nodes: The terms used in coding and any sub-nodes are introduced. This is not the same as 
a theme, but rather the term that was used during coding and analysis. Whether nodes were 
abandoned, collapsed into  
Summary of data: The information contained in the summary cells is reviewed and 
explication of those summary points is provided, as well as direct quotes from the original 
data that support these summaries and explications. Quotes are in italic with direct 
reference to what meeting minute they originate from. 
Characterisation of Theme: Here, the component characteristics that would identify and 
differentiate a theme that arises from analysis are presented. These are the main points of 
interest from each summary of data that pertain directly to the research questions.  
Figure 12-4. Example of memo format for findings 
4.8 Results of Qualitative Data Analysis 
                                       Theme 1: “Decision Processes” 
This theme captures time constraints, resources, and operational functions of the 
committee that play a role in how evidence-based policy is made. Project management and 
administrative concerns that might have bearing on how evidence is used in policymaking 
is captured here.  
Nodes: As decision-making is often influenced by the operational concerns of 
policymakers, two sub-nodes were defined that encompass two main sub-sets of 
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operational phenomena the policymakers encountered when making decisions.  The first 
sub-node is entitled “informational concerns”, and pertains to discussions within 
committee deliberations where they had difficulty accessing information that was 
necessary to inform their deliberations either because that information was unavailable (did 
not exist) or because there were issues barring the necessary collaborations or data 
generation exercises that would provide the desired information. For example,  
 
“The Committee noted the lack of evidence on vaccine efficacy, since the vaccine had not 
yet been evaluated in an efficacy trial” (Meeting Minutes, Feb 2014).  
 
 The second sub-node, “operational concerns”, was used to cache all of the concerns the 
committee expressed about limited resources of time, financial support, staff support, or 
statutory constraints on the committee’s breadth of operation.  For instance, 
  
“The Chair noted that the JCVI secretariat was not sufficiently resourced to undertake 
systematic reviews, and suggested specified members consider the issue and report back to 
the Committee” (Meeting Minutes, February 2014).  
 
This shows that often there are underlying operational issues that can influence the use of 
evidence (in this case, the use of systematic review) to inform policy decisions.  
Summary of data: Operational factors in general, and operational considerations that fall 
within the two sub-nodes detailed above, play a fundamental role in the function of JCVI 
and its use of evidence in its policymaking processes.  As in the illustrative example above 
from the minutes of February 2014, typical approaches to information gathering for 
policymaking such as critical and systematic literature review may be beyond the reach of 
the committee due to poor resourcing.  This means that even when the committee identifies 
that it needs data and scientific information, it may be beyond the committee’s capability 
to acquire the desired information. 
Staffing, and ensuring that there are adequate human resources available to continue 
operations and fulfil the statutory obligations of the committee, is a concern. As expressed 
below, 
 
“The committee were informed that a recruitment drive for a new chair and members 
would begin shortly. Members expressed surprise that a recruitment had not yet begun and 
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expressed concerns that the simultaneous departure of the chair and several members 
could leave the committee with insufficient multidisciplinary expertise to fulfil its terms of 
reference’ (Meeting Minutes February 2013).  
 
Since JCVI membership is voluntary and unpaid, and yet its purview requires that 
members provide highly technical expertise, finding the appropriate potential member who 
is well-qualified and is willing to take on the additional work for no pay can be a hindrance 
to the best use of scientific information or modelling. 
 
Other issues that were coded into the “operational concerns” sub-node include changes in 
resourcing or shifts in governance that can affect the function of JCVI.  While these 
changes were unlikely to directly affect whether JCVI could access or use evidence 
optimally, others pertain directly to how JCVI utilises scientific evidence and how they are 
perceived by other bodies, as demonstrated in the following quote, 
 
“Revisions had been made to describe in greater detail JCVI practice on gathering and 
assessing evidence.  This is to support an application to National Institute of Health and 
Clinical Excellence (NICE) for JCVI to be recognised by NICE as an accredited source of 
evidence and advice.  This would allow NICE to defer consideration of immunisation-
related issues to JCVI, and allow JCVI guidance to be used in the development of quality 
standards and other NICE guidance” (Meeting Minutes February 2013).  
 
It’s important to note here that this is an application that JCVI is making to state its case as 
an exemplary expert source of information that handles scientific data in the policymaking 
context in an optimal way, so while this is largely positive, it is important to note that 
JCVI’s relationship with other policymaking bodies and its statutory breadth of function 
can exert an effect on  how JCVI evaluates evidence and how it is understood by the public 
and other policy stakeholders as a policymaking body.   
 
Other general operational concerns that fall under “Decision Processes” are those 
procedural issues that are common to most policymaking committees, but in the case of 
JCVI and similar bodies, may have an impact on how evidence is evaluated. For instance, 
 
“It was further agreed the Committee as a whole should play a more active role in 
deciding the priorities for the agenda items for future meetings and that in order to be fully 
informed the Committee should receive the necessary supporting documentation in good 
127 
 
time and that this information should be accessible as soon as it is ready to be shared” 
(Meeting Minutes, February 2014).  
 
As in the quote above, what on the surface may seem like a quibble regarding time 
management speaks directly to both the volume of work that the committee is tasked with, 
and the heavy time resource consumption of doing such work. Committee members would 
need to have available evidence and information well in advance of deliberations to 
appropriately comment after thorough review, but epidemiological information can change 
rapidly in the midst of an outbreak or infection control measure.  Here we see the conflict 
between the committee desiring ample time to consider any new evidence before any 
deliberations, and that evidence not necessarily being readily available for their review. 
Finally, the decision processes by which JCVI evaluates information are themselves 
debated as a matter of operational concern, as we see in the following quote, 
 
“The Committee noted there had been considerable debate in recent meetings regarding 
the system employed by JCVI to assess cost-effectiveness, and whether this remained 
appropriate” (Meeting Minutes, February 2014).   
 
This means that not just evidence itself, but systems to evaluate evidence and incorporate it 
into analysis are questioned and debated by the committee, and questions arise as to 
whether the appropriate evaluative methods are being used. This can be positive, as open 
debate about methods and consensus-building about best practices are fundamental 
practices for such a committee to return high-quality policy recommendations. However, it 
should be noted that conflict could potentially arise when a panel of experts from a diverse 
array of disciplines cannot agree on the best approaches and methodologies.  
 
Characterisation of Theme:  Decision Processes appear to be able to be divided into two 
aspects: operational concerns surrounding access to information, and operational concerns 
pertaining to the day-to-day operations of the committee. While it is more obvious that a 
lack of evidence or a lack of access to evidence would affect how scientific information is 
used to underpin policy decisions, it is likely less readily clear to non-experts how day-to-
day operations like time management, budget, statutory mandates, and relationships to 
other committees or bodies also has a significant effect on how committees such as JCVI 
use evidence in policymaking.  This delineation is important because it reveals that the 
effective use of scientific evidence in policymaking is subject to fluctuations dependant on 
128 
 
factors that might not be immediately identified by laypersons as significant. 
 
    Theme 2: “Ethical and Social Considerations in Policymaking” 
This theme encompasses the relationship of the evidence-based policymaking process to 
the wider social and scientific community. For instance, how evidence or modelling is used 
when issues such as accountability to the public and the wider policymaking and scientific 
communities arise. It also encompasses the ethical obligations to these communities, for 
instance, the balance of fiscal cost to social good of policy implementation, and the ways 
in which evidence might be used to weigh those obligations.  
Nodes: This node did not warrant additional sub nodes when coding, however, it is 
important to note that some instances of ethical consideration were much more overt than 
others. Often, the obligation to the community or the severity of the burden of disease on 
the community is directly discussed, although sometimes, the social or ethical importance 
of weighing evidence or making a scientifically- or modelling-based decision in the service 
of the public good is less overt.  While a significant amount of researcher reasoning was 
involved in making these distinctions, they did not warrant two separate sub-nodes, as they 
are not qualitatively distinguishable phenomena.  
Summary of data: Policy recommendations regarding immunisation programmes and 
infection control for entire populations have obvious and inherent ethical dimensions.  
However, how these ethical dimensions are reflected in deliberations that are informed by 
scientific evidence and modelling methods may not be as readily discernible to outside 
observers. In general, the following summary of data reflects that, either explicitly or 
implicitly, the policy stakeholders are carefully considering what the social and ethical 
implications are when they are considering evidence to inform their recommendations. 
However, there may be some question as to whether “Ethics” in this context means the 
committee is conducting itself ethically, in best service of the social good, within the 
boundaries of its mandate, and whether that would fall into this theme. Those concerns are 
likely more operational in nature, (e.g. “Is the committee fulfilling its mandated 
function?”) and I found no data that would suggest the committee grappled with ethics in 
such an operational way. Rather, as stated above, it appears the committee is grappling 
with the complexities of allocating resources in the general and vulnerable populations. 
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Concern for the well-being and prevention of disease in specific populations that may be 
more vulnerable to disease was evidenced at several points in the JCVI deliberations, as 
demonstrated in the following quote, 
 
“The Chair explained that this ad-hoc meeting of JCVI via teleconference had been 
convened to consider whether a temporary programme should be introduced to offer 
pregnant women immunisation against pertussis to protect their newborn infants in light of 
the continuing outbreak of pertussis that is increasing in severity” (Meeting Minutes Aug 
2012).  
 
It is important to note that this example comes from an ad hoc, or irregular meeting, of the 
committee undertaken with the specific aim of protecting a vulnerable population from a 
current outbreak of disease. This reflects that attention to epidemiological trends and 
evidence as it changes between meeting periods is just as critical as deliberating current 
evidence during regular meetings.  There is obvious social responsibility reflected in 
convening on an ad-hoc basis to consider evidence to protect a specific sub-population of 
people, in this instance, women and their infants.  
 
Resource allocation is an additional consideration the committee is regularly confronted 
with, and it too has clear ethical and social implications for which the weight of scientific 
evidence or modelling would play a major role. JCVI is using scientific evidence to 
determine the availability and distribution of a wide array of prophylactic measures to the 
general public, or to specific populations that might be more vulnerable to disease, but 
these decisions often involve the possibility of a trade-off where services in another area 
may be disrupted, as we see in the below quote, 
 
“There are sufficient stocks of this vaccine to support a temporary programme for at least 
six months without putting the routine childhood immunisation programme at risk from 
supply issues.  Alternative vaccines would require procurement arrangements that would 
take some time to put in place” (Meeting Minutes, 2012).  
 
As above, there is a sense of urgency that pervades some types of these deliberations, 
where the ethical imperative to act quickly and the resources to do so are sometimes in 
competition, and this is evidenced by the consistent referral to time constraints the 
committee faces when making these decisions that need to be made quickly. Obviously, 
this time-element intersects with how easily the committee can procure high-quality 
130 
 
evidence or outside expert counsel in the time needed to come to a decision.  
 
JCVI also regularly considers evidence about the safety of a vaccine they may recommend 
be added to the schedule of immunisation, or be distributed via a temporary programme to 
attempt to control a current epidemic or outbreak. In these scenarios, the ethical and social 
considerations are clearer than those of resource allocation, with the committee weighing 
the possible risk of vaccine-related adverse events against the possibility of protecting a 
vulnerable population as they do below, 
 
“The benefit of immunisation during pregnancy to infants is likely to outweigh the 
potential increase in reactions in pregnant women” (Meeting Minutes, Aug 2012).  
 
The burden of risk that JCVI assumes in assessing the risk of adverse events presents a 
clear ethical issue, and weighing the best available scientific evidence on the incidence of 
disease versus the incidence of adverse events to make that decision constitutes one of the 
ways in which evidence is used to help decide ethically fraught or socially consequential 
issues in policymaking. Sometimes this includes considering evidence that is unclear or 
contradictory, as the committee notes in the following, 
 
“The committee noted that there is conflicting evidence on the potential for the blunting of 
the immune responses to the first routine infant immunisation following immunisation 
during pregnancy” (Meeting Minutes Aug 2012).   
 
And while the ultimate decision is made that the benefits of immunisation in this instance 
outweigh the risks, JCVI notes that despite their confidence in making the 
recommendation, they strongly urge further research to address the conflict, thus 
augmenting their confidence in making statements of risk to the public. 
 
The final data summarisation point is of note, as it addresses not only how evidence might 
inform or support policy deliberations with ethical dimensions, but how ethical 
considerations may inform the development of evidence generation exercises, like 
modelling, These ethical dimensions and the considerations surrounding them are below, 
 
“Quality of life losses in close family members of those affected by invasive meningococcal 
disease had now been included in some scenarios in the model as requested by the 
Committee, although they had not been included in the principal analysis” (Meeting 
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Minutes February 2014).   
 
Here, the need to address the impact of those individuals affected by disease is being 
integrated into some of the modelling exercises being used to underpin policy 
recommendations; this is a decision which has clear ethical and social dimensions. 
Although these social impact concerns are not a standard part of the modelling analyses 
that were performed by the committee, it is notable that evidence is not only used to 
support social impact decisions, but rather social impact decisions are being used to inform 
the development of evidence. This is particularly notable in the context of this study, as it 
demonstrates a sophisticated conceptualisation of the potential of modelling exercises to 
explore policy outcomes, regardless of the quality of modelling or its output.  
 
Characterisation of Theme: While it is clear that the entire enterprise of JCVI has social 
and ethical dimensions and impact, it appears that those considerations are more explicit 
and overt in some scenarios than others. Ethical and Social Considerations as a theme 
should thus be characterised by both the explicit and implicit discussions of actions that 
have a social or ethical impact, but also the integration of social and ethical concerns into 
modelling exercises or commissioned studies that seek to provide information to the 
committee.  
  
      Theme 3: “JCVI Attributes” 
This theme is concerned with the characteristics of the committee: its scope, role, and 
membership that might have an influence on how evidence is accessed, used, and 
interpreted in the service of policymaking. 
Nodes:  There was significant coding overlap with this node and operational concerns 
outlined in memo one.  For instance, the need for members to be at an advanced level of 
technical proficiency and educational qualifications, and the need for these members to 
have no declarable conflicts of interest (for instance, no personal financial involvement 
with vaccine manufacturers), are attributes of the committee and its functions.  But because 
these functions as they were coded overlapped entirely with the data presented in Memo 1, 
and the characteristics of JCVI that would influence evidence use were determined to be 
subsumed under “Decision Processes”, this node was collapsed into that theme.           
                                  Theme 4: “Modelling in Policymaking” 
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This theme describes the use of modelling methods specifically to underpin policy 
decisions, including assumptions and functions of modelling methods in the process of 
policymaking deliberations, and the operational concerns (time, money, etc.) surrounding 
the use of modelling to inform policy. 
Nodes:  This node did not warrant additional sub-nodes when coding as the definition of 
the theme was broadly encompassing, and the discussion of modelling methods in the 
original meeting minutes text was well-characterised and straightforward. As I was not 
focusing on the types of modelling being used or their specific evaluative purpose beyond 
their use as a source of evidence to underpin policy recommendations or to inform policy 
deliberations, no sub-nodes were created for different types of modelling or specific uses 
of modelling. Rather, the summary of data aimed to generally characterise how the models 
are used and perceived, and what challenges and issues arose when employing them. 
 
Summary of data: Modelling in JCVI deliberations appears to be a fundamental and 
regular tool used to evaluate scenarios, generate data, and explore possible impacts, costs, 
and outcomes. However, the role modelling plays in policymaking deliberations seems far 
from a simple one, with modelling exercises often characterised as someone burdensome, 
as we see in the following,  
 
“These complex analyses would take time to conduct” (Meeting Minutes, August 2012). 
 
The picture of modelling as a complex endeavour that can place serious demand on JCVI 
time resources is confirmed across meetings and topics, appearing again here, with the 
 
“The extensive deliberations since 2011”  
 
on the appropriate parameterisation of a model is mentioned in the June 2012 minutes, 
with an additional note directly after stating that, 
 
 “cost-effectiveness model had been revised twice since first being examined by the 
Committee.”  
 
There is a sense from the above quotes that the need to continually deliberate what 
information should be included in the model, and to adjust the parameters as a result of 




There is also the issue that arises that, even when the parameterisation or adjustment period 
of the modelling that takes place, the model needs to be validated using an outside source 
in the form of review, as noted by the committee below, 
 
“an independent review of the input parameters and modelling, a report on which had 
been provided to Committee” (Meeting Minutes June 2012).   
 
This review would obviously require external collaboration and fiscal resources that a non-
budgeted committee like JCVI would find difficult to grapple with. However, it 
demonstrates that JCVI is consistently thorough even when faced with challenges, and 
appears to be indicative of how evidence is used and validated in JCVI deliberations. This 
contributes to the impression of JCVI as an entity that is using the highest-quality available 
evidence to support its decisions.  
Although this inquiry is not focused on the various types of modelling here per se, JCVI 
may also need to consider multiple types models when considering a single issue, such as a 
cohort model and then a transmission model. This is also true for the various sources used 
to inform the model. Committee members are tasked with the consideration of data from a 
wide range of sources, including: governmental data, data from pharmaceutical companies, 
evidence from other committees, etc. Gathering and evaluating the quality of this evidence 
is likely to be time intensive and open to much debate amongst members, as seen here in 
the extract below, 
 
“The Committee agreed that all stakeholder comments received and all recently published 
evidence had been properly considered by the Committee at its meeting of 2 October 2013 
and those changes requested in light of those deliberations had been appropriately 
incorporated into the impact and cost- effectiveness model presented to the Committee” 
(Meeting Minutes, February 2014).   
 
Across cases, uncertainty surrounding whether the parameters used in the model is a 
common theme, as evidenced by the following,  
 
“The Committee noted that uncertainty remained regarding a number of key parameters” 
 
and the primary concern was that, in some cases, that range of uncertainty would cross a 
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certain threshold of a determining factor like cost-effectiveness, which could “make-or-
break” a particular immunisation programme.  This concern is expressed in this excerpt, 
 
“The three iterations of the cost-effectiveness model presented to the Committee had 
ranged between positive and negative cost-effective prices, and it was possible the range of 
uncertainty present in the final version of the model crossed the threshold between cost-
effective and cost-ineffective” (Meeting Minutes, February 2014).  
 
This is an interesting point of note, as uncertainty seems to be driving the modelling 
exercises at this point, and the hope seems to be that the committee can add and remove 
parameters or ranges of uncertainty until a favourable outcome is reached. There’s no 
discussion on how a model is chosen as the “correct” one once multiple iterations of the 
model are made and parameters changed.  It does seem to be that the model is so 
fundamental to underpinning decisions as a form of “evidence” that the policymakers will 
re-parameterise the model until it shows a favourable outcome. Clearly, this is not the best 
or most meaningful use of this kind of scientific evidence.   
 
However, the JCVI does seem to have some procedures available to them that can assist in 
limiting uncertainty when using modelling exercises and perhaps mitigating the 
aforementioned data “fishing” that appears to be taking place in the example above, as in 
the following, 
 
“This, as set out in the Code of Practice, would ensure relative certainty that the vaccine 
would have a net positive impact on the health of the population” (Meeting Minutes, 
February 2013).  
 
The JCVI code of practice in this instance seems to function as a touchstone where 
assuring the net positive of outcome for the public health is an appropriate answer to 
uncertainty, particularly when the uncertainty involves questions of cost effectiveness 
versus the overall health benefit to the population.   
 
Characterisation of Theme: Modelling is clearly a fundamental, necessary tool in the 
policymaking process.  Modelling is flexible enough to integrate evidence from a wide 
variety of sources, including societal and ethical impacts, however, there do appear to be 
instances of using the model over multiple iterations in order to gain a favourable 
“evidence outcome” to support a desired programme or initiative.  Modelling is both 
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central to the committee’s deliberations and presents a wide array of challenges, both in 
time and cognitive and deliberative effort.  
        
                      Theme 5: “The Nature of Evidence in Policymaking” 
This theme is concerned with the evidence the committee uses to underpin its policy 
decisions.  This includes access to scientific information, commissioning of scientific 
studies, the use of published literature or systematic review, and the different types and 
sources of data the committee uses. 
Nodes: This node did not warrant additional sub-nodes as it is inclusive of various types of 
evidence, identifying any barriers to attaining that evidence, and using that evidence to 
inform policy deliberations. While it was not useful to parse the specifics of each type or 
source of evidence in order to form a more general characterisation of evidence use in this 
context, it was necessary to understand the variety of sources used to provide evidence and 
the challenges that JCVI and similar committees may have in accessing them.  
 
Summary of data: Even within a single case (meeting) the JCVI may consider evidence 
from a wide range of sources on a wide range of topics, taken from the August 2012 
minutes alone, JCVI considered evidence from the following sources as we see below,  
 
“an analysis had been produced by the Health Protection Agency (HPA); Latest 
epidemiological data from England & Wales; Summary of Product Characteristics (SPC) 
(from a pharmaceutical company); evidence gathered by the HPA and MHRA on analyses 
of the impact and cost effectiveness of strategies; peer-reviewed studies in the literature.” 
(Meeting Minutes, August 2012). 
 
This quote above suggests that one major issue pertaining to evidence use in this context is 
the high level of variability of data source. The committee is responsible for choosing 
which source is appropriate for which kind of data or evidence as well as being responsible 
for determining what the quality or usefulness of that data is. Having to rely on such a 
variety of sources and types of data may additionally burden this selection process and 
effect deliberation. Frequently the source of the evidence being used to inform the 
committee is not readily discernible from the meeting minutes.  However, as noted in 
Theme 1 “Decision Processes” above, operational concerns, such as lack of resources may 





There are several points in the JCVI deliberations where the committee perspective on the 
quality of the evidence they are using is mentioned, as it is here in the following, 
 
“A number of substantial and well-considered consultation responses”  
 
and in the following quote, even denoting where there was, 
  
“lack of evidence on vaccine efficacy”  
 
or lack of evidence on  
 
“other topics of deliberation” (Meeting Minutes, August 2012).  
 
 But the sources of evidence and scientific consideration that JCVI encounters extends 
beyond the traditional as the committee also considers the deliberations of other 
organisations and entities in its decision-making, as noted in the below extract,  
 
“Committee noted the plans of other administrations in the UK” (Meeting Minutes, 
February 2014).  
 
The impact of these peripheral or “grey” areas of evidence-gathering should not be 
underestimated, as the findings of other committees or administrations may have direct 
impact on what JCVI chooses to recommend, as seen in the above excerpt.   
 
The committee also participates in a fair amount of “horizon scanning”, meaning they are 
looking forward to studies or initiatives that will generate data that can assist them and 
discussing their usefulness for purpose. For instance, they discuss an upcoming study in 
the following quote, 
 
“The committee considered that such a study would be very helpful given the planned 
extensive use of this vaccine in children and supported this study” (Meeting Minutes, 
February 2013).   
 
They will typically note that they support or endorse the activity, and while there’s no 
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formal impact of the committee doing so, such endorsements bring into relief a direct 
relationship between primary research and policy, and how policymakers desire research 
that assists them in their understanding and their activities surrounding recommendation 
development. 
 
 Occasionally, JCVI will even go so far as to state explicitly that a particular study for 
which there is no plan would be useful,  
 
“it would be very important to study the impact of the temporary programme” (Meeting 
Minutes, February 2013).  
 
This kind of direct and open communication can be rather beneficial to researchers who are 
interested in applied outcomes in setting a research agenda, although it is not necessarily 
desirable for a government committee to dictate which outcomes research would be most 
“useful” if that could be construed as coercive to researchers. Yet, it is important for the 
committee to be transparent and communicative about where it is lacking information and 
evidence base.  
Characterisation of Theme: While there is a wide variety of evidence that the committee 
has at its disposal, time and resource limitations may prohibit them from using all desirable 
forms of evidence.  Sometimes the evidence is simply not extant.  However, there is a time 
and resource demand even when the evidence is available as the evidence must be 
reviewed and judged for worth and fit-for-purpose. Finally, the committee is very 
communicative when it lacks evidence, when evidence is contradictory, or when it decides 
a particular study is warranted.  
4.9 Discussion 
What follows is a discussion of this data in the context of each research question and in the 
context of the literature.  Here, how the data above addresses research questions is 
summarised. Suggestions for future research, how to use these observations to improve the 
use of evidence generally, and modelling more specifically, in policymaking endeavours, 
and limitations of this study, are given in the final Conclusions section.  
1) What are the primary challenges that public health policymaking settings experience in 




As is clear in the emergence of the sub-nodes in Theme 1 “Decision Processes”, the 
primary challenges to the use of modelling methods (and evidence in a more general sense) 
appear to be operational.  The committee often expresses it does not have sufficient time, 
money, information, or access to use modelling successfully, and this is particularly true 
for deciding what data to use for the parameterisation of models and how to determine 
which evidence they have available is the most “certain”, to ensure that the model outputs 
are actionable. Rychetnik (2002) notes that the appropriate use of evidence in healthcare 
settings requires a tripartite approach as follows, 1) It must be determined if the research is 
of high enough quality to underpin a decision on whether or not to implement interventions 
or policy, 2) the research outcomes must be determined, and 3), whether the available 
research is generalisable to the potential target population must be determined.  
Such a multi-phase process of evidence evaluation, while a thorough approach, is likely to 
compete with the time pressures evident in the committee deliberations.  Time pressure is 
thus likely a primary challenge for committees operating in public health contexts where 
the need to evaluate and integrate evidence is central to decision-making. 
 
The committee’s model of operation demands that it justify all decisions with an evidence-
base. In absence of scientific certainty, using models as that primary evidence base may 
fall short of expectations of predicting an optimal outcome. Communicating that scientific 
uncertainty in the name of transparency as a public entity requires a careful command of 
policy craft. The ability to negotiate scientific uncertainty, develop persuasive 
communication surrounding policy recommendations to ensure public buy in, while also 
implementing a standard transparency policy may be severely limited by a lack of 
dedicated resources and established best practices (Brown et al., 2015). As the committee 
expresses concern about resource allocation and certainty about the strength of evidence, 
and is under pressure to ensure all decisions are completely evidence-justified, this 
uncertainty-transparency interface is also another primary challenge both identifiable in the 
literature and evident in the findings of this chapter.  
However, despite the concerns that the committee expresses about the quality and 
availability of data to use in the model, they seem to be able to use the data generated by 
their modelling endeavours to underpin immunization programmes in such a manner that 
their proposed programmed go on to be successful and improve coverage rates for their 
target populations. Overall, it is consistent with the literature that committees such as JCVI 
seem to be unduly burdened by the imperative to provide high-quality data justifications 
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for every decision, without the resources necessary to easily manage a multi-phase, large-
scale project like modelling they might use to provide that necessary justification.  
However burdened they may be, they achieve success in the majority of their outcomes (in 
this case, effective disease control and overall high rates of vaccination) by implementing 
solutions that are provisional and circumstantial, not by enacting fundamental reform of 
the governmental systems that generate the impossible bind, or “wicked problem”, of 
demanding the evaluation or generation of high-quality evidence without the allocation of 
resources for doing so (Head & Alford, 2013). Clearly, governmental systems that are 
inherently “complex” systems provide the context for the operation of  the majority 
committees such as JCVI, and thus, this is identified as the third primary challenge to the 
effective and efficient use of modelling, and evidence more generally, to underpin policy 
decisions.  
 
Beyond the difficulties of operations and evidence availability, the committee expressed 
concerns about its role in matters that have obvious ethical implications or dimensions and 
widespread social impact. Recent studies that JCVI might use to underpin decision-making 
about the costs and benefits of adding a new vaccine to the immunisation schedule account 
for some variables on an ethical dimension by integrating different quality of life indicators 
(Christensen, Hickman, Edmunds, & Trotter, 2013), but whether this is sufficient to 
assuage all involved stakeholder concerns remains an issue. JCVI does not seem to be fully 
comfortable with parameterising and integrating social impact or ethical dimensionality 
into its models as a matter of primary analysis, but there are clearly members on the 
committee who would favour this approach. This disparity in approaches can lead to 
protracted negotiations about the correct way to inform the model and which 
considerations are a public health priority. JCVI is mandated to consider a wide range of 
stakeholder perspectives and evidence sources to inform its policy recommendations. As 
this is unlikely to change in the foreseeable future, and thus, the high level of time and 
deliberative effort required by modelling in the context of the committee will likely remain 
fairly static. 
2) How are policymakers using the models to inform their policies as deliberations 
progress in a natural setting?  
Models are being used in a variety of ways as deliberations progress, however, they seem 
to be used in two primary modes: 1) To generate analysis about cost-effectiveness and 
immunisation coverage that justifies policy decisions about immunisation programmes, 
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and 2) To explore impact and outcomes of possible policy decisions and explore 
parameters not included in “primary” analysis, such as social impacts and ethical 
dimensions of possible policy choices. Some of the uncertainty the committee express here 
stems from the characteristics of the models themselves and their lack of functionality that 
is well-suited to carry social impact information as a parameter in a way that is meaningful. 
Other concerns about scientific uncertainty seems more obvious, in that they stem from the 
data being used to parameterise the model being incomplete, uncertain, or in some cases, 
completely unavailable, and these concerns are consistent with modelling efforts in 
general, across model types (Riley, 2007).       
 
However, some of the model use is questionable beyond a lack of sophistication with the 
methodology.  When uncertainty exists in the cost-effectiveness data, there appears to be a 
trend toward creating multiple iterations of the model with increasingly wide ranges of 
possibilities (reflected in wider ranges of parameters) in order to manipulate the outcome 
of the model toward a favourable outcome. This allows JCVI to justify an action it has pre-
ordained as desirable. This is also consistent with the literature, as such ethical use 
concerns are common to policy stakeholders and researchers that are at least partially 
reliant on modelling methods to underpin policies or predict possible outcomes, and recent 
literature addressing best practices for the use of dynamic models in these scenarios in 
order to mitigate these concerns (Pitman et al., 2012).   
 
There also seems an overreliance on the model output as a “final destination” for evidence 
that JCVI can use to support its policy decisions, meaning model outputs are considered 
sine qua non of evidence-based policy deliberations, to the detriment of other forms of 
evidence.  This is also less optimal use of modelling methods, as models they are in no 
way fully predictive of potential outcomes or capable of accounting for all critical 
variables, and should be used in tandem with a complete range of evidence sources, and 
not as the sole data-driver of policy decisions affecting the public. Additionally, best 
practices for modelling use in the healthcare scenario demands a high-level of model 
validation and public transparency about the validation process (Eddy et al., 2012); these 
are validation processes which would be difficult for the committee to maintain if they are 
over-reliant on the model itself to produce high-quality evidence. Predictive validity and 
external validity of the model are the most likely to be compromised if the modelling 
outcomes are not compared to “real world” data, and are instead treated as though they are 




Despite this deficit in use, it is clear that modelling plays a central role in the generation of 
data that allows JCVI to support its policy decisions, and that using modelling for these 
endeavours is often a good fit-for-purpose. Modelling is offering the policymakers the 
flexibility they need to keep up with the most current evidence and scenarios, changing 
data in the model parameters as they acquire new epidemiological data in real-time, which 
is a valuable asset.  They don’t always find the modelling iterations come to fruition 
quickly enough to provide the evidence they need to support their policy recommendations 
on short notice. 
 
However, modelling in this context is offering a policy trade-off familiar to many such 
contemporary committees: it is a “lean” methodology that doesn’t require many fiscal 
resources; significantly less than more traditional studies the committee could commission 
to examine these issues. The idea of “Lean” government is a relatively recent one, which is 
emerging as a response to traditional approaches to governance and policymaking, and 
aims at reducing the complexity and resource consumption in the public sector by reducing 
and compacting organizational structures and processes, while concurrently increasing the 
demand for technological innovation (Janssen & Estevez, 2013). Modelling methodology 
is an excellent fit into this paradigm, however, modelling is an exacting process for 
policymakers, and what they save in money, they lose in complex deliberations about 
parametrisation that would take up significant amounts of time.  
3) Are modelling exercises used to directly inform the policy recommendations, (for 
instance, using the data they generate to directly justify decisions), or are they used in a 
more casually informative way? Is it possible to ascertain why they are used in this way by 
examining real-time use during decision-making deliberations? 
 
The findings in this chapter suggest modelling in this context is not causally informative, 
and is, in fact, almost always being used to directly inform or justify the policy 
recommendations of JCVI. Even when modelling is being used for secondary analytical 
concerns, (for instance, when being used to gauge social impact of a particular policy 
choice), it is never framed as an exploratory exercise of note for later deliberations, but as a 
fundamental component of figuring out the best way for JCVI to proceed for the issue at 
hand.  Models as used by JCVI used to ascertain coverage, safety and the potential for 
adverse events, the effects of potential programmes on specific (often vulnerable) 
populations, cost-effectiveness, epidemiological data, and the aforementioned social and 
ethical dimensions of policy choices; all of these are appropriate uses as suggested by the 
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wider literature (Weinstein et al., 2001).   
 
Upon close examination of the data and the resulting summary of findings in each cell of 
the matrix framework, most of the work that JCVI performs is data-driven.  This means not 
only that evidence and data underpin the deliberations and decisions that JCVI makes, but 
that the actions of JCVI, and the committee’s understanding of the current epidemiological 
situation is wholly dependent on a wide variety of data sets. The entire cycle of activity 
JCVI undertakes functions by the committee either acquiring, weighing or generating, 
evidence and data.  Modelling as a way to both weigh (analyse) data and to generate data 
that justifies policy choices sits at the centre of this cycle of activity.    
 
There are two primary reasons modelling is being used in this way during the 
policymaking process. The first is its availability: from experimental studies to systematic 
literature review, JCVI has been clear in its meetings that it is too under-resourced to 
employ more diverse or traditional methods of data generation or analytical reasoning, 
again, a commonality that might be found amongst governmental committees working in 
the new “Lean” environments (Janssen & Estevez, 2013).  In lieu of the ability to perform 
a systematic review or cohort study and have that provide the basis for policy judgments, 
modelling provides the necessary “evidence-base” to account for the policy 
recommendations being made.  The second reason for its central role in JCVI has less to do 
with the specifications of the individual model or the output of the model, but with the 
absolute imperative that all policy decisions and recommendations that are being made by 
JCVI be “data-driven”.  Since the need to develop policy with data is such a directly 
informative one, rather than using models in an exploratory fashion, models are almost 
always used in this context to provide some kind of analytic justification for action. 
 
Yet, Despite some of the challenges present with such singular use of modelling methods 
in a policy setting, modelling does present opportunities to both underpin policy by 
providing excellent, partially predictive data for a given scenario, and to explore variables 
policy stakeholders know to be important, but are difficult to quantify (such as quality of 
life).  Overall, the policymaking-modelling interface here, while sometimes fraught, is 
promising. Possibilities for leveraging this information to improve the use of evidence and 
modelling in similar scenarios, future directions for research, and limitations of this 




This study has successfully identified and characterised themes that describe the activity 
surrounding the use of scientific evidence generally, and modelling methodology 
specifically, to underpin public health policy. Primary challenges to public health 
policymakers in using methodology in these scenarios have also been identified: 1) time-
pressure and operational resource limitation interfacing with the demands of systematic 
evaluation of evidence, 2) the conflict between scientific uncertainty and the need for 
transparency about that uncertainty with the public, 3) the complexity of the bureaucratic 
system in which the evidence is being evaluated, and 4) the lack of advanced expertise and 
confidence that policymakers have with the limitations and best practices of modelling use, 
particularly for the modelling that considers social or ethical impacts of policy decisions.  
 
Identifying these challenges that are specific to public health policymaking, and the ways 
in which modelling methods are utilised in this setting, is itself a critical task.  Applying 
strategic management principals to these operational deficit problems would likely provide 
at least provisional solutions to some of the more pressing challenges that JCVI and similar 
committees face. For instance, the provision of increased funding for expert modelling and 
scientific consultation when the committee is deliberating in crisis situations would serve 
to facilitate the necessary systematic approach to evidence evaluation.  
 
This additional resourcing would result in higher-quality evidence evaluation and 
modelling exercises when time pressure is particularly demanding, and potentially increase 
positive health outcomes. Ancillary to that, increased interaction with expert modellers 
might increase the confidence that committee members have with the potential and 
limitations of modelling methods. This additional resourcing could be allocated on an ad 
hoc basis, so per annum funding remains relatively stable, and “Lean” operational 
objectives can still be achieved, bringing the needs of the committee and the needs of the 
larger organisation into better harmony. Future applied services research might explore 
some of the potential operational and strategic management solutions to facilitate public 
health policy committee functions in these complex bureaucratic contexts, as that 
information is woefully absent from the literature.  
 
While the complexity of the governmental system itself is likely to remain a “wicked 
problem”, intractable and beyond the scope of committee functions, the competing 
demands of such a system could be more successfully addressed on an ad hoc basis if there 
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were more explicit guidelines and best practices that provided a foundation to committee 
members and guided their deliberations. This is particularly true where the committee 
struggles with making command decisions in a climate of scientific uncertainty while 
simultaneously providing transparency about that uncertainty and the decision-making 
process to the public.  Research that specifically addresses that interface in this context is 
key. While much research focuses on communication about vaccines and public 
confidence about safety, much less research focuses on how policymakers communicate 
uncertainty about these issues in a way that is both transparent and preserves the public 
trust, and what capacity building the policymaking bodies might need to develop in order 
to achieve this goal.  
 
Finally, it is clear from the literature that precedes this data, and the findings from the 
qualitative analysis, that policymakers on such committees are 1) unlikely to be experts in 
the construction of models or the interpretation of their outputs, and 2) have limited terms 
of service and variable technical expertise.  As the use of modelling in these scenarios is 
only likely to increase in future practice, providing the appropriate training to ensure that 
involved committee-members and policymakers have the necessary technical savvy to 
effectively use modelling methods is an imperative for the governmental agencies that 
oversee such committees. Barring this approach (since committee-members are term 
limited), ensuring that there is ample contact between policymakers and expert modellers 
would be a best practice for any such committee of this type. 
4.11 Limitations of the Study 
The general limitations of this study are largely methodological: the sample size is 
relatively small and the deliberations analysed are the product of one committee in the UK, 
and thus, caveats about how generalisable these findings are in more resource-limited 
settings apply. Sampling in the Framework approach to qualitative research is not able to 
fully represent to larger populations (i.e., all committees in public health) but serves to 
reduce highly complex descriptive data into meaningful themes in order to understand 
complex phenomena in health services research. The literature surrounding the use of 
evidence in policymaking is very large and constantly growing, and it would be an 
impossible task to review the entirety of research relevant to these inquiries. It is 
recognised that thus, this study is specific to a very limited point in time in the course of 
the evidence-driven policy agenda, and as political and social understanding grows, so 
does the meaningfulness of these findings. There is also the concern for this and future 
145 
 
studies that, as research using these open access sources grows, policymakers will be less 
open and explicit in their deliberations when politically sensitive issues or scientifically 
contentious or uncertain topics come up. Ideally, increasing numbers of collaborations 





Chapter 5 – Extended Conclusions and Recommendations  
5.1 Modelling and Evidence in Context 
This thesis has addressed fundamental questions regarding how modelling methods can be 
used to unify literature about addressing epidemiological questions in a policy context, 
how the public confidence in modelling methods might impact upon their projected 
behaviours, and how modelling methods are used to inform the public health policy 
process. However the question of modelling as an emerging tool in public health and 
policymaking is one with complex intersections, unexplored applications, and an ever-
increasing literature, and it is unlikely that any one single body of work can address these 
in their entirety. Thus, understanding modelling methods in context must be a continual 
effort, employing the talents of interdisciplinary teams of researchers, clinicians, and 
policymakers. As reflected by some of the evidence presented in this body of work, these 
methods are likely to become increasingly popular to underpin policies that directly affect 
the public health and well-being, so it also becomes an ethical imperative to educate the 
public about what the capabilities and limitations of models are and how they are used 
(O’Neill, 2004), particularly if we are interested in building the public’s confidence in our 
recommendations that stem from model-based results.   
 
Beyond the discussion of modelling methods specifically, this thesis also presents data and 
information that is pertinent to the use of evidence in public policy more generally. In this 
age of the evidence-driven policy paradigm, endeavours that seek to understand the use 
and perception of methodological tools that generate or evaluate evidence become 
increasingly important as they not only ensure that evidence is of the highest quality, but 
because they constitute contributions to our epistemological understanding of the scientific 
method (Scotland, 2012) and its use in non-scientific settings. Scientific inquiry as a way 
of understanding human phenomena demands we also include our methods in our 
systematic evaluation. Evidence is important, but the evidence we generate is only as 
reliable and valid as the methods we use to generate it, and this thesis adds to that 
fundamental understanding of how this increasingly popular method is being used, and 
challenged, in the settings of most public interest. 
 
This chapter will present the broader conclusions from each of the three data-driven 
chapters that comprise the majority of this body of research.  These conclusions will be 
framed in the context of addressing the deficits and leveraging the strengths identified in 
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the findings and discovered in course of research, and will include recommendations to 
improve the use of modelling methods in the various scenarios presented in the chapters.  
These recommendations will be grounded in literature that encompasses process 
optimization, research development, strategic management, and organisational 
improvement, in order to assure that the recommendations themselves are based on 
evidence that reflects best practices in both research and policymaking settings. In the 
following section, that literature is briefly introduced and reviewed, in the interest of 
orientation and transparency.  
5.2 Process Optimisation, Research Development, and Policymaking 
Management  
 
In order to recommend best practices that address deficits in the use of modelling methods, 
an understanding of the foundational principles of organisational improvement, strategic 
management, and process optimisation research is of fundamental importance. Research-
based policymaking is a process, and the adoption and meaningful use of emerging 
technology like modelling methodology fits into the study of optimising processes in 
organisational settings. Thusly, this section outlines the body of research that underpins the 
recommendations for more “meaningful use” of modelling methodology in this chapter of 
the thesis.  Beginning in section 5.3, these principles are then applied to the findings of 
each data-driven chapter.  
 
The notion of “meaningful-use” of healthcare technology stems from the provision of an 
American federal law that intends to address issues of whether technological innovations in 
healthcare management can actually improve the function of public health systems, and 
thus, healthcare outcomes (Hogan & Kissam, 2010).  The meaningful use statute seeks to 
provide a framework for the evaluation of whether entities like Electronic Health Records 
(EHRs) are used in a way that actually improves the quality of healthcare provision, and 
encourages this meaningful use by creating incentives for the widespread implementation 
of EHRs (Hogan & Kissam, 2010). This framework is useful to consider in order to 
understand what “meaningful use” might mean for similar emerging technologies meant to 
improve the provision of healthcare delivery, such as modelling methods.   
 
In order to dispense these incentives, the U.S. Department of Health and Human Services 
(HHS) set definitions of what constitutes “meaningful use” under these proposed 
regulations (Hogan & Kissam, 2010). In short, meaningful use seems to encompass two 
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concepts related to the utilisation of the given technology in such a way that a) the use of 
the technology is being executed up to standards of good practice and b) that the use of the 
technology is contributing to measurable benefit to the public health (Hogan & Kissam, 
2010).  The idea of regulating the use of an electronic tool used to manage data in a 
healthcare setting is not without its pitfalls and controversies, however.  Scientific 
researchers, policymakers, and other stakeholders may all have different standards by 
which to measure whether the adoption and use of EHRs (or any other technology in 
healthcare) is successful, and this lack of standardisation across organisations and 
disciplines can lead to challenges in tracking the progress of meaningful use (Hogan & 
Kissam, 2010).  
 
In light of that lack of standardisation, what exactly is meant by “meaningful use” in this 
context could encompass a wide range of indicators and targets, and, in order for providers 
to glean the incentives provisioned in the meaningful use statute, the bar for success was 
set rather high by the Federal government (Jha, 2010), and some would argue, rather 
arbitrarily.  The reasoning behind this challenging standard of excellence for the use of 
EHRs was in deference to data suggesting that the mere adoption of EHRs was an 
insufficient condition to improve health outcomes significantly, so policymakers involved 
in the development of the statute sought to ensure that the effective use of EHRs was based 
on scientific evidence supporting the benefits of various uses of EHRs to improve the 
quality of care (Jha, 2010).   
As with EHRs, modelling methods are a technological tool used in healthcare policy 
settings with a substantial amount of potential to improve the quality of healthcare 
decision-making, and thus, improve overall healthcare processes and outcomes.  Yet, 
systematic review of the literature reveals little effort to standardise or to establish best 
practices for the optimal use of modelling methods in healthcare and policymaking 
scenarios, let alone a movement that would incentivise researchers and policymakers 
working on healthcare issues to engage in said best practices.  Granted, the extent of 
diffusion of this or any other popular technology across diverse policymaking and research 
settings would make independent oversight prohibitive, if not impossible. So while the idea 
of “meaningful use” as applied to modelling practice should be considered with a fair 
amount of caution, the idea that there is a single concept that might encompass both ideas 
of best practices in use and positive impact of use has translatable possibilities.   
 
Despite the difficulties of measuring meaningful use, good scientific practice would dictate 
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that since modelling methods have the potential to become the predominate method by 
which we generate and evaluate evidence for the purposes of public health policymaking, 
there should be some identifiable effort to evaluate the use of modelling methods and 
subject them to the same type of impact assessment as similar organisational tools in the 
healthcare setting, like EHRs. Prior to this thesis, it does not appear as though that specific 
effort has been made. This is likely due in large part to the fact that most people would 
view modelling methods solely in their role as a tool in the scientific or research 
methodological literature, and in fact, that is where the bulk of the (limited) evaluative 
research on these methods falls.  However, this thesis presents significant evidence that 
strongly suggests that the optimal use of this method is highly context-dependent, and 
evaluative study of it should also be framed in the context of technological innovation in a 
policy setting. 
 
A notable perspective from the health organisational management literature suggests 
findings that harmonise with the findings in this thesis: that one of the most significant 
elements of successful implementation of technology in the health policy setting is that of 
human behaviour and interaction, specifically the importance of knowledgeable and 
resourceful leadership and staff involved in the use of the technology, and overall high 
levels of participant buy-in to whatever technology is being introduced into the system 
(Buntin, Burke, Hoaglin, & Blumenthal, 2011).  The parallels between the findings in this 
thesis and this perspective from organisational research continue in the call for further 
studies that document and outline the challenging aspects of implementing health 
information technology and also address solutions for these challenges more specifically 
(Buntin et al., 2011).  
 
While the findings in this body of work represent a partial beginning to this endeavour, 
much work on the relationship of policymakers and systems to the technologies used to 
support healthcare decisions remains to be done. Buntin and colleagues note (2011) that 
directions for this type of research can benefit from the perspectives of the continuous 
quality improvement literature, and that themes that would yield needed data include: 
implementation strategies training needed before implementation begins, support while use 
is ongoing, and the possibility of unforeseen consequences of technology adoption.  
 
Although these recommendations for exploration seem to speak to the needs of a 
contemporary healthcare system that seeks to improve the use of technology on the cutting 
edge, efforts to improve the function of the healthcare decision making and delivery 
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systems are far from new. Elwyn et al., (2012) explain that over that last fifty years, a wide 
array of approaches have been taken to improve the quality of healthcare provision, and 
that many of them, such as professional education redesign, improvements in peer review, 
and the implementation of total quality management tools have produced some desirable, if 
not long-lasting, results. However, Elwyn and colleagues continue that none of these 
studies have fully addressed the intractability of many persistent challenges in the 
healthcare system that block the best use of decision-making tools, and thus, the provision 
of optimal care. As argued throughout this thesis, this is likely at least partially due to the 
convergence of problems that arise when interdisciplinary approaches to managing 
evidence-driven healthcare decision-making are neglected.  
 
It remains important to note that this call toward increased process improvement or 
evaluation of methods being used in a policy setting is not uncomplicated. Evaluation itself 
is complex, and the outcome of an evaluation effort in policymaking settings would need 
to clearly communicate the underlying reasons why a particular technology or 
improvement protocol in the healthcare policy setting has or has not worked and would 
need to provide information for how any failures can be addressed (Parry, Carson-Stevens, 
Luff, McPherson, & Goldmann, 2013).   Process improvement initiatives are often as 
complex and interdisciplinary as the systems they aim to improve, and the generalisability 
of the results of these evaluations can be limited if the evaluation doesn’t consider both the 
independent qualities of the process it is examining as well as the context in which that 
process is occurring (Parry et al., 2013). To answer this, I argue for the adoption of 
formative, theory-driven evaluation. Parry et al. (2013) describe process improvement as 
iterative in nature, and highly variable depending on whether processes are at an emergent, 
innovative stage of development or are more widely disseminated. Again, this idea of 
context-dependence comes to the fore, and the outcomes of the evaluation of process 
improvement initiatives that seek to optimise the use of modelling methodologies in the 
policy environment would need to be highly dependent on which modelling environment 
or scenario was being examined. 
 
Creating these context-sensitive recommendations for the optimal use of modelling 
methods in policy-organisational settings also requires consideration of evidence use in 
these settings more generally, and how those issues of evidence-use in general might 
reflect on the use of modelling.  Although evidence-based policymaking shares an 
originating literature and body of research with evidence-based medicine, the randomised 
controlled trials and systematic reviews that evidence-based medicine mostly depends 
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upon to provide its justifications for action many not provide a sufficient evidence 
foundation for the  complexities of public health policy problems (Orton, Lloyd-Williams, 
Taylor-Robinson, O’Flaherty, & Capewell, 2011).   
 
If the challenges of evidence-based policy are viewed as an issue of process optimisation, 
then the processes of evidence-based policymaking can be said to involve a series of steps: 
problem delineation or definition, the development of possible options for resolution, 
followed by the implementation of the policy (Orton et al., 2011). The types, quality, and 
quantity of evidence required at each of these steps can vary greatly, and thus, the evidence 
used in public health policymaking must addresses not just the question whether 
intervention is effective, but also issues that are less readily available in the research 
evidence, such as organisation, implementation and feasibility (Orton et al., 2011). This 
process improvement perspective, and an understanding of the challenges that come with 
use of evidence to underpin policies or initiatives as organisational, and not just a scientific 
problem, could greatly improve the use of modelling methodologies in both research and 
policymaking settings.   
 
Now that a basic foundation has been established that provides a process-improvement and 
organisational development perspective on the use of evidence in policy, what follows in 
section 5.3 are general recommendations on the use of modelling for policy-relevant 
questions and in policymaking settings in a broad sense. Section 5.4 begins more specific 
recommendations for improved use of modelling methods on a chapter by chapter basis.  
The final subsection of the body of the thesis, 5.5, provides some suggestions for further 
research.   
5.3 General Recommendations on the Improved Use of Modelling Methods 
Currently, approaches to public health policies and programmes are largely based upon 
ecological models: perspectives that are the result of a convergence of ideas from various 
disciplines and fields of study including, but not necessarily limited to, those in sociology, 
biology, education, and psychology (Richard, Gauvin, & Raine, 2011).  Within the 
framework of this approach, the current expectation for public health policy initiatives is 
that they will account for increasingly complex individual and environmental  
characteristics and variables, such as socioeconomic status, gender, sexual orientation, and 
level of education, that might impact upon the success of a given policy or initiative 
(Richard et al., 2011). Likewise, epidemiology as a field has begun to recognize the 
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benefits of integrating these social and environmental factors into its traditionally more 
causal models (Richard et al., 2011). While this more inclusive approach to understanding 
public health problems is a sign of needed progress, psychosocial and ecological variables 
are themselves highly complex, and integrating them into modelling endeavours is not a 
straightforward process.  
 
Joshua Epstein (2009) touches upon foundational issues in taking a more ecological or 
systems approach to all types of computational modelling relevant to epidemiological or 
health policy questions. Epstein notes that human behaviour has a profound effect on 
everything from disease transmission and progression to the success of vaccination or other 
behavioural change policies and interventions, and modelling human behaviour is a more 
complicated undertaking than one of simple information fitting. Epstein (2009) describes 
people as “prone to error, bias, fear and other foibles”, and while that may be 
circumstantially true, it is only relevant in modelling endeavours in so far as that “fear and 
bias” can be incorporated in a model in a meaningful way by using data drawn from the 
literature documenting measurable behaviours with measurable impact. 
 
Epstein (2009) continues that the principal challenge for modelling is to represent such 
behavioural factors appropriately, and this body of research confirms this assertion. Funk, 
Salathé, & Jansen, (2010) note that predicting which actions people take to protect 
themselves during an epidemic is highly dependent on “temporal and societal context” and 
is likely difficult to parse and predict in the age of rapidly disseminating information and 
every-increasing connectedness. Funk et al., (2010) also point out that there are 
innovations in tracking human behaviours in real time using a variety of technological 
approaches, while noting that, despite these advances, that modelling exercises that seek to 
characterise or explore human behaviour on the transmission of infectious diseases were 
are often based on flimsy anecdotal evidence or the “common sense” of the modeller, often 
taking a game theory approach to rational behaviour in their models.  Funk and colleagues 
(2010) continue that modelling exercises are “almost never validated with quantifiable 
observations.”  
 
This lack of validation seems antithetical to Epstein’s (2009) call to appropriately inform 
models in order to get the most out of them, and Funk et al., (2010) note that there is a rich 
and substantive empirical literature that address the sociological, psychological and public 
health elements of human reactions to the presence of the disease, even if that knowledge 
is rarely applied to questions of how these elements affect disease dynamics in the context 
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of models. For instance, Davis, Stephenson, Lohm, Waller, & Flowers, (2015) offer recent 
evidence addressing how members of the general population might respond to 
communication about risk during a pandemic event by adopting personal protection 
protocols like social isolation and hygiene. The authors explain that some of the resistance 
to behaviour change we perceive from the public could potentially be the result of concrete 
barriers (be them psychological or physical) in implementing the recommended actions.  
 
Findings such as those in Davis et al., (2015) provide precisely the types of measurable 
human responses (and explanations for them) that inform the modelling exercises in 
Chapter 2, but too infrequently inform other modelling endeavours that seek to address the 
intersection of psycho-social and epidemiological issues. Because this area of modelling 
inquiry is likely to provide the type of information that policymakers exploring possible 
intervention recommendations and risk communication strategies would utilise, it’s of 
central importance to make sure similarly high-quality information about human behaviour 
is used to parameterise a model in a policymaking setting.   
 
Thus, a primary recommendation for improved modelling practice in policy-relevant 
scenarios is to discontinue modelling psycho-social constructs such as “fear”  that cannot 
be measured or quantified in any way meaningful to the public interest, and to instead 
include quantifiable data about measurable behaviour such as whether people act upon the 
information that’s relayed to them about protective actions and how effective the action is 
at preventing a given disease (Funk et al., 2010). Although human behaviour during a 
pandemic event can be exceptionally difficult to predict, a more systematic approach to the 
parameterisation of modelling exercises can lead to more sophisticated and useful outputs, 
and thus is strongly recommended.  
 
Yet, it is not just the appropriate parameterisation of a model that matters. Determining 
whether a model reflects reality sufficiently to be predictive in any sense is also a major 
challenge. While modelling methods may be used to both explore the dynamics of 
pathogen transmission during an epidemic event and to predict the impact of an 
intervention upon an epidemic, it is worth reiterating that the extent and quality of 
available data with which to do so can be variable, and that the ideal of  having timely, 
adequate data to integrate into the model isn’t always achievable (Grassly & Fraser, 2008). 
Beyond parameterisation, model choice and design also impacts upon how successful a 
modelling endeavour is. In order to maintain their usability, interpretability, and 
accessibility, models should be kept relatively simple, but not so much so that they cannot 
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reflect the complexities of the reality it is addressing (Grassly & Fraser, 2008) .   
 
However, striking this balance between accessible simplicity and generalizable 
sophistication requires a balanced, even expert, approach to model design and choice, and 
a systematic approach to the processes by which the complexities in the model are chosen 
and integrated (Grassly & Fraser, 2008). As discussed in previous chapters of this thesis, 
this kind of expertise constitutes a highly technical skill, and the scenarios in which 
modelling exercises are being increasingly used don’t necessarily ensure that an expert 
modeller is readily available. One modelling exercise to inform a public health policy 
could require, for instance, the input of a psychologist, a policy analyst, an epidemiologist, 
and an expert modeller in order to ensure that the model is not only built to the correct 
specifications of complexity or simplicity, but that the highest-quality psycho-social or 
epidemiological data is being chosen and interpreted into model parameters. It is thus a 
further recommendation that the design and choice of a model is considered as carefully as, 
and in conjunction with, the data that informs the model parameters.  
 
As discussed in section 5.2, the “human element” can be pivotal to the success or failure of 
methodological use in a policymaking setting.  The above recommendations all require that 
each member of the modelling team is able to meaningfully contribute to either model 
content or design, and ideally, that all members of the team are operating under 
experienced leadership and have a shared vision for the purpose, potential, and meaning of 
the modelling exercise.  And while it is understood that such an ideal team in a committee 
setting is likely unrealistic, it is important to note that the properties of the policymaking 
team can play as critical a role in the success of a modelling endeavour as any feature of 
the model itself. In light of this, it is a recommendation that modelling or model 
interpretation that happens in a committee, research group, or other group policymaking 
setting is performed by an appropriately qualified and interdisciplinary team.   
 
While the pitfalls of interactions between policymaking bodies and researchers include the 
coercion of research agendas to address policy questions, those issues are covered mire 
extensively in Chapter 4. Despite those possible complications of these relationships, there 
should be a move toward the deliberate creation of more interdisciplinary partnerships 
between modelling experts, policymakers, and researchers to specifically address these 
disciplinary intersections in the literature. These partnerships would ideally be continual 
exchanges, and not just circumstantial in nature. Established knowledge transfer 
relationships, or strategic alliances, are less likely to suffer from issues of undue influence 
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or persuasion, and previous familiarity has been demonstrated to facilitate meaningful 
collaboration on problem solving tasks (Inkpen & Tsang, 2005).   
In order to support the recommendation for these partnerships, it’s important to briefly 
consider the guidelines from the literature for fostering them. Collaborative, multi- and 
interdisciplinary relationships across fields can create competition between the aims of 
innovation and organizational knowledge transfer and the costs that arise from the effort of 
coordination and relationship development in these collaborations (Cummings, 2005). 
Costs can come in the form of developing new recruitment and retention initiatives to 
encourage and incentivise scientists to work on projects with policy implications and bear 
the operational weight of cross-organisational collaboration (Börner et al., 2010).  
 
The management of scope in these collaborations requires significant coordination effort 
on behalf of all involved parties in order to achieve the most effective outcomes (Börner et 
al., 2010). Scope considerations range from the inter-organizational to the intersectional, 
with issues of geographical scale and analytic capability potentially further complicating 
matters (Börner et al., 2010). As the interdisciplinary teams engaged in these types of 
boundary-crossing initiatives often need to consider multiple levels of analysis, ranging 
from the molecular and clinical to the psycho-societal and political levels of policy 
analysis, spanning these “often-divergent worldviews” of science or translation to practice 
can often require its own translational expertise (Börner et al., 2010).   
 
The ready availability of this expert translational opinion, access to systematic and critical 
literature review specific to purpose, and the lack of general resource support are additional 
concerns that can affect the use of modelling specifically, and evidence more generally, in 
a policymaking or research setting. This is particularly true of the use of modelling in 
governmental settings (such as we see in Chapter 4), and has been a common theme in the 
development of this research and the body of literature it reviews.  Declines in funding for 
salary and training support for researchers and scientific experts in government or public 
sector policy settings can make these types of careers undesirable and prohibit talented 
candidates from applying or participating in these interdisciplinary teams (Moses III & 
Dorsey, 2012).   
In the current austere environment, scientists and policymakers involved in the 
development of evidence-based policy often feel compelled to assume the responsibility of 
communicating the connection between public health and well-being and their 
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policymaking and research activities to funders (Moses III & Dorsey, 2012). There are 
additional expectations of policy stakeholders and scientists operating in a resource limited 
environment as they are asked to accomplish more with less resources.  For instance, many 
decisions about the best treatments and interventions must also be weighed against the 
cost-effectiveness or operational feasibility of the various policy options, a situation where 
clinical or scientific judgment about health could take a backseat to concerns like short-
term economic stability or logistics concerns (Moses III & Dorsey, 2012).  
As economic austerity is likely to continue unabated in settings where models are being 
used to support policy decisions, it is important to consider the possibility of alternative 
options for funding and research support (Moses III & Dorsey, 2012).  Public-private 
collaborations and partnerships with non-profits and public interest groups are possible, 
and perhaps in some circumstances such as basic biomedical research, even desirable, but 
they present the opportunity for conflicts of interest and undue influence that could serve to 
further complicate an already complex policymaking scenario (Moses III & Dorsey, 2012).   
 
Due to the possibility that a public-private funding interface can cause ethical conflicts, 
instead of immediately resorting to outside sources of funding, the recommendation here is 
increased attention to and explicit documentation of how the lack of resource support from 
the original funding body directly impacts upon the use of modelling methods or other 
forms of evidence in the policymaking process. This should be done with a view to 
redoubling lobbying efforts for ad hoc funding.  While it may be unreasonable to expect 
increased overall annual budgets for advisory committees from the government or national 
health services, it is much more realistic to assume that a committee could secure ad hoc 
funding from its governing body if it can submit a detailed, itemised proposal for costing 
out a modelling exercise (Prowle & Harradine, 2014).  However, providing and defending 
this itemisation depends on the committee or group understanding exactly what is entailed 
in executing a successful modelling endeavour, including cost. 
 
Thus far, this section has offered general recommendations on the appropriate approaches 
to integrating data from behavioural, observational, or experimental studies into the 
parameters of modelling exercises, the role of proper design of modelling exercises, the 
role of multidisciplinary teams in policymaking underpinned by modelling, and the 
provision of operational support for modelling endeavours.  The final general 
recommendation made here applies not to the modelling endeavour itself, but rather to the 
literature, or lack of it, surrounding the use of modelling methods in policy settings.  
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In order to successfully implement any of the above recommendations that might improve 
the use of modelling, a larger knowledge base addressing the aforementioned issues of 
parametrisation, model choice, and the operational needs of modelling exercises is 
necessary to guide policymakers and research teams so that they may begin to create best 
practice standards for modelling use. As of this writing, no unifying literature that 
describes challenges during implementation of modelling use in policymaking or provides 
guidelines or standards for use exists.  While this thesis is by no means comprehensive or 
exhaustive, it does seek to provide a starting point for more unified discussion around the 
development of standards of practice for modelling methods.  
 
The development of these standards is important because the expectations of performance 
for modelling methods are increasing in proportion to their growing popularity for 
approaching entrenched problems that exist in complex policy systems (Homer & Hirsch, 
2006). The expectation of modelling in this contemporary paradigm is that modelling 
methods will be able to functionally integrate the highly multivariate data that comes with 
the prevailing ecological approach to public health problems, which includes “disease 
outcomes, health and risk behaviours, environmental factors, and health-related resources 
and delivery systems” (Homer & Hirsch, 2006). While this “system dynamics” approach to 
modelling does indeed show promise as a means to create more encompassing models that 
are more accurately predictive, the growth of the modelling method is likely to be stymied 
by the challenges that this thesis describes if there is no concerted effort to address them.   
 
What follows in the next section is discussion that addresses the findings of each of the 
data-driven chapters in the context of the more general recommendations about optimising  
modelling use that appear above, but with more specific focus on the particular challenges 
that are identified in the findings particular to that chapter.  
5.4 Extended Chapter Conclusions and Recommendations for Improvement 
In this section, the specific issues that each study’s findings present are addressed, and 
recommendations to approach these issues are outlined.  While there is considerable 
overlap between these studies regarding some of the challenges that have already been 
identified in the section prior, there are many elements from the findings of each study that 
warrant individual consideration and a more targeted approach to the formulation of 
recommendations for improved practice.  Similarly, each individual study includes a 
conclusions and discussion section that serves to crystallise findings in a more traditional 
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manner, and those issues may also appear here. However, this section serves to draw out 
individual findings for the purpose of considering ways to address challenges more 
contextually than a traditional discussion section. This section begins with Chapter 2 and 
concludes with Chapter 4.  In the final section of the chapter, a few brief suggestions for 
future research directions are given.  
 
Chapter 2: Modelling Infectious Disease for Pandemic Planning: How do non-
pharmaceutical interventions and disease severity affect epidemiological dynamics? 
It is important to preface the extended discussion of this particular exercise by noting that 
it was not solely designed and executed to answer its primary research questions. Because 
the question of whether technical expertise in modelling methodologies is central to the 
success of a given modelling endeavour recurs multiple times in this thesis, it is important 
to disclose that I am not an expert modeller, and came to this research by way of more 
traditional public health training, grounded in an interdisciplinary social science 
background. Thus, there is a meta-evaluative aspect to the exercises in this chapter.  
 
As this thesis developed, it became obvious that I would personally grapple with many of 
the issues of technical expertise, modelling design, parameterisation, and generalisation of 
findings that I was researching and documenting. In light of that information, and in the 
spirit of lending qualitative depth to the experience of the development of this body of 
research, I begin this section by briefly describing the challenges and successes 
experienced in completing this particular study, and how I think those experiences fit into 
the context of the literature on modelling that appears in subsequent chapters of the thesis. 
I split this discussion between the following two paragraphs.  In the first, I describe the 
challenges faced as a non-expert modeller and how I sought to resolve them. In the second, 
I explain how I leveraged my previous experience and training in order to successfully use 
the model to generate data that addressed my policy-relevant research questions. After 
those two paragraphs, the discussion moves to the actual model findings and 
recommendations to address the issues those findings revealed.  
 
1) Challenges approaching the modelling process:  With no previous expertise or 
experience in computational epidemiological modelling, the most significant barrier I 
faced was the deficit in my technical modelling skillset.  This type of modelling requires an 
understanding of the structure and function of the ordinary differential equations that 
constitute the model itself, the ability to parameterise the terms in that model appropriately, 
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and the ability to translate that model into code in a given programming language to use a 
computational platform to solve the differential equations. I was able to find substantial 
amounts of information regarding the basics of executing these tasks in the robust online 
communities that have grown up around the various programming languages available, but 
was given guidance as to where to look, information other non-experts are unlikely to 
have. Supervised by an interdisciplinary team, some of whom did have expertise in 
modelling, I was able to learn the basic, necessary skills over time; a substantially longer 
time period than a policymaker would have to complete such a task. This was a situation 
that, while suitable for research supervision, would be less than ideal in the context of a 
policymaking setting.  I found that the challenges I encountered harmonised with those I 
drew from the literature.  
 
2) Advantages to approaching the modelling process as a non-expert: As mentioned above, 
one of the technical skills necessary to complete the modelling scenarios presented in 
Chapter 2 is the ability to appropriately choose parameter values for the modelling 
scenario. In order to focus the model on an epidemiological question of policy relevance it 
is necessary to know how to draw from an array of multidisciplinary literature in order to 
appropriately inform the model, this was a task for which training across multiple social 
science and public health disciplines was of assistance. Having an “outsider” perspective 
on modelling methods also advantaged the process of informing the model in that I was 
able to decide upon which aspects of disease transmission and behaviour change to focus 
without being unduly influenced by preconceptions of what an epidemiological model of 
this type would typically look like and how it would be parameterised. This observation 
was also reflected in the previously reviewed literature on the importance of 
interdisciplinary perspectives and ecological approaches to ensure good quality modelling. 
Now that the necessary subjective research processes relevant to this chapter have been 
noted, the next paragraph will begin our review of the findings and recommendations for 
approaches to address the challenges therein.  
 
The influenza pandemic that killed an estimated 20 to 40 million people in 1918 (N. Cox, 
2003) looms over much of the public health inquiry and practice that addresses influenza in 
the contemporary paradigm. This is not merely because it represents an historical artefact 
of note, but due to the possibility that a similarly destructive influenza pathogen could 
emerge in the immediate future and cause similarly substantial morbidity and mortality 
(Khanna, Kumar, Choudhary, Kumar, & Vijayan, 2008). It follows then that much of the 
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current research on influenza might be focused on the prevention of such an occurrence, 
either through improved surveillance or other control measures.  
However, because of the possibility that control measures will be insufficient, and a 
serious pandemic event will eventually ensue (Khanna et al., 2008), it is also important to 
focus on issues of pandemic planning in the case of such an event. Thus, the modelling 
exercises in Chapter 2 are aimed not only at understanding how traditional epidemiological 
factors like routes of transmission and clinical severity might impact the spread of disease 
and possible burden on healthcare delivery, but on how the measures taken during a 
pandemic might help, or fail, to mitigate the impact that said disease will have on a given 
population.   
With that in mind, the first notable finding worth further consideration from Chapter 2 
intersects with the issues of parameterisation and data availability outlined in previous 
sections.  The outcome of any modelling endeavour is obviously highly dependent on the 
data values used to parameterise it, and those values are most often to be found in the 
scientific peer-reviewed literature.  In Chapter 2, both the assumptions about transmission 
and clinical severity (model 1) and the assumptions about handwashing, its frequency in 
the general population, and its efficacy (model 2) are based on a review of the virological, 
clinical, and behavioural literatures, and drawn from a range of epidemiological, 
experimental, and observational studies.  
 
The idea that these parameters arose from a range of possible values within a larger body 
of literature is important: this means there is a possible range of outcomes depending on 
how those values are calculated. For instance, in our Chapter 2 modelling scenario, there is 
no one answer to how efficacious handwashing is in the prevention of onward transmission 
of influenza (Snyder, 2010b), but yet, the parameterisation of ϕ is not arbitrary. Although 
we don’t know exactly how big the effect of handwashing is (because there is no 
experimental literature that gives us this exact value), we know two things: that the value 
of handwashing is greater than 0 and less than 1 (Grayson et al., 2009), and that it is 
anchored to how many people are actually performing the task during a pandemic threat 
event (Jones & Salathé, 2009a). For instance, even if the efficacy of handwashing was 1, if 
only a few people are performing it regularly, its effect on onward transmission would be 
diminished. Conversely, if the actual value for handwashing efficacy is closer to zero, if 
the frequency of handwashing is high and it is a widely adopted behaviour, we may expect 
to see some cumulative effect on disease transmission dynamics. So, if we know from the 
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behavioural literature that handwashing is a relatively easy to adopt and popular activity 
amongst the public in response to infection risk, and we know handwashing has some 
effect, we can calculate a value for ϕ (the effectiveness of handwashing x the frequency of 
handwashing), even though we are lacking a precise value from experimental studies. 
 
This example is important because, even though there is often a robust literature on any 
given parameter of interest, even though systematic review may be performed, that 
literature will very rarely offer up a single, definitive value for use in the model (Fone et 
al., 2003). Therefore, the expectation amongst modelling teams should always be that there 
is likely to be a range of potential values that could be explored, and that subsequently, 
there will be a range of possible outcomes.  Understanding the relationships between 
values that may come from disparate literatures (for instance, in our example, the question 
of handwashing efficacy is drawn from the virological experimental literature, and the 
question of handwashing frequency comes from the behavioural and risk communication 
literature) is fundamentally important. Thus, a recommendation from Chapter 2 would be 
that any standard of practice would strongly urge transparency about the certainty of values 
and their origins when using models to underpin policy. Clarity about how those ranges are 
calculated, where they come from, how certain they are, and how the range of certainty 
might influence modelling outcomes is a matter of fostering public trust, and can also 
protect policymakers if the policy efforts underpinned by the modelling outcomes fail 
(O’Malley, Rainford, & Thompson, 2009).  
 
Further to these issues, modelling-policy teams working on the types of epidemiological 
and intervention questions like we see Chapter 2 need to be aware of the possibilities of 
unintended, and unexpected, outcomes.  Even when the parameters, or parameter 
estimates, being used in the model seem conservative or well-founded, and the range of 
outcomes are anticipated to fall into a known range of options, the modelling-policy team 
should be prepared for some results to be counter-intuitive.  For instance, from our Chapter 
2, model 2 handwashing example, we see that the same number of people overall get sick 
throughout the course of our epidemic, but slightly more are infected with severe disease 
than in the previous model. This outcome is obviously dependent on the interaction 
between all parameters, but the addition of a non-pharmaceutical intervention was not 
anticipated to result in overall higher rates of severe disease in our model.  
 
Yet, it follows that when parameter values are uncertain due to a lack of conclusive 
information or are chosen on an ad hoc basis, it cannot be said with certainty that the 
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interactions in the model are a strong approximation to the disease dynamics in the real 
world (Goeyvaerts et al., 2015). This is true in a general sense of all models, but it 
becomes a more urgent consideration with uncertain parameter values. In consideration of 
the high-stakes involved in designing a public health policy based on outcomes from 
modelling scenarios that include uncertain ranges of parameters, it is important that this 
aspect of these epidemiological modelling exercises is more fully explored. These 
unexpected outcomes, and questions of how closely models are even able to approximate 
real world phenomena, should both be further characterised in the literature and as a part of 
best practices guidance in any move toward standards of practice for modelling into inform 
public health policy.  It is additionally recommended that there be some effort to educate 
modelling-policy teams on the risks they are assuming in basing public policies or 
communications about risk on modelling exercises when those exercises are based on 
uncertain values. 
 
The final finding of note from Chapter 2 relates to the lack of impact found from 
handwashing behaviour. Clearly, it’s notable on its own that handwashing doesn’t 
significantly reduce mild disease in the expected quantity, and the increase of severe cases 
is also of note. But in the context of the literature surrounding behaviour change during 
pandemics, it becomes a particularly meaningful finding, and an important point of 
consideration when deliberating appropriate standards of practice for modelling in policy 
settings.  Hand-hygiene was selected as the behavioural proxy of choice in the model 
because it is so widely studied, and the one of the most recommended and adopted 
personal protective behaviour during outbreaks of influenza (Rubin et al., 2009; Updegraff, 
Emanuel, Gallagher, & Steinman, 2011).  
 
Concurrently, there has been a significant amount of time and resources spent on targeting 
risk communications so that people will continue to adopt behaviours like handwashing 
when they are recommended by public health entities (Reynolds & Quinn Crouse, 2008).  
But this relationship is confounded by the fact that there’s little concrete evidence to 
suggest that handwashing is optimally effective at preventing influenza transmission or 
infection, and in fact, there has been contention that handwashing has no meaningful 
efficacy against influenza at all (A. E. Aiello et al., 2010; Biran et al., 2009; Grayson et al., 
2009; Snyder, 2010b).  When we consider that the virological and epidemiological 
literature is inconclusive on handwashing efficacy, and our Chapter 2 findings suggest that 
hand hygiene may not have any substantive effect on outcome indictors anchored to 
pandemic planning, it is important to explore the question of allocating additional 
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resources on risk communication that promotes an as-of-yet unconfirmed method of 
personal protective health behaviour as the most effective.   
 
One answer is that the epidemiological community is overly invested in the research that 
suggests handwashing is a health behaviour that is easy to persuade the public to adopt and 
has few concrete barriers.  Its ease of use is an attractive feature in any intervention, and it 
appears reasonable to continue to aggressively promote a health behaviour that is known to 
have scientifically-established benefits for preventing infection and onward transmission 
with other serious pathogens (Edmonds et al., 2013).  An alternative explanation is that the 
individuals and institutions responsible for the promotion of hand hygiene are typically 
housed in policy settings, and may be unaware that the efficacy of hand-hygiene for the 
prevention of influenza is still scientifically questionable.  If this is the case, it is likely the 
natural result of scientific “siloing”, wherein individuals working on the same problem 
from different disciplinary perspectives are unaware of what developments are being made 
on the problem in a different discipline, and this is particularly true in a situation where 
information diffusion is happening across organisational types (Green, Ottoson, Garcia, & 
Robert, 2009).   
 
As suggested in the previous subsection of more general recommendations, proactive 
creation and maintenance of interdisciplinary teams focused on epidemiological modelling 
problems may help ameliorate this problem. But, more specific to the findings in Chapter 
2, a more robust understanding of the nature of scientific uncertainty and how it functions 
in modelling-based decision making is necessary amongst all stakeholders involved in the 
process of using models to answer policy-relevant epidemiological questions (Walker et 
al., 2003).  It is the final recommendation from Chapter 2 that issues of scientific 
uncertainty, and the ethics of risk communication and health communication in the context 
of scientific uncertainty, be at the fore of any standards of modelling use in the policy 
setting. 
 
Chapter 3: How does the use of contemporary modelling tools to produce public health 
policy influence the public’s projected health behaviour?  
 
Chapter 3 of this thesis presents evidence suggesting that the public confidence in 
modelling methods to underpin public policy, and to inform recommendations about their 
projected health behaviours, could be improved.  It also suggests that the public is most 
likely to respond more favourably to evidence generated by traditional experimental 
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methods, which, due to their high-resource demand and lack of suitability for some policy 
problems, are unlikely to be the predominate form of evidence that informs how we make 
recommendations to the public about their health behaviour. This chapter section presents 
an extended discussion of communication and educational strategies that could be 
employed to ensure that the public has increased knowledge of, and confidence in, the role 
of modelling methods in policy development and research. 
As previously stated at the end of Chapter 3, these public education and communication 
objectives could be achieved in a variety of ways, including, but not limited to, a change in 
science curricula and pedagogical approaches, increased attention to how policy 
recommendations that request behaviour change are communicated to the public when 
those recommendations are based off of model-generated evidence, (including protocols 
for strategic communication); and improved communication between the media and the 
scientific-policy community to ensure modelling methodology is accurately represented as 
a standard methodological tool that is accepted by the research and policy communities as 
an integral part of good scientific practice.  What follows is a discussion of all of these 
aforementioned strategies in the context of modelling.   
 
Since the findings in Chapter 3 echo the literature suggesting that the adoption of emerging 
research technologies and tools like modelling methods require public confidence in order 
to be successful, (Slovic, Flynn, & Kunreuther, 2013) the first strategy suggested here is 
aimed at addressing how models are discussed and described in formal and informal 
learning environments.  Gaining public confidence requires the public achieve a certain 
level of comfort, knowledge of, and familiarity with the proposed technology, concept, or 
method (Stocklmayer, Rennie, & Gilbert, 2010).   
 
Typically, the process of instilling that kind of familiarity and engendering comfort with an 
emerging scientific concept or technology would be undertaken by integrating the target 
information into the curriculum of a formal educational environment, like a school 
(Stocklmayer et al., 2010). However, more contemporary approaches also favour 
knowledge transfer about scientific concepts in informal settings outside of traditional 
schools, such as in work settings or casual conversational settings within the community 
context (Stocklmayer et al., 2010).  The assumption may be that the best place to approach 
the issue of educating the public about how modelling methods work is in a traditional 
school environment, but that might not necessarily be the case, as many young learners in 
particular can be highly critical of formal learning environments (Stocklmayer et al., 
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2010). A key strategy to ensure learners engage with the scientific concept you’re 
promoting across learning environments is to relate the new concept to something they 
perceive as currently relevant to their day-to-day life experiences (Stocklmayer et al., 
2010). 
 
With that strategy in mind, it would be advantageous to develop learning objectives about 
models by leveraging the public confidence in a concept with which they are already 
familiar and feel is relevant to their current health behaviours: scientific experiments.  The 
data in Chapter 3 suggests that the public is most confident in the data generated by 
scientific experiments and are most likely to project they will change their behaviour in the 
future if the evidence used to support that recommendation has been generated 
experimentally.   
 
So, demonstrating how modelling parameters in public health are informed by the types of 
data with which they already hold in high regard (experiments, observational studies, and 
epidemiological data, for instance), might create a useful cognitive inroad to creating more 
positivity in the public perception around the quality of evidence generated by modelling 
methodology. Current research on the psychological effects of familiarity suggest that it is 
possible to mitigate negative perceptions of modelling if it’s relatable to something already 
familiar: for instance, if models are introduced in learning environments as programs that 
process the kind of information the public is already comfortable with, modelling methods 
may benefit from a kind of “halo effect” surrounding the public perception of scientific 
certainty attached to experimentally-generated data  (Mariconda & Lurati, 2015). 
 
While the importance of transparency about the role of modelling when proposing policies 
has already been discussed in the extended discussion on Chapter 2, transparency and 
communication about modelling in the context of these Chapter 3 findings pivot not on 
political concerns, but on psychological ones. For instance, an increase in organisational 
behaviours that increase transparency, or even just give the appearance of increased 
transparency, engenders greater trust from the public in that organisation (Norman, Avolio, 
& Luthans, 2010).  It logically follows that increased transparency around the 
parameterisation of models, clarity on outcome uncertainty from models, and openness 
about the challenges of modelling use in policy settings have the potential to increase the 
public’s trust in a given organisation’s activities.  But beyond issues of trust, there is 
additional evidence to suggest that increased transparency can also increase the public 
perception of organisational and leadership effectiveness (Norman et al., 2010), a 
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perception that is not without benefits when seeking to glean public support for public 
policies underpinned by modelling exercises. 
 
All of the above strategies and approaches, save the discussion about organisational 
transparency, pivot on the idea of increasing public competencies surrounding scientific 
learning and modelling methods.  The following discussion aims to discuss strategies for 
building the communication capacity of organisations and entities that are responsible for 
addressing the public on the matter of policies or behaviour change recommendations that 
are underpinned by modelling methods. One recommended strategy to approach the 
communication of risk or policy information to the public in a way that may increase 
confidence in modelling is by enhancing the relevance the health information within the 
message by specifically targeting the message to a given audience, as evidence suggests 
that tailored messages appear to stimulate greater cognitive activity than do messages that 
are not tailored to the specific audience (Kreuter & Wray, 2003).   
 
It is important to note that, when considering new health communication strategies that 
could increase the public confidence in modelling, that deficits in public knowledge are 
rarely the fundamental driver of societal conflict over scientific or health information, and 
in fact, science literacy likely plays a rather limited role in informing public perceptions 
and decisions about scientific ideas (Nisbet & Scheufele, 2009). So, despite the importance 
of educating the public about models as a standard part of good scientific practice, 
resistance to behaviour change policies or risk communication may not be a result of 
ignorance about modelling methods or the underlying science, but rather a result of 
conflicting values or perception of authority (Nisbet & Scheufele, 2009). This is also 
partially borne out in the data generated in Chapter 3, as respondents reported having more 
confidence in the advice or opinions of scientific experts than in modelling methods.  The 
public bias toward expert opinion and deference to “personal expertise” is well-established 
in the literature (Brossard & Nisbet, 2006), and reflected in Chapter 3 findings, but how 
scientific literacy about modelling methods might mitigate these communicator effects is 
unclear.  
 
This demonstrates the importance of combining efforts at education about models with 
communication that is more persuasive than instructive, for optimal effect. Any standard of 
practice for the use of modelling methods should account for the need to design curricula 
for the public for use in both formal settings and more informal ones, such as science 
museums, and to design communication about modelling and modelling findings that is 
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persuasive and strategic, rather than messaging designed to fill some perceived 
“information deficit”. It would also be important to note that education about, and 
communication about, modelling methods should be treated mutually exclusively. 
 
The findings in Chapter 3 were aimed at characterising a phenomena that has been more 
extensively studied in other domains: it is well-known that the public perception of 
scientific information can play a role in health behaviour. However, this was the first 
known attempt to gauge how that relationship works in terms of scientific methodology 
specifically, and served as a proof-of-concept that confidence in scientific methods, and 
not just trust in scientists, might in some ways mediate public health behaviour in response 
to policy recommendations.  With that, it is also important to note that while this 
endeavour identifies a possible phenomenon, the sample size of these studies is 
geographically and size limited, which makes it prudent to exercise caution when 
generalizing the results and conclusions. 
 
One of the limitations of the study may be the brief nature of the qualitative inquiry.  Short 
answer mini-interviews as they appear in the Chapter 4 study may be sufficient to place 
respondents on a continuum of understanding when using a pre-existing framework or 
building upon one, but longer, more detailed interviews would allow this phenomena to be 
more completely characterised, and in fact, may help to provide the foundation for a 
scholarly literature that looks specifically at how the public’s confidence with scientific 
methods specifically moderates their behaviour or support for scientifically underpinned 
policies. It is strongly suggested that when exploring this topic, mixed methods continue to 
be used. Despite the small sample size and brevity of the qualitative interviews, the 
questionnaire responses and qualitative data in tandem strongly suggest a critical route of 
inquiry, and the methodological foundation for that inquiry should continue to reflect the 
complexity of the phenomenon. 
 
Finally, this chapter examines public understanding of science in the context of climate 
change and infectious disease policy and recommended behaviours for such. These policy 
scenarios were of interest for several reasons: the amount of political and research funding 
for both is currently quite impressive, and the coverage of both issues in the mass news 
media raises the salience of these issues in the policymaker and public consciousness. 
More specifically, these two scenarios were also selected because they both are fields 
where the use of modelling methods is rapidly increasing, and the use of more traditional 
methods of inquiry are being augmented or even replaced with new research technology. 
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They were also selected due to a juxtaposition: climate change research and reporting is 
often related in the news media and policy recommendation with “models, whereas this 
isn’t as frequently the case with reporting on infectious disease; and this despite the fact 
that modelling method are roughly as common in both fields of academic and 
policymaking inquiry. My desire as a researcher was to look at the perception of the 
methodology both in a context where it may be familiar to the public and where it may not. 
It is thus recommended that efforts to explore this phenomenon look at each domain of 
inquiry as a separate entity, and understand the public perception of modelling in one 
domain may not translate to the next.  
 
Chapter 4: The Evidence-Based Policy Agenda and Policymaker Relationship to Scientific 
Evidence  
 
Although the study in Chapter 4 is presented as the last data-driven chapter in this thesis, in 
many ways, it sits at the very centre of the issues this thesis seeks to address. Primary 
challenges to public health policymakers when using modelling methodology in high-
stakes, low-resource, time-sensitive contexts are often neglected or poorly understood by 
researchers. Yet challenges like these can play a central role in policies that can impact the 
well-being of entire populations of people, and as such, should be the cornerstone of any 
standard of practice for the use of modelling methods in such settings.   
 
The primary findings from Chapter 4 allowed us to identified four primary challenges for 
the use of modelling the policy setting: 1) time-pressure and operational resource limitation 
interfacing with the demands of systematic evaluation of evidence, 2) the conflict between 
scientific uncertainty and the need for transparency about that uncertainty with the public, 
3) the complexity of the bureaucratic system in which the evidence is being evaluated, and 
4) the lack of advanced expertise and confidence that policymakers have with the 
limitations and best practices of modelling use, particularly for the modelling that 
considers social or ethical impacts of policy decisions.  
 
These issues, and some possible strategies for resolving them, have been discussed in 
previous sections of this chapter.  Noting this, this section will address the seemingly 
intractable nature of these issues, contextualising this thesis as a whole by using the 
literature on complex adaptive and sociotechnical systems, and “wicked problems” in 
public administration, to more completely characterise the underlying reasons for the 
entrenchment of the identified challenges in the use of modelling methods. Further, 
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literature illustrating some of the strategies that can be employed to better understand 
evidence-informed policymaking as a complex system is introduced and discussed.  In the 
final subsection, some future directions for research conclude the thesis proper.  
 
Evidence-based policymaking can be identified as a socio-technical system, with the 
technical work processes of policymaking itself, and the social systems that constitute the 
working environment, interacting to create the overall system of interest (Westbrook et al., 
2007). The constituent parts of the social system may include employees, managers, and 
contractors and their behaviours, activities, skills, attitudes and beliefs; while the technical 
aspects of the system might encompass the tools, devices, materials, and techniques that 
are used to accomplish the tasks in which the work is performed (Westbrook et al., 2007). 
The overall performance of an organization can be said to be functioning optimally if both 
sides of these equation are working in a balanced fashion, although it should be noted that 
what constitutes optimal function or balance is likely to be subject to the perspective of the 
individual or entity making such a determination.   
Westbrook et al., (2007) state that sociotechnical organizational design theory is 
particularly relevant to the understanding of wicked problems in contemporary healthcare 
delivery systems. The authors continue that sociotechnical theory predicts that the 
introduction of a new tool (computational modelling methods, for instance) into a complex 
organization is “unlikely to bring immediate benefits without careful investigation of, and 
responses to, the impact on other technical and social subsystem elements” (Westbrook et 
al., 2007, pg.747). This is why, beyond generating data surrounding the use of modelling 
within this system, it is important to consider nature of the system itself when an attempt to 
develop standards of best practice for these tools is made. In short, the issues within the 
practice of modelling in policy settings cannot be addressed without understanding the 
problems of the policy setting itself. 
 
The primary functions of large governmental health organizations involve increased 
pressures for efficiency and improved performance in the design and implementation of 
policies and social services which are responsive to the needs of a great diversity of 
individuals and communities (Albury, 2010).  This is an exceptionally challenging charge, 
and a scenario which frequently gives rise to “wicked problems” that are characterised by 
their overly complex, intractable, and unpredictable nature, and their general resistance to 
solutions that might be applicable elsewhere (B. W. Head & Alford, 2013). Many of the 
challenges facing policymakers and researchers working to use modelling methods to 
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develop policy solutions, such as time pressure with limited resources, or the tension 
between scientific uncertainty and the need for transparency, could easily be defined by 
their “wickedness”. Likewise, some of the solutions proposed in this thesis to address them 
may be similarly stymied by these deeply entrenched problems elsewhere in the public 
administrative system. 
To understand the wicked problem space, it is important to conceptualise of public policy 
challenges as overlapping and interconnected subsets of problems that exist across policy 
domains, levels of government, and hierarchies, both within and between organizations and 
political jurisdictions (Weber & Khademian, 2008).  This is important to the modelling-
policy interface as the committees, planners, and interdisciplinary teams at this interface 
often sit at the intersections of these domains, jurisdictions, and organisations, with 
funding, staffing, and oversight split between them (Weber & Khademian, 2008).  This 
interdependency means that wicked problems are necessarily connected to other problems, 
which is why an issue like economic development or pharmaceutical manufacturing or 
import regulation could disrupt the use of modelling methods to address a problem like the 
introduction of a new vaccine to the immunisation schedule.  
 
However, as Head and Alford (2013) explain, there are degrees and dimensions of 
“wickedness,” and the problems that affect the policy-modelling interface may be more 
responsive to proposed solutions if those solutions are implemented with an understanding 
of the characteristics that make them singularly challenging. Head and Alford (2013) 
continue that targeted, partial, provisional solutions are more likely to produce results in 
this scenario than more holistic or encompassing proposals, as most of these wicked 
problems are relatively unique in comparison to other issues that arise in these settings. 
 
Wicked problems are often the result of chronic policy and organisational failures (Ferlie, 
Fitzgerald, McGivern, Dopson, & Bennett, 2011) which are aided and abetted by the very 
nature and structure of traditionally hierarchical government. Ferlie et al., (2011) describe 
increased “fragmentation” of governmental entities after major reform and austerity 
measures have “hollowed out” the state, and note that these types of environments provide 
the needed climate for the growth of wicked problems.  
 
There is some evidence to suggest that, in the UK, there is a shift toward models of a more 
“networked” style of governmental agency and organisation, (such as the National Health 
Service) and that these types of government organisations are more readily able to extend 
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their function beyond the scope of any one agency in order to initiate a cross-boundary, 
collective response to a given issue (Ferlie et al., 2011). Given the extent to which 
collaborative and interdisciplinary effort has been highlighted in the literature and in these 
findings as central to the success of modelling methods in policy settings, it would be 
prudent for anyone wishing to optimise this process to attend to the various ways in which 
cross-cutting organisational capacity and structure can contribute to entrenching or 
resolving a barrier to performance.  
 
Confronting and managing such deeply entrenched problems in a complex system requires 
the ability to draw upon a large knowledge base, and the understanding that the effective 
transfer, receipt, and integration of this knowledge will require consistent and ongoing 
effort in an environment where the teams of people managing the problem are likely to 
change long before the problem itself is resolved, even partially (Weber & Khademian, 
2008).  In fact, it is possible there are no complete solutions to these wicked problems, as 
they are the natural result of the interdependencies in the complex adaptive sociotechnical 
systems; but even if this is the case, it makes the argument for evidence-based, data-driven 
standards for practice for the use of tools like modelling methodology that much more 
important.  Wicked problems, like those that occur in the process of modelling and the 
policymaking contexts in which modelling happens, do not have “right” or “wrong” 
solutions, but rather the possible outcomes of management efforts exist on a continuum of 
“good” and “bad” (Wexler, 2009), and the level of success of those outcomes is dependent 
whose perspective is being considered.   
 
Modelling methods present the whole of human society with a powerful tool with which to 
generate meaningful evidence for action, and an exciting innovation with which to evaluate 
policy options for some of our most urgent and burdensome social and public health 
problems.  But the use of such a high-impact methodology should be supported by the 
most robust guidelines possible and the highest standards of practice to achieve the best 
possible outcomes for the human populations those policies affect.  While it is unlikely that 
there are overarching solutions for modelling problems specifically, and the wicked 
problems of policy more generally, this thesis makes a significant contribution to the data 
needed to address the dimensions of modelling practice that could make a difference in 
how policy is created and implemented.  What follows in the final section are some 
suggestions for further research that will assist policymakers, researchers, and other 
involved stakeholders make the most of modelling methods. 
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5.5 Future Directions for Research and Practice 
Each chapter of this thesis addresses different aspects of modelling use for policymaking 
and public planning.  Covered here are topics ranging from the actual use and 
parameterisation of modelling methods in a pandemic planning scenario, to understanding 
the public perception of modelling methods and public willingness to undertake behaviour-
change recommendations that come from modelling exercises, concluding with an in-depth 
qualitative exploration of the challenges and uses of these models in a real-world 
policymaking setting.   
 
This data was generated in the hope of addressing deficits in the existing literature that 
prohibit a more complete understanding of how to improve the quality of modelling use in 
decision-making, and thus, the outcomes of policies.  The scope of such an undertaking 
prevents exhaustive or comprehensive coverage of all research in the multiple fields and 
disciplines of interest, but in the course of conducting this research, several areas were 
identified where knowledge gaps in the literature prohibited more complete answers from 
being constructed.  
 
In the epidemiological, virological, and clinical literature, there is a notable lack of 
literature on the efficacy of handwashing protocols for the prevention of respiratory 
diseases, especially influenza.  This may be because there has been a perceptual 
extrapolation of efficacy to influenza from studies using gastrointestinal pathogens that 
confirm handwashing prevents infection and transmission in those scenarios. It may also 
be because there is mounting pressure to recommend interventions that are easy to 
persuade people to do and that have a low-cost imprint on government prevention and 
planning budgets. Whatever the reason, the literature on handwashing efficacy for 
respiratory pathogens, so critical to informing a high-quality model on epidemic or 
pandemic control outcomes, is lacking, conflicted, and contradictory.   
 
This gap is more than an inconvenient deficit, however.  It points to a troubling trend 
where practitioners in policy settings continue to communicate risk mitigation and health 
behaviour recommendations that have a limited basis in actual science. It demonstrates that 
there’s a communication and knowledge exchange gap between the recommending 
policymakers and the scientists.  Both areas need more robust findings in order for 
modelling exercises that would require parameterisation with these values to achieve 




There was no existing literature that directly addressed how the public perception of a 
particular scientific methodology might influence their confidence in the public health 
recommendations made on the basis of that method.  In an age where science and health 
communication, scientific literacy, and public engagement are central to both inquiry and 
practice, it is highly advisable that all possible intersections of human perception, 
behaviour, and information dissemination that are pertinent to the development of policy 
recommendation are explored.   
 
Further research directions in this area would include studies that explored individual 
reasoning for the effects we see in Chapter 3, such as contributing data to answer the 
question of why experimental methods and the opinions of experts are most likely to 
persuade people to behaviour change.  Another recommendation would be to focus efforts 
on research in this area that is prescriptive rather than descriptive, in order to help guide 
both education and communication efforts in the future.  While there is an existing 
literature that addresses communication effects and theories of health behaviour change, 
the role of the public’s methodology perception in these areas is unclear. There is also 
room for more unification in the literature surrounding the construction of persuasive 
health communication that would be useful to policymakers and governmental 
organisations in designing successful health promotion campaigns and public-facing policy 
communications.  
 
Data surrounding policymaking confidence in the outcomes of modelling exercises should 
be generated.  The final design and implementation of a given public health or social 
policy could be profoundly affected by tension or confusion within a group using 
modelling to generate or evaluate evidence, and in-depth characterisation of this 
phenomena would be very useful for policy and public administration professionals who 
oversee and staff these committees, departments, and teams working on these issues. While 
the positive impact of interdisciplinarity on modelling team productivity and quality has 
been established here and in previous studies, what facets of interdisciplinarity, and indeed, 
which disciplines and skillsets, are most useful on these teams is poorly understood.  
Studies that could generate some evidence that would help guide the creation of teams that 
are most likely to be successful in modelling endeavours could be very useful to both 
researchers and administrators. 
 
Finally, modelling methods are a prominent tool in sociotechnical systems, and there is an 
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abundance of literature that employ them to answer a vast array of policy-relevant 
questions.  Yet, few comprehensive efforts have been made, until now, to understand how 
these models are being used in policy practice, and how their use resonates outside of the 
peer-reviewed literature. Brief discussions about the perils of model parameterisation, 
model design, and understanding uncertainty exist, but too little attention has been paid to 
modelling in context, models as the primary tool by which policies are underpinned, and 
modelling as it exists in the public perception. These gaps are not a matter of intellectual 
curiosity, but of good public health practice.  The confluence of the evidence presented in 
this thesis and the existing literature strongly suggest that modelling methods matter: how 
we use them, who uses them, where they are used, and how we are communicating their 
outcomes all play a role in whether the policies supported by them are successful, and the 
populations those polices address are healthy.  Continued pursuit of robust knowledge in 



















From Chapter 3 
Qualitative Analysis Coding Scheme 
Qualitative Analysis Categories, Category Descriptions, and Examples of Respondent 
Quotes 
Category name Description Illustrative examples from mini-interviews 
Dimension 1 - 
WHAT 
MODELS ARE 
What models represent  
Simplification Models that represent a 
simplified or 
uncomplicated version of 
something 




Models that represent 
something, without 
specification.  
Something to represent something, like, an object to 
represent it...? 
Theory Models that represent 
abstract theory or 
structures (or are theory) 
I think they mean … theoretical structures of … real 
life events.  
Duplications of 
reality 
Models that are 
duplications of the real 
world or copies of reality.  
To me, it would be computer models, going through 
climate changes, or full representation of the full 
global market of what’s going on. 
Standard case Models that represent the 
‘standard case’ 
 Like the standard model and ... a template for 




Models that represent an 
idealised or ‘perfect’ cases 
(to be aimed for) 
Models? Erm … a perfect … example of something that 
you would want to aspire to, you know, with climates 
or anything I suppose. 
 
Mock-ups Models as mock-ups or 
prototypes (e.g. that 
represent something that 
will be built in the future) 
I think they mean, like, they do a model before they do 
the real thing, first. 
Non-Scientific / 
Vague 
Answers that seem non-
scientific or vague 
(laughs) Erm, what kind of scientists? 
Erm, I have no idea … 
Probably talking about … health of people ... I don’t 
know, I really don’t know.     




Uses of models and what 





Models used to simplify 
complex phenomena in 
order to understand them 
better. 
 
Yes, so something that you can make in either 
miniature or recreate in a science laboratory that can 
echo a real life event … yes. So you can make a model 
of a tornado by doing some clever … in a tunnel … you 
know, with controlled environmental pressure, and then 
that will be looking at what’s happening in the real 
world with real atmosphere. 
 
Exploration Models used to look into 
the future to see how 
things might affect our 
lives in the future, 
extrapolation of current 
trends into the future. 
Um, I take it they use it to look at things like strategies 
for the future or to identify areas that perhaps you need 
to have government intervention laws in place for 






(NB: Our definition is looser than that of Odenbaugh 
for whom this category referred specifically to the use 
of models to explore unknown possibilities in the form 
of ‘what-if’ questions or scenarios whereby the interest 
is in how models can be used to explore what might 






Models used to test 
scenarios that might arise 
(either naturally or as the 
result of regulatory 
control) and see how these 
would impact the world or 
society. 
Um, I think it’s ... they kind of put together scenarios ... 
that represent reality and then try and sort of imagine 
how things might develop. 
 
(NB: In Odenbaugh, this category refers to the use of 
models for the tightening up of ideas and concepts 
through making assumptions fully explicit through the 
modelling process, as well as the development of new 





Models used to predict Models? Erm, about, kind of making predictions, taking 
what we know already and trying to see if that trend 
will continue and the future. 
Models are ways of them trying to understand and 
analyse the environment, or world, for the purpose of 
making predictions about weather climate changes, and 
such. 
 
Alright, okay, um, models of course, they can help you 
to predict what might be going on in the future and 
what we should do at the moment to help us establish a 





This refers, in Odenbaugh, 
to the communicational 
role of models. In other 
words, this category does 
not relate to the value of 
models in trying to 
explain the mechanisms 
underpinning a 
phenomenon, but rather to 
the role of models in 
explaining those 
mechanisms and 
structures to others. 
Again, something ... used to like, explain something, 
say, some kind of study, they used a model to explain 
the study.  
I would imagine a model of something that they use if 
you like to explain something. 
Non-
Scientific/Vague 
Answers that seem non-
scientific or vague 
Em ... they put on the stuff that the one that they make, 
that they do, will have all of those things on it. 
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Questionnaire – From Chapter 3 
 
1) Background information (please enter age and circle those that apply) 
Age:  Highest level of involvement in science: School – High School – Undergraduate – 
Postgraduate – Professional research scientist 
Gender: Male – 
Female  
Attendance at public science events: More than twice in last year – 1-2 times over last 
year – Previously, but not for a while – Never  
 
2) The questions below relate to methods used in science and how confident we can be about 
the findings. Take time to read each statement and tick the one box per line that best describes 



























































































In your opinion, what level of confidence can we have in scientific predictions or 
recommendations based primarily on the following sources of information, assuming 
that any research is carried out properly? 
Experience: The accumulated life experience of experts (e.g. 
doctors and nurses or climate experts) 
     
Experiments: Scientific experiments      
Mathematical models: Models that use mathematical equations      
Computer models: Computer models or simulations      
Historic studies: Studies using historic data       
Current data: Studies using recent data       
The questions below relate to levels of confidence required in science used by 
politicians to make policy. 
In general, how confident should scientists be about their 
predictions before the government uses them to make 
recommendations that affect their lifestyle to the public? 
     
Specifically in relation to flu, how confident should we be about 
scientific predictions that an outbreak will spread worldwide 
before making recommendations to the public that affect their 
lifestyle? 
     
Specifically in relation to climate change, how confident should 
we be about scientific predictions about climate change before 
making recommendations to the public that affect their lifestyle? 
0     
 
































Models are an important part of good science about infectious disease      
Models are an important part of good science about climate change      
The government should use predictive models when planning for flu 
pandemics. 
     
The government should use predictive models to plan for climate 
change. 
     






















































a) The findings below relate to swine flu. In your opinion, how are they supported? 
The predictions relating to the worldwide 
spread of swine flu  
       
How swine flu is passed from one person to 
another 
       
The link between individual behaviour and 
swine flu spread 
       
b) The recommendations below were provided by the government during the swine 
flu pandemic in 2009. How do you think they were supported? 
Washing hands with soap & hot water or 
using hand sanitizer gel often 
       
Using clean tissues to cover nose & mouth 
when coughing or sneezing 
       
Staying at home if you feel ill and think you 
might have swine flu 
       
Setting up a network of “flu friends” (e.g. to 
collect medicines) 
       
c) Considering the same recommendations, now respond to the following: 
I would believe that the recommendations 
would be effective in protecting me if these 
were based on: 
       
I would believe that the recommendations 
would be effective in avoiding a worldwide 
pandemic if these were based on: 
       
d) I would do the following things if I thought the evidence for these was based on 
… (categories above): 
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Washing hands with soap & hot water or 
using hand sanitizer gel often 
       
Using clean tissues to cover nose & mouth 
when coughing or sneezing 
       
Staying at home if you feel ill and think you 
might have swine flu 
       
Setting up a network of “flu friends” (e.g. to 
collect medicines) 
       
 
 






















































a) The findings below relate to climate change. In your opinion, how are they supported? 
Predictions relating to future world climate        
The relationship between greenhouse gases and climate 
change 
       
The link between individual energy consumption and 
climate change 
       
b) The recommendations below have been provided by the Government on ways to combat 
climate change. How do you think they are supported? 
Turning down your heating by one degree        
Buying energy saving products (home appliances or light 
bulbs) 
       
Choosing fuel-saving cars        
Driving less        
Flying less and offsetting carbon emissions        
Wasting less food        
Buying “climate friendly” foods        
c) Considering the same recommendations, now respond to the following: 
I would believe that the recommendations would be 
effective in reducing my impact on climate change if these 
were based on: 
       
I would believe the recommendations would be effective in 
reducing society’s impact on climate change if they were 
based on: 
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d) I would do the following things if I thought the evidence for them was based on … 
(categories above): 
Turning down my heating by one degree        
Buying energy saving products (home appliances or light 
bulbs) 
60       
Choosing a fuel-saving car        
Driving less (only answer if you have access to a car)        
Flying less and offsetting carbon emissions        
Wasting less food        
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